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Abstract
Medication management in older people: the MEMORABLE
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Ian D Maidmento ,1* Sally Lawsono ,1 Geoff Wongo ,2 Andrew Bootho ,3
Anne Watsono ,4 Jane McKeowno ,5 Hadar Zamano ,6 Judy Mullano 7
and Sylvia Bailey8
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3School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK
4Medicines Management Department, West Heath Hospital, Birmingham Community Healthcare
NHS Trust, West Heath, UK
5Sheffield Health and Social Care NHS Foundation Trust, Sheffield, UK
6Bradford School of Pharmacy, School of Life Sciences, University of Bradford, Bradford, UK
7Australian Health Services Research Institute (AHSRI), University of Wollongong, Wollongong, NSW,
Australia
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Birmingham, UK
*Corresponding author i.maidment@aston.ac.uk
Background: The number and proportion of older people in the UK are increasing, as are multimorbidity
(potentially reducing quality of life) and polypharmacy (increasing the risk of adverse drug events).
Together, these complex factors are challenging for older people, informal carers, and health and
care practitioners.
Objectives: MEMORABLE (MEdication Management in Older people: Realist Approaches Based on
Literature and Evaluation) aimed to understand how medication management works and propose
improvements.
Design: A realist approach informed three work packages, combining a realist review of secondary
data with a realist evaluation of primary interview data, in a theory-driven, causal analysis.
Setting: The setting was in the community.
Participants: Older people, informal carers, and health and care practitioners.
Interventions: Studies relating to medication management and to reviewing and reconciling
medications; and realist-informed interviews.
Main outcome measures: Not applicable.
Data sources: MEDLINE, CINAHL (Cumulative Index of Nursing and Allied Health Literature) and
EMBASE were searched (all searched from January 2009 to July 2017; searched on 1 August 2017).
Supplementary articles were identified by the Research Team. Data were also obtained through interviews.
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Review methods: Searches of electronic databases were supplemented by citation-tracking for
explanatory contributions, as well as accessing topic-relevant grey literature. Following RAMESES
(Realist And Meta-narrative Evidence Syntheses: Evolving Standards) guidelines, articles were screened
and iteratively analysed with interview data, to generate theory-informed (normalisation process
theory) explanations.
Results: Developing a framework to explain medication management as a complex intervention across five
stages: identifying problem (Stage 1), starting, changing or stopping medications (Stage 3) and continuing to
take medications (Stage 4), where older people, sometimes with informal carers, make individual decisions
and follow routines that fit medication management into their day-to-day lives, engendering a sense of
control. In getting diagnosis and/or medications (Stage 2) and reviewing/reconciling medications (Stage 5),
older people and practitioners share decision-making in time-limited contacts: involving four steps – sense-
making, relationships, action and reflection/monitoring (normalisation process theory); and conceptualising
burden – through a detailed analysis of Stage 5, generating a theoretical framework and identifying five
burden types amendable to mitigation: ambiguity, concealment, unfamiliarity, fragmentation and exclusion.
Proposing interventions: risk identification – a simple way of identifying older people and informal carers
who are not coping, at risk and who need appropriate help and support; and individualised information –
a short, personalised record and reference point, co-produced and shared by older people, informal carers
and practitioners that addresses the experience of living with multimorbidities and polypharmacy.
Limitations: Few studies directly address the complexity of medication management as a process and
how it works. Limitations included, having identified the overall complexity, the need to focus the
analysis on reviewing/reconciling medications (Stage 5), the exclusion of non-English-language
literature, the focus on non-institutionalised populations and the broad definition of older people.
Conclusions: MEMORABLE explored the complexity of medication management. It highlighted the way
interpersonal stages in the medication management process, notably reviewing/reconciling medications,
contribute to the mitigation of burdens that are often hidden.
Future work: Co-produced studies to scope and trial the two proposed interventions; studies to extend
the detailed understanding of medication management, linked to burden mitigation; and a study to
clarify the medication management outcomes wanted by older people, informal carers and practitioners.
Study registration: This study is registered as PROSPERO CRD42016043506.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Services
and Delivery Research programme and will be published in full in Health Services and Delivery Research;
Vol. 8, No. 26. See the NIHR Journals Library website for further project information.
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Glossary
Adverse drug event An unintended harm from taking medication.
Burden People’s experience of the workload associated with an intervention and how it is balanced,
or not, with their capacity to undertake that work, for example taking medication as prescribed, and
remembering the instructions (e.g. which medication and how many tablets to be taken when and
how), and making this part of day-to-day routines. (This is linked to Capacity and Workload.)
Capacity The resources a person can draw on, for example physical, cognitive, affective, to undertake
a task or series of tasks. (This is linked to Workload as part of Burden and Coping.) Note that this is not
capacity under the Mental Health Act.
Carer See Formal carer and Informal carer.
Context The circumstances or influences that activate or inhibit the responses of those involved in an
intervention. The responses are part of the mechanism. (This is linked to Mechanism and Outcome.)
Context–mechanism–outcome configurations The association of causal components that explain what
works in an intervention (see Intervention below) for who, why and in which circumstances.
Coping The experience of managing burden, its workload and capacity requirements, within people’s
day-to-day lives.
Formal carer A trained and managed practitioner who is paid to provide care support, including
support with medication management.
Implementation The ‘purposive and directed’ work by which a process, practice, programme or project
is brought about. (May C, Finch T. Implementing, embedding, and integrating practices: an outline of
normalization process theory. Sociology 2009;43:535–54.
Informal carer Typically a family member who provides support with medication management as part
of their informal care role. May also include neighbours and friends.
Intervention A process, practice, programme or project that provides resources to which participants
respond. In MEdication Management in Older people: Realist Approaches Based on Literature and
Evaluation (MEMORABLE), the interventions are medication management (overall) and reviewing/
reconciling medication (as a specific stage in medication management).
Mechanism The responses of those involved in an intervention to the resources or opportunities
offered by that intervention. Responses may include thoughts, feelings or actions. They are activated
or inhibited by circumstances or contexts that then have an effect. (This is linked to Context and
Outcome.)
Medication adherence ‘The extent to which the patient’s action matches the agreed recommendations’
[National Institute for Health and Care Excellence (NICE). Medicines Adherence: Involving Patients in
Decisions about Prescribed Medicines and Supporting Adherence. Clinical Guideline 76. London: NICE; 2009;
© NICE 2009. Medicines Adherence: Involving Patients in Decisions about Prescribed Medicines and Supporting
Adherence. Available from www.nice.org.uk/guidance/cg76. All rights reserved. Subject to Notice of rights.
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to
regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its
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content in this product/publication] and informed by their involvement in and agreement with decisions
about their treatment.
Medication management (see also Stages of medication management) In MEMORABLE, what older
people do to deal with medication and make it part of their day-to-day lives, with or without the support
of informal carers. In addition, what practitioners do as part of a complex process of care to support
older people with the treatment of their co-morbidities and maintain their health and well-being.
Medication optimisation ‘A person-centred approach to safe and effective medicines use, to ensure
people obtain the best possible outcomes from their medicines’ (NICE. Medicines Optimisation: the Safe
and Effective Use of Medicines to Enable the Best Possible Outcomes. NICE Guideline 5. 2015; © NICE
2009. Medicines Optimisation: the Safe and Effective Use of Medicines to Enable the Best Possible Outcomes.
Available from www.nice.org.uk/guidance/ng5. All rights reserved. Subject to Notice of rights. NICE
guidance is prepared for the National Health Service in England. All NICE guidance is subject to
regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its
content in this product/publication). Optimisation involves shared decision-making by engaging with
evidence-based medicine as well as individual needs, preferences and values.
Medication reconciliation At a care transition, ‘identifying an accurate list of a person’s current
medicines and comparing them with the current list in use, recognising any discrepancies, and
documenting any changes, thereby resulting in a complete list of medicines, accurately communicated’
(NICE. Medicines Optimisation: the Safe and Effective Use of Medicines to Enable the Best Possible Outcomes.
NICE Guideline 5. 2015; © NICE 2009. Medicines Optimisation: the Safe and Effective Use of Medicines to
Enable the Best Possible Outcomes. Available from www.nice.org.uk/guidance/ng5. All rights reserved.
Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England.
All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no
responsibility for the use of its content in this product/publication).
Medication review ‘A structured, critical examination of a person’s medicines with the objective of
reaching an agreement with the person about treatment, optimising the impact of medicines, minimising
the number of medication-related problems and reducing waste’ (NICE. Medicines Optimisation: the
Safe and Effective Use of Medicines to Enable the Best Possible Outcomes. NICE Guideline 5. 2015; © NICE
2009. Medicines Optimisation: the Safe and Effective Use of Medicines to Enable the Best Possible Outcomes.
Available from www.nice.org.uk/guidance/ng5. All rights reserved. Subject to Notice of rights. NICE
guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular
review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in
this product/publication).
Multimorbidity Two or more long-term conditions occurring together.
National Institute for Health Research The research arm of the NHS, funded by the Department of
Health and Social Care, which aims to improve the health and wealth of the nation through research.
Normalisation process theory A substantive theory that explains how changes are introduced and
made routine by those involved.
Older people In MEMORABLE, people aged > 60 years who are living at home.
Outcome The pattern of results, effects or impacts generated by contexts and mechanisms acting
together. These may occur in the short or longer term, and be expected or unexpected (e.g. an improved
coping experience, an enhanced relationship with general practitioner or pharmacist). (This is linked to
Context andMechanism.)
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Output An intervention product (e.g. a prescription, the report of a medication review).
Patient and public involvement The engagement of service users as active partners and advisors in
the research process.
Polypharmacy In MEMORABLE, scoped as taking five or more medications or, if less, having a
complex regimen. Note that polypharmacy may be appropriate or inappropriate.
Practitioner A trained employee in the health or care sector providing services to an older person.
They may or may not be professionally registered to practice.
Programme theory A theory about how an intervention is intended to work, often written as if–then
statements. In MEMORABLE, programme theories were ‘candidate’ at the start of the research and
‘final’ when they had been revised through the synthesis of the literature review with the evaluation of
narrative data.
Stages of medication management In MEMORABLE, the five stages by which medication management
can be understood: Stage 1 – identifying a problem; Stage 2 – getting diagnosis and/or medications;
Stage 3 – starting, changing or stopping medications; Stage 4 – continuing to take medications; and
Stage 5 – reviewing/reconciling medications. Some stages involve the older person on their own,
sometimes with support from an informal carer; some involve the older person, again on occasion with
informal carer support, and a practitioner.
Workload The tasks or series of tasks associated with an activity. (This is linked to Capacity as part of
Burden and Coping.)
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List of abbreviations
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GP general practitioner
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NICE National Institute for Health
and Care Excellence
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Research
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Plain English summary
Why we did this study
Older people are taking more tablets. Medication can be difficult to manage. Not everyone takes their
tablets as recommended, putting them at risk and leading to waste. Helping with medication can be a
big responsibility for family or friends. There are time and money pressures on practitioners.
Medication management is an increasingly important issue.
What we have done
The MEdication Management in Older people: Realist Approaches Based on Literature and Evaluation
(MEMORABLE) study looked at what has been written about medication management. We listened
to older people and family carers about the way they manage their medication. Doctors, nurses,
pharmacists and paid carers have told us about their experiences. Everyone has made suggestions
about what would make medication management better and easier.
What we found out
We now understand that medication management has different stages, such as starting new tablets
or going to reviews with a doctor, nurse or pharmacist. What is done in each stage should help fit
medication into older people’s lives. Shared decisions about routines and goals help older people feel
in control and cope.
When older people find medication a burden, they may not tell anyone. We suggest that health and
care staff need a simple way, such as a couple of questions, to find out who is not coping and needs
more help, advice or support.
We also understand that older people and family carers get a lot of information from health and
care staff. Information may not seem relevant when it is only about one of their health problems or
medications. It may be difficult to remember. We suggest that older people should have their own
information, about them and all their illnesses and medications, put together in a way that they can
use and share with others if they want to. This individualised information would help them to manage
their medication as part of their day-to-day lives.
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Scientific summary
Background
The number and proportion of older people in the UK population are rapidly increasing. Many older
people live with more than one long-term health condition. Living with multimorbidity can significantly
reduce an older person’s quality of life. Older people also spend increasing amounts of their time
engaging with a range of separate health and care services.
Older people are taking increasing numbers of medications to treat multimorbidity. Medication-related
adverse events, across all age groups, have been estimated to be responsible for 5700 deaths and cost
the UK £750M annually. The burdens and risks from medication use fall disproportionately on older
people. There are also burdens and risks for informal carers, and health and care practitioners.
Overall, there are immediate, significant, growing and complex challenges from multimorbidity,
polypharmacy and medication management for older people, informal carers, and health and care
practitioners and services, making it an increasingly important personal, health and care issue.
Aim and objectives
The MEdication Management in Older people: Realist Approaches Based on Literature and Evaluation
(MEMORABLE) study seeks to understand how medication management works and to propose
interventions that would contribute to improvements.
Aim
To use realist synthesis including primary data collection to develop a framework for a novel
multidisciplinary, multiagency intervention(s) to improve medication management in older people who
are on complex medication regimens and resident in the community.
Objectives
The aim for MEMORABLE was underpinned by three linked objectives. The second and third objectives
were closely related. Objective 2 focused on the key principles and underlying mechanisms, whereas
objective 3 focused on developing an applied intervention:
1. to understand how and why any potentially relevant interventions to optimise medication
management work (or do not work) for particular groups of older people in certain circumstances
2. to synthesise the findings from objective 1 into a realist programme theory of an intervention(s) to
support older people who are living in the community to manage their medication
3. to use realist programme theory developed from objective 2 to inform the development of an
intervention(s) to assist older people who are living in the community to manage their medication.
Methods
With a robust research structure involving a Project Group, Stakeholder Group and Research Team, with
patient and public involvement, MEMORABLE aimed to establish a causal understanding of medication
management using a realist approach: what works, for whom, why and in which circumstances.
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The MEMORABLE study was informed by Realist And Meta-narrative Evidence Syntheses: Evolving
Standards (RAMESES) guidelines and contained three work packages: work package 1 – realist synthesis of
the literature (understanding contexts and mechanisms); work package 2 – realist evaluation of experiential
narratives (exploring mechanisms); and work package 3 – developing a framework for intervention(s)
and dissemination.
Work package 1 involved a systematic search and review of the literature, using realist approaches.
A total of 1018 articles were identified. Abstracts were screened and 140 full-text articles were
selected for review based on their descriptions of medication management. From these, 24 articles
were finally reviewed because of their explanatory focus, based on key terms such as ‘concept’ or
‘framework’. This work package generated the evidence base that supported the understanding of
medication management as a five-stage process, accommodating multiple perspectives, with reviewing/
reconciling medications as a key stage within it.
Work package 2 involved 50 interviews in total: older people (n = 13), informal carers (n = 16) and
health and care practitioners (n = 21). This package provided rich, causal accounts of the way medication
management was experienced in people’s day-to-day lives.
Work package 3 involved the synthesis of evidence and experiential data from work packages 1 and 2 to
explore medication management as a complex intervention, as an implementation process and through
the experience of burden. Causal explanations of medication management and reviewing/reconciling
medications were generated through context–mechanism–outcome configurations and applying
normalisation process theory. Finally, subsets of context–mechanism–outcome configurations were used
to explain reviewing/reconciling as a key stage and to generate two proposed interventions to improve
medication management: risk identification and individualised information.
Results
Using the methods summarised above, MEMORABLE produced the following findings.
Medication management as good practice
As background, MEMORABLE scoped medication management, reviewing medications and reconciling
medications as good practice, drawing on policy and guidelines. This scoping described tasks associated
with good practice but lacked a causal explanation of how these tasks might work to have an impact.
MEMORABLE went on to address this explanatory gap.
Medication management as a complex intervention
The MEMORABLE study set out medication management as a complex intervention that occurs as
a five-stage process: Stage 1: identifying problem; Stage 2: getting diagnosis and/or medications;
Stage 3: starting, changing or stopping medications; Stage 4: continuing to take medications; and
Stage 5: reviewing/reconciling medications.
These five stages fall into two broad groups based on who is doing what within them:
l First, by the individual work done by older people when they are making decisions and acting on
their own or with an informal carer (Stages 1, 3 and 4). In these stages, older people and informal
carers, when they are involved, develop routines to effectively manage and feel in control of their
medication on a day-to-day basis.
l Second, by the interpersonal work older people do with practitioners, with or without an informal
carer (Stages 2 and 5). These stages are associated with shared decision-making. Importantly, the
work done in these stages informs older people’s and informal carers’ decisions and actions at home.
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All five stages are linked horizontally as a process, but have loops from one stage to another: two
medication loops, one diagnostic loop and several disruption loops. An example of a medication loop is
when an older person needs to make adjustments in Stage 3 following changes to their medication in a
Stage 5 review, such as starting some new tablets while stopping others; a diagnostic loop arises from
a review where new symptoms are noted and the older person is referred back to their GP (Stage 2).
Older people experience disruption loops when there is a change or uncertainty that requires a
decision or action (Stage 1).
Medication management as implementation
Informed by normalisation process theory, the medication management process was interpreted
through the cycles of work conducted in each stage and across stages: sense-making, relationships,
action and reflection/monitoring. This interpretation captures the vertical processes in each stage as
well as contributing to understanding how work evolves over time, such as the way sense-making or
relationships develop as medication is managed as older people’s long-term conditions progress.
Medication management as burden
In response to themes emerging from the data, MEMORABLE conceptualised ‘burden’ as a potential
mechanism of interest in medication management to inform further analysis, considering it in detail for
Stage 5: reviewing/reconciling medications.
Stage 5: reviewing/reconciling medications and burden
Using this key interpersonal stage as an exemplar, five burdens were identified. These burdens were
then linked to the appropriate normalisation process theory step in that stage of the medication
management process to demonstrate where and how burden might be mitigated through different
types of work carried out by those involved:
l The ambiguity burden about reviewing/reconciling medications within medication management.
This involves sense-making by clarifying the purpose and content of medication reviews
and reconciliations.
l The concealment burden due to a lack of information-giving. This prevents older people and
informal carers from understanding, personalising and using what they want or need to know.
This is also about sense-making and establishing meaning through information to increase personal
efficacy, agency and control.
l The unfamiliarity burden arising from not seeing the same practitioner consistently. This is about
establishing continuity and mutual trust in relationships as the foundations for interpersonal work.
l The fragmentation burden limits the way older people and informal carers are understood and their
needs addressed as a whole when they are seen across a range of services. This is about the
importance of inter- and intra-agency collaboration in strategic and operational networks.
l The exclusion burden when older people and informal carers are not recognised for their experience
and expertise, nor fully or effectively engaged in decisions that affect their health and care. This is
about action and enacting collaboration through shared decision-making.
Proposed interventions: risk identification, individualised information
Findings from MEMORABLE include two proposed interventions to improve medication management:
l Risk identification – a simple way of identifying older people and informal carers who are not
coping, are at risk and need appropriate help and support through a more detailed follow-up,
such as being fast-tracked to a medication review (Stage 5).
l Individualised information – a short, personalised record and reference point, in an accessible
format, co-produced and shared by older people, informal carers and practitioners. Rather than
focusing on generic advice about a single diagnosis or treatment, information needs to be
individualised to enable older people and informal carers to manage the impact of their own
multimorbidities and polypharmacy in their day-to-day lives.
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Conclusions
Using this realist approach, MEMORABLE set out the way medication management was understood as
being good practice, as a complex intervention, as implementation and as burden.
Within the medication management process, reviewing/reconciling medications was scoped as good
practice. More in-depth analysis of this stage enabled dimensions of burden to be better understood,
identifying five types: ambiguity, concealment, unfamiliarity, fragmentation and exclusion. This focus
highlighted the way reviewing/reconciling medications might contribute to burden mitigation in the
way that older people, informal carers and practitioners relate, make sense and carry out actions
within this stage, and other linked stages.
Recommendations for future research from MEMORABLE include studies to develop and trial the
proposed interventions of risk identification and individualised information; studies to extend the
understanding of medication management as a complex intervention and as implementation, linked
to burden mitigation; and a study to clarify the outcomes that older people, informal carers and
practitioners want from medication management.
Study registration
This study is registered as PROSPERO CRD42016043506.
Funding
This project was funded by the National Institute for Health Research (NIHR) Health Services and
Delivery Research programme and will be published in full in Health Services and Delivery Research;
Vol. 8, No. 26. See the NIHR Journals Library website for further project information.
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Chapter 1 Background
I didn’t take all [these medications] at once. It’s gradually built up. You wonder where it’s all going to end.
OP29 – older person
I just feel overwhelmed sometimes about making that decision. It just feels too much sometimes.
C32 – informal carer
You’ve attempted to address your responsibility as a clinician with a responsibility of a budget. And you
know, the population side of it. But you’ve also done what you think is best for the individual in front of
you. That’s the challenge.
P53 – general practitioner
Overview
The number and proportion of older people in the UK population is increasing.1,2 In terms of their
health, many older people are living with more than one long-term condition.1,3,4 There are challenges
in living with multimorbidity, such as reduced quality of life and increasing amounts of time spent
engaging with health and care services.5–9
Older people are taking increasing numbers of medications to treat multimorbidity.10 There are
burdens11–15 and risks8,16 from medication taking and medication management that fall disproportionately
on older people. Medication-related adverse events include both medication errors and side effects.17–20
These events have been estimated to be responsible for 5700 deaths and cost the UK £750M annually.21
More recently, definitely avoidable adverse drug reactions have been estimated to cost the NHS £98.5M
every year and have contributed to 1708 deaths.22
Burdens and risks also have an impact on informal carers1,2,23–26 and practitioners involved in supporting
older people’s health and care.3,4,6,8,27–29
These circumstances raise significant challenges for older people, informal carers, and health and care
practitioners and services.
In light of these challenges, the MEdication Management in Older people: Realist Approaches Based on
Literature and Evaluation (MEMORABLE) study seeks to understand how medication management
works and to propose interventions that will contribute to making improvements.30,31
Older people
In the UK in 2010, more than 10 million people were aged > 65 years.32 According to the Office for
National Statistics:2
The UK population is ageing – around 18.2% of the UK population were aged 65 years or over at
mid-2017, compared with 15.9% in 2007; this is projected to grow to 20.7% by 2027.
Reproduced from the Office for National Statistics.2 Contains public sector information
licensed under the Open Government Licence v3.0
In 2017, one in five people in the UK population was over the age of 65 years and this is expected to
increase to one in four by 2037. Longevity is linked to lifestyle improvements as well as advances in
technology and health care.2
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Older people’s health: multimorbidity
As they age, some older people are living with multimorbidities that affect their lives. These are
conditions that cannot be cured but can be managed with medication and other treatments.3 In 2011,
just over half of those aged > 65 years resident in the community reported having long-term
conditions affecting what they do, day to day.1 Many older people aged ≥ 75 years are living with two
or more long-term conditions.4
There are challenges for older people who are living with multimorbidity and for their families,
practitioners and services. These challenges arise from a reduction in quality of life, increasing
difficulties with day-to-day activities and more time spent engaging with and being supported by the
health and care system.5–8
These challenges are exacerbated when they are also associated with increasing cognitive impairment
or a diagnosis of dementia.19,33–36
Medication taking among older people: polypharmacy
As a result of more people living with multimorbidity, older people’s medication use including
prescribed and over-the-counter treatments has ‘increased dramatically’ over the last 20 years:10
The number of [older] people taking five or more items quadrupled from 12 to 49%, while the proportion
of people who did not take any medication has decreased from around 1 in 5 to 1 in 13.
Gao et al.10
There can be clinical indications for polypharmacy such as in diabetes mellitus or hypertension for
example, or among older people with multimorbidity.3,37 However, there are also risks, including
adverse drug reactions involving side effects and drug interactions6 as well as side effects associated
and unique to each different medication.17–19 For a health service that developed around curing acute,
single conditions and treatments, multimorbidity and polypharmacy are emerging as areas of concern,
with implications for policy and practice.27,29,38–44
Burdens and risks
Older people experience burden as a result of their experience of ageing, multimorbidity and
polypharmacy.11–15,42 Polypharmacy, intended to assist with the management of symptoms and conditions,
also has risks associated with it, such as drug–drug and drug–disease interactions, inappropriate
prescribing, risks of non-adherence to complex drug regimens and medication errors.7,16–19 Patients should
be protected from avoidable harm.45 Nonetheless, harms continue,20,46,47 leading to significant costs.21
Informal carers and practitioners
Informally, many older people rely on family carers to manage their medications.48 The number of
informal carers is growing and the demands on them are increasing, according to the Office for
National Statistics’ report in 2013:1
In 2011, 14 per cent (1.3 million) of the household population aged 65 and over provided unpaid care
(this includes: looking after a partner, older parent, or adult child); this included 6.9 per cent who provided
1-19 hours unpaid care a week, 1.8 per cent who provided 20-49 hours of unpaid care a week, and 5.6
per cent who provided 50 hours or more unpaid care a week.
Reproduced from the Office for National Statistics.1 Contains public sector information
licensed under the Open Government Licence v3.0
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Formally, within health and care, a range of practitioners provide services to support older people
along complex care pathways.4,6,8 They too face a number of challenges; for example, the evidence base
for practitioners can be based on evidence for a single diagnosis41 and services can appear fragmented
and communication between them difficult.3,5,6,9,28
The MEMORABLE study
The MEMORABLE study has been designed and carried out in response to the background outlined
above. It uses realist methodology49–51 to understand how, why, for whom and in what circumstances
medication management works. With that understanding, MEMORABLE then proposes interventions
that will contribute to improvements. To achieve these purposes, its aims and objectives are set out
below (taken from the protocol for this study).30
Aim
To use realist synthesis including primary data collection to develop a framework for a novel
multidisciplinary, multiagency intervention(s) to improve medication management in older people who
have complex medication regimens and are resident in the community.
Objectives
Underpinning the overall aim were three linked objectives. The second and third objectives, in
particular, were closely related. Objective 2 was focused on the key principles and underlying
mechanisms, whereas objective 3 was more focused on developing an applied intervention based on
the findings from earlier objectives:
1. to understand how and why any potentially relevant interventions to optimise medication
management work (or do not work) for particular groups of older people in certain circumstances
2. to synthesise the findings from objective 1 into a realist programme theory of an intervention(s) to
support older people living in the community to manage their medication
3. to use realist programme theory developed from objective 2 to inform the development of an
intervention(s) to assist older people living in the community to manage their medication.
Chapter 2 sets out the methods by which this research has been carried out, from which the findings
are reported in Chapter 3.
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Chapter 2 Methods
This chapter sets out the way MEMORABLE was carried out. It describes the research groups thatcontributed to MEMORABLE, provides an overview of the realist research methodology and sets
out the work packages and steps followed in this realist research process. Additional MEMORABLE
documents are available at www2.aston.ac.uk/lhs/research/memorable (accessed March 2020), including
information on those involved in the project and recording how it progressed (e.g. minutes, newsletters).
Research groups/patient and public involvement
The MEMORABLE study was supported by a number of working groups that provided its governance,
management and delivery structure. These are listed below in the order in which they were established,
along with details of their membership, activities, outputs and contributions to the study as a whole.
These groups enhanced the capacity of the staff employed on MEMORABLE, Dr Ian Maidment (the
Chief Investigator) and Dr Sally Lawson (the Research Associate) and enriched the range of experience
and expertise available from the start to the end of the study.
Co-applicant Group
This was an informal group of five individuals who were invited by the chief investigator to collaborate
on the development of the initial research proposal. Support and advice about the need for the research
also came from a patient and public involvement (PPI) event in November 2015 run by Dr Maidment and
the research’s PPI lead, Mrs S Bailey. The event involved eight older people and their informal carers.
The Co-applicant Group brought together topic, practice, research, information and public participation
interests in medication management. Members collaborated on the development and submission of the
MEMORABLE proposal to the National Institute for Health Research (NIHR). They generated the initial
Protocol31 and MEMORABLE’s first published paper: Developing a framework for a novel multi-disciplinary,
multi-agency intervention(s), to improve medication management in community-dwelling older people on
complex medication regimens (MEMORABLE) – a realist synthesis.30 The Co-applicant Group evolved into
the Project Group.
Project Group
With an established membership of nine, this group was the monthly reference point for work on
MEMORABLE, responsible for overseeing the project and disseminating the research. Members
provided expertise in medication management, medicine, nursing, pharmacy, research and information
methodology, and PPI. This group was key to maintaining momentum in the research and assuring
delivery of the protocol.
Stakeholder Group
This group had a more fluid membership than the Project Group, including experts by experience,
practitioners, managers and researchers. It had an independent lead from within the Project Group,
who co-chaired it with the Chief Investigator. It met on five occasions to review key outputs from the
research. Each meeting lasted for about 1.5 hours. Meetings were scheduled to fit with the evolution of
the research and the need to gain diverse input from multiple perspectives. The group provided advice
and feedback to the Project Group on the veracity of the emerging evidence, programme theories and
proposed interventions, as well as the dissemination strategy. It had an important role in making sure
that recommendations from the research were appropriate, practicable and likely to make a difference
for older people, informal carers and practitioners.
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Research Team
This small team of five included the chief investigator and the research associate. It was one of the
key sources of topic, practice, research and information expertise for MEMORABLE. It met five times
to consider discussion papers prepared by the research associate. Meetings were usually face to face
and lasted for half a day, with follow-up contact by telephone and e-mail, if needed. It was the forum to
engage in extended discussion and debate, and to resolve topic and research issues. The team significantly
augmented the expertise available to the chief investigator and research associate, and provided detailed
support to and scrutiny of the research, its content and outputs.
Patient and public involvement
While this study was being carried out, the Project Group regularly checked what was being done.
The group had a PPI lead who was a co-applicant for the study and who contributed to all meetings,
and is a co-author of this report. The PPI lead also provided advice on the way MEMORABLE was
engaging with older people and informal carers, including advice on the types and the content of
information, as well as facilitating links with potential participants in the research. In addition, the
Stakeholder Group provided advice on findings and recommendations as these emerged from the
study. This group had several older people and informal carers on it, along with people working in
health, care and research. Both groups contributed to the dissemination strategy for MEMORABLE.
The researchers valued and benefited from people’s expert, experiential input to the many discussions
and debates. However, they also acknowledge the difficulties of ensuring that there is PPI ‘representation’
and the need to consider the workload (volume and time scale) that such a complex study can create for a
single PPI lead.
Realist methodology
This section sets out some of the principles of realist methodology49,51–54 with a short account of the
way that they were applied in MEMORABLE. Work packages and steps in the research process has the
more detailed account of how these principles were followed in practice.
Realist approach
This theory-driven approach helps explain the way complex interventions work in real-world situations.
It supports the identification of what works, for whom, why and in which circumstances: the methodology’s
four ‘W’s.49–53,55,56 Thus, it enables researchers to address complexity53 by unpacking the context-sensitive
mechanisms that are the generative causal processes found within an intervention.49,51,57 Realist approaches
are interested in the behaviours of those involved, from individuals to groups and organisations; the
influential factors that bring about, prevent or modify those behaviours; and the outcomes that result,
intended and unintended. One of the purposes of this approach is ‘to improve the thinking that goes
into service building’. (Reproduced from Pawson et al.50 This is an Open Access article distributed in
accordance with the terms of the Creative Commons Attribution (CC BY 3.0) license, which permits others
to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is
properly cited. See: http://creativecommons.org/licenses/by/3.0/.)
As medication management can be understood as a complex intervention,58,59 the characteristics
and purpose of realist methodology are particularly well aligned to meeting MEMORABLE’s aims
and objectives.
Realist review and realist evaluation
Realist methodology has two arms. The first, realist review, explores data from secondary sources
such as published studies and reports60 and the second, realist evaluation, engages with primary data.61
MEMORABLE was set up as a realist synthesis, combining realist review with realist evaluation.
METHODS
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In this approach, knowledge from the literature was analysed with the first-hand experiences of those
engaged in medication management, augmenting the potential contribution of both data sets to
theorising about how this complex intervention works.
Theory in realist methodology
Two levels of theory are associated with the realist approach: programme theory and substantive theory.
Programme theory is generated within a study to explain what the intervention has been set up to
do and how that intervention might work.51,60 Initial or candidate programme theories developed at
the start of a realist research project are then confirmed, refined or refuted through iterations of
data synthesis.50,51,53 Finalised, evidence-based programme theories can inform the development of
recommendations or specific proposals. These might involve modifying an existing intervention, or
perhaps suggesting a new intervention to try to achieve the outcomes that matter, typically by
addressing contextual influences.
In addition to the iterative way programme theories evolve, they have another characteristic which
is that they are finally formulated at a ‘middle-range’ level of abstraction.51 This means that the
programme theory is specified in a way that permits empirical testing. Both realist reviews and
realist evaluations aim to produce middle-range realist programme theories. Being realist in nature
contributes to the transferability of theories to other settings in which that same intervention may be
delivered, or even to other interventions. This transferability is based on the assumption that in other
settings or interventions the same mechanisms may be in operation. This is the way that realist
methodology contributes to the accumulation of knowledge.55,62 Candidate or initial programme
theories for MEMORABLE were drafted at the beginning of the research: see Step 4: Candidate
programme theories and substantive theory. Final programme theory for a key stage in medication
management is contained in Figure 5.
Underpinning the analytical work on programme theories are the context–mechanism–outcome (CMO)
configurations.51,53,56 Generated from the data, they have explanatory potential in their configured
format. It is, therefore, important that they are set out and reported in their entirety rather than
disaggregated into lists of single components.63 CMO configurations contain:
l Contexts – influential factors that activate people’s responses, enabling or inhibiting their decisions
and actions. In MEMORABLE, contexts can include older people’s diagnoses or medication, the
interpersonal relationships they have with health and care practitioners as well as system factors
such as access to services or information.
l Mechanisms – the vital but often hidden operational ‘cogs’ that turn in response to the influence of
contexts. Mechanisms can include the way people feel, think or act in relation to the resources in an
intervention. They are activated by, and sensitive to, contexts. It is the interaction between contexts
and mechanisms that leads to outcomes.51,52,57 In MEMORABLE, mechanisms included older people’s,
practitioners’ and informal carers’ diverse responses to what was happening in medication
management such as confidence, control, experience and expertise, and mutual trust.
l Outcomes – the pattern of impacts and effects resulting from the way that contexts and
mechanisms interact. In MEMORABLE, these included older people’s and informal carers’ coping
experiences, achieving appropriate or inappropriate treatment, following adherent or non-adherent
behaviours, quality of life as well as health and care relationships and resource use.
The CMO configurations are generated from, and stay close to, the data and are used to explain
causation and therefore why certain outcomes happen under certain contexts within the scope of a
programme theory.
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Substantive theory is pre-existing, higher-level theory about how phenomena are supposed to work,
perhaps domain-specific such as theories of behaviour, learning or change.64 Identifying and applying
substantive theory brings a particular lens to the research, helping with the development of initial
programme theories, supporting data analysis and providing analogy. In MEMORABLE, normalisation
process theory (NPT)65,66 was chosen as the relevant substantive theory. See Chapter 3, Medication
management as implementation, for details of NPT and its application in the research.
Having provided an overview of the research methodology, the next section sets out a more detailed
account of the way the methodology was followed in the work packages and the steps by which
MEMORABLE was delivered.
Work packages and steps in the research process
This section begins by describing the work packages that were initially set out in the protocol.31 It then
continues with an account of the iterative and flexible way that they were followed in practice,
responding to the data and emergent concepts generated within the research.
Work packages
The protocol31 identifies three work packages to be carried out within MEMORABLE, following on from
Project Start Up led by the Co-applicant Group, described in Co-applicant Group above. These packages
conform with a realist research process,49,51,55 based on the recommended phases for this type of study:50
defining the scope of the review, searching for and appraising the evidence, extracting and synthesising
findings, and drawing conclusions and making recommendations. The protocol details each package
as follows:
l Work package 1: realist synthesis (understanding context and mechanism) – this package focuses
on the realist review and involves developing the search strategy; selecting and screening
articles for their relevance/rigour; analysing data; and developing the candidate or initial
programme theories.
l Work package 2: realist evaluation (exploring mechanism) – this package is about gathering and
analysing experiential, narrative data through realist-informed interviews (29 older people and
informal carers, and 21 practitioners from health and care, including formal carers).
l Work package 3: developing framework for intervention(s) and dissemination – this final package
involves refining the programme theories; undertaking any additional interviews or searching as
required; identifying key mechanisms and related contexts; identifying and developing intervention
strategies needed to change contexts and trigger mechanisms; presenting the intervention
framework for feedback and further refinement; and dissemination.
Steps associated with work packages in the research process
The MEMORABLE study progressed through seven sequential and partly iterative steps (Figure 1).
This figure highlights the non-linear way that the research advanced, with overlaps and iterations,
particularly around steps 3, 4 and 5. Such overlaps and iterations are expected in researching a
complex intervention such as medication management.58,59,68
Describing this figure, below, steps are grouped by work packages (work package 1: realist synthesis –
steps 1–4; work package 2: realist evaluation – step 5; work packages 1 and 2: iterations – steps 3a
and b, 4a and 5a and b; and work package 3: developing framework for interventions and
dissemination – steps 6–7). The results from this process are presented in Chapter 3.
METHODS
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Work package 1: realist synthesis (understanding context and mechanism)
Step 1: scope of the research
Medication management was scoped during Project Start Up through two strands of work. First,
the Co-applicant Group drafted the MEMORABLE protocol,31 setting out the background to the
research, highlighting:
l increases in the number of older people and comorbidity in the population1,2
l safety concerns and consequences of susceptibility to poor medication management in terms of
harm and hospital admission20,21,27,28
l older people’s experiences of complex care pathways8,28,69
l the pivotal role of informal carers and formal carers24,70
l National Institute for Health and Care Excellence (NICE) guidance identifying the need for a
collaborative approach to supporting older people with long-term conditions in managing
their medication.71
Second, just prior to the start of research, a formative Project Group held a day’s facilitated workshop
to share knowledge on the principles and practice of realist methodology and to discuss the
practicalities of applying them to MEMORABLE. This enabled the group to establish ownership of the
planned research and build the team. It also mapped out a simple, tentative medication management
process, drawing on the experience and expertise of those present. This mapping process began to
theorise about the dynamics and complexity of the intervention and informed subsequent work on the
stages of medication management. Although this early informal theorising does not follow the formal
progression of the research process set out in Figure 1, it was nonetheless a valuable early contribution
Work package 1
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FIGURE 1 Research process summary: work packages and steps. Reproduced with permission from Maidment et al.67
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to scoping how medication management might work that was gradually refined as data were
accumulated; a candidate programme theory in all but name (see Table 5).
Step 2: initial literature search and review
This step involved searching for and reviewing abstracts to broaden the understanding of medication
management within MEMORABLE’s aim and objectives. Within a realist review, the aim of the search
and synthesis noted by Pawson53 is to identify a body of literature to support ‘explanation building . . .
to articulate underlying programme theories’ so that these can be interrogated using the evidence.
In MEMORABLE, evidence would be enriched by combining data from the literature and interviews.
Accordingly, the literature search was not intended to maximise the number and range of articles on
medication management but to be more purposeful in identifying articles with rich data that would
best support the generation and exploration of programme theories about what works, for whom, why
and in which circumstances. This followed Pawson’s guidance on abstracting policy and theory building,
described in detail by Booth et al.55
The Research Team, which included a qualified information professional, conducted a pilot search
to sensitise the team to the literature and to help in determining the scope of the protocol and
subsequent review.52 Details of this pilot search are given in Appendix 1. Once this initial set of
literature had been reviewed closely, categorised and coded, the team finalised a search strategy for
the initial literature search that would contribute to the review itself.
The initial literature search used terms set out in Table 1, accessing MEDLINE (724 references),
CINAHL (Cumulative Index of Nursing and Allied Health Literature) (152 references) and EMBASE
(139 references). It included published articles from 1 January 2009 to 31 July 2018. The initial cut-off
was chosen because 2009 was the year in which NICE published its clinical guideline on medication
adherence.72 The Research Team had anticipated that systematic reviews published from 2009
onwards would access earlier studies, sufficient to cover the scope of the MEMORABLE realist review.
A total of 1018 abstracts were identified, reducing to 974 once duplicates, for example, were removed
(Figure 2).73 Abstracts were then reviewed for inclusion, referral or exclusion by the Research Associate
using agreed criteria: population (≥ 60 years, living at home in the community), setting (UK, relevant
high-income country), condition (multimorbidity) and interest (medication management). A 10% sample
was also reviewed by two members of the Research Team to ensure consistency. A total of 140 articles
were agreed for full-text review. The review was piloted by mapping abstracted data using a logic model
format74 to identify descriptive accounts of medication management. This contributed to a better
understanding of medication management, amplifying and updating the background information
in the protocol.
TABLE 1 The MEMORABLE study’s search concepts
Topic Search terms
Medication management Medication adherence – polypharmacy – medication management – medicines
optimisation – concordance – compliance – adherence – regimen
Health services misuse/inappropriate prescribing – drug prescriptions/practice patterns –
physicians/inappropriate prescribing – drug utilisation/medication errors – de-prescribing
Older people Age/aged
Long-term conditions Chronic disease
Other limitations English language
Reproduced with permission from Maidment et al.67 This is an Open Access article distributed in accordance with the
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and
build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.
org/licenses/by/4.0/.
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On reviewing the initial data set, the researchers concluded that the breadth and volume of the data
explored a range of diverse issues that extended beyond the scope of the immediate needs of the
research. More importantly, as a data set, the 140 articles generally lacked explanatory accounts to
support the analysis of programme theories. As the research priority was to understand more clearly
how medication management might work, it was agreed to focus more closely on a subset of articles
containing causal accounts of this intervention. This approach was endorsed by the Project Group.
Step 3: further literature searches and review
Following this decision, the 140 articles were then searched for those containing the terms ‘concept,
framework, model or theory’ to identify those articles that might include a logic model, programme
theory or a theory of action or change.74 A total of 29 articles were identified for full-text review and
24 were reviewed following the exclusion of duplicate articles that contained two of the search terms,
such as concept and theory.
Articles were analysed and the data were coded into NVivo Pro 11 (QSR International, Warrington, UK).
Two approaches were followed. The first used a predetermined coding framework based on the five
factors and associated characteristics listed in a World Health Organization (WHO)12 report on adherence
to long-term therapies. These factors and characteristics were frequently cited in the literature.
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The data were structured and reported using the five factors as headings with 27 associated subheadings,
listed below to highlight their relevance to MEMORABLE:
l patient factors – relevant to older people and informal carers: demographics (age, diagnoses-multimorbidity,
education, gender, living situation, nationality-culture), independence-dependence-functional ability
(dexterity, hearing and sight, mobility, self-care, self-management), knowledge-beliefs-attitudes (about
health, about medication, health burden, health literacy), mental health (anxiety, depression, cognitive
capacity), physical health
l medication factors – aligned with polypharmacy: adverse events (including consequences of taking
or missing doses, drug–disease interactions, drug–drug interactions, drug–food interactions),
medication changes, medication information and instructions, medication name and type, medication
number and regimen, packaging, storing, time horizon to benefit
l health-care provider factors – addressing practitioner and practice issues: challenges,
communication and shared decision-making, co-ordination and consistency of care, person-centred
care, practitioner roles, trust and confidence
l health-care system factors – covering health and care organisations: access to dispensers of
medication, access to information, access to prescribers, access to review
l socioeconomic factors – the infrastructural underpinning of health and care organisations: evidence,
finance, policy, technology.
However, this initial framework proved unwieldy because coding was constrained to fit with the list
of existing factors and terminology, rather than more accurately reflecting the accounts in each text
and the causal links between factors identified within and between texts. A different approach was
needed. A second analysis coded data directly from the articles. Individual nodes and the eventual
node structure emerged, emphasising the meaning and links attributed in each text and across multiple
texts. The node summary is set out in Appendix 2. Nodes were then grouped under headings such as
diagnoses, medication, health and care relationships, and an analysis framework established (Table 2).
This framework combines the headings or factors and the levels at which they operated to ensure that
coding was causally structured. In the table, factors are set out as potential contexts, mechanisms or
outcomes, by levels, and a working definition formulated for the research. This work made an
important contribution to sense-making at this stage and to later analysis.
TABLE 2 Factors in the initial analysis framework
Factor in analysis framework Working definitions in MEMORABLE
Potential contexts
Individual level Diagnoses: multimorbidity Two or more long-term conditions
Medication: polypharmacy and
treatment regimen
Five or more medications or, if fewer, a complex
regimen that is proving difficult to manage
Identity and day-to-day life Older people aged ≥ 60 years, encompassing the
individuality of older people and the unique bundle
of personal influences on their decisions and actions
Interpersonal level Health and care relationships and
communication
Formal relationships and communication with
practitioners
Family and social relationships
and communication
Informal relationships and communication with
significant people in older people’s lives, including
informal carers
Institutional/
infrastructural level
Health and care system The provision of services by organisations
Support systems and information Access to support and information services including
via third sector or online, and published resources
(e.g. patient information leaflet)
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This analysis was summarised in a discussion paper for a Research Team meeting to inform their work
on drafting initial programme theories and reported to the Project Group.
Step 4: candidate programme theories and substantive theory
In this step, the Research Team continued to refine the tentative medication management process
developed in step 1 as a theory of action or process. In addition, they drafted three candidate
programme theories about medication management; one from the perspective of older people, one
from the perspective of informal carers and one from the perspective of practitioners. These three
candidate theories were developed from the literature searches and preliminary review, and drew on
TABLE 2 Factors in the initial analysis framework (continued )
Factor in analysis framework Working definitions in MEMORABLE
Potential mechanisms
Individual level Workload Can be ‘high or increasing’ (e.g. ‘high’: a large number of
medications and a complex regimen, or ‘increasing’: the
addition of a new medication) or ‘low or decreasing’
(e.g. ‘low’: a few medications with a simple, stable regimen,
or ‘decreasing’: further simplification of the regimen)
Capacity Can be ‘high or increasing’ (e.g. ‘high’: knowledge and
motivation about medication management or ‘increasing’:
gaining knowledge and confidence by experience) or ‘low
or decreasing’ (e.g. ‘low’: unable or unwilling to make
sense of their medication and how it should be taken, or
‘decreasing’ as a result of an acute exacerbation or loss of
informal support)
Burden The combination of workload and capacity as it
impacts on people’s health and well-being. Burden
can come from people’s diagnoses, their medication
at the individual level, health and care relationships at
the interpersonal and the heath and care system at
the institutional or infrastructural level
Potential outcomes
Individual level Coping experience The way people are able to manage the burden of
medication management in their day-to-day lives
Health literacy People’s knowledge of their health, diagnoses and
medication
Appropriate/inappropriate
treatment
Whether or not medication is prescribed to meet
people’s treatment needs, optimising safety, benefit
and cost
Adherence/non-adherence The degree to which people take their medications as
recommended by and agreed with the prescriber
Performance/clinical outcomes The impact of the medication in terms of the
diagnosis or symptoms for which it was prescribed
Quality of life The impact of taking medication on the older person
that accords with their values, goals and preferences
Interpersonal level Health and care relationships The interaction between older people or informal
carers and practitioners
Family and social relationships The interaction between older people and informal
carers as well as a wider network of family and friends
Institutional/
infrastructural level
Resources The operational and strategic goods, services and
other outputs provided by organisations
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the Research Team’s own wider expertise and experience. It appeared that the ‘dissonance’ of agendas
between different participants might have some traction:
l Older people – if an older person, living in the community with multiple diagnoses and complex
medication regimens, feels that there is a dissonance/difference between their own priorities and
those of the practitioners dealing with their medication management, then positive outcomes will
not be achieved for and with them.
l Informal carers – if an informal carer who is providing help with medication management for an
older person living in the community with multiple diagnoses and complex medication regimens
feels that there is a dissonance/difference between the priorities of the person they care for,
themselves or the practitioner dealing with their medication management, then positive outcomes
will not be achieved for and with the older person.
l Practitioners – if a practitioner feels that they have to focus on structural/practice outcomes, then
they are not able to accommodate other agendas/priorities, leading to a lack of influence on the
knowledge, attitudes, behaviours and outcomes of older people who are living with multiple
diagnoses and complex medication regimens in the community.
These theories extended the Research Team’s attempts to explain what works in medication
management, for whom, why and in which circumstances to achieve the outcomes that mattered to
those involved in the process.
Informed by the data, the simple medication management process that was mapped out informally in
step 1 was also revised at this time. In its original format, it appeared to suggest that medication
management was a linear process. However, it became increasingly clear that the process model
needed to accommodate more of the complexity of potential loops and iterations that people might
experience in their day-to-day lives (see Tables 5 and 6). These concepts were then available to discuss
with interview participants in work package 2.
Several substantive theories of interest were considered at this stage but none were sufficiently well
evidenced from the literature, pending clarification from the interview data.
Work package 2: realist evaluation (exploring mechanisms)
Step 5: interviews and analysis
In order to enrich the data through which the candidate programme theories were being evaluated and
to construct CMO configurations by which they might be explored, interviews were carried out with
older people (n = 13), health and care practitioners (n = 21) and informal carers (n = 16) (total N = 50).
A summary of interviewee profiles are set out in Appendix 3. This work was subject to approval by the
sponsor (Aston University), by a regional Research Ethics Committee by proportionate review and by
the Health Research Authority (approval issued 26 September 2017: REC reference: 17/EE/3057).
Invitations to participate in the research were issued directly through recruitment sites, such as NHS
secondary and primary care organisations, and Join Dementia Research; by purposefully sampling
individuals known to the researchers through professional and work contacts; and indirectly through
publicity for the launch of the research and an item about MEMORABLE aired on BBC Breakfast that
generated interest in taking part [see URL: www.youtube.com/watch?v=rz5UZ3mWx3o&feature=
youtu.be (accessed March 2020)].
All recruits received a participant information sheet and consent form to complete before taking part in
an interview that generally lasted about 1 hour. Interview schedules for each group followed a realist
approach49,75 (see Appendix 4 for annotated details of the common contents). Older people and informal
carers were usually interviewed face to face and practitioners most often by telephone. Interviews were
audio-taped. The tapes were anonymised and transcribed, the transcripts then being checked for accuracy
by the Research Associate. The transcripts were kept on password-protected computers for analysis.
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Interviews were designed to enable a purposeful conversation to evolve in which the participant could
describe how and why medication management worked for them as a process and to achieve the outcomes
that mattered to them. The Research Associate followed the interview schedule using a conversational
interviewing style, enabling participants to provide causal accounts of medication management in their
day-to-day lives. The approach was nuanced to participants’ experiences and expertise: how older people
fitted a complex regimen into their daily routines; how practitioners were directly involved in administering,
prescribing or reviewing medication, or indirectly involved by managing staff that undertook those
activities; and how informal carers supported increasingly dependent relatives.
Interview data were abstracted for a small number of randomly sampled participants in each group,
whether older people, informal carers or practitioners, to trial the analysis framework. This involved
the identification of explanatory statements for the factors that they identified as significant from their
own experience. When possible, links between factors were identified from the transcripts. These were
reviewed, while the recording was listened to, to check accuracy and aid interpretation. Hearing the
nuances in the original narrative was found to be valuable, such as the pauses and emphases by which
‘structures and plots’76 could be better understood. Data were initially mapped into an Microsoft Excel®
(Microsoft Corporation, Redmond, WA, USA) spreadsheet to test the framing of the analysis and the
way it might help identify causal patterns. Once verified, this enabled the larger data set to be coded
using NVivo.
At this point, data from the literature and an increasing number of interviews were being analysed
separately, driven by the way the work packages were being progressed in series. The researchers
were discussing and reflecting on both data sets in order to refine the process, respond to emerging
themes and obtain a better understanding of this complex topic. The Research Associate worked
iteratively, carrying out further cycles of purposeful searches and more integrated data analysis to
engage more fully with the increasing volume and richness of data being generated.
Work packages 1 and 2: iterations
Steps 3a/5a: further literature searches and review, interviews and evaluation (iteration) –
to identify key concepts and processes
Based on access to increasingly extensive data sets, the Research Team identified shared decision-
making as an important aspect of the work transacted in the medication management relationships.
From this, they were able to develop the understanding of the stages in the medication management
process further. They distinguished those stages that were carried out individually by the older person
and in which individual decision-making would feature, from those in which the older person interacts
with a health or care practitioner through shared decision-making.
Informed by the richness of the data becoming available, discussion and debate in the team resulted in
‘dissonance of agendas’ being discounted as a candidate theory for intervention development. Based
on emergent themes, the team acknowledged the increasingly complex work involved in medication
management day to day and decreasing capacity from factors such as ageing, disease progression and
frailty affecting older people; informal carers’ lack of knowledge and support, or competing demands from
work roles; and practitioner time constraints. Informed by their own experiences, discussions with the
wider Stakeholder Group supported by data from simple searches on workload capacity, burden emerged
as the key potential mechanism of interest, experienced individually and transacted interpersonally.
To inform the way burden might be located in MEMORABLE, a limited search for articles that linked
burden to multimorbidity, chronic disease and polypharmacy was conducted.14,77,78 As part of the
analysis, a further nine articles were sourced from those studies, largely kinship and sibling studies.79–81
In line with MEMORABLE’s primary focus on the experience of older people living with comorbidities
and polypharmacy, burden was disaggregated into burden associated with older people’s diagnoses
and ‘the lifetime burden of chronic illness’39 as well as ‘treatment-generated disruptions’.13 The scope
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of burden was also extended to older people’s interactions with health and care practitioners
and systems15,39 to include ‘the workload of healthcare and its impact on patient functioning and
wellbeing’.82 The significance of informal carer and practitioner burden was also acknowledged
although these concepts were pursued through narrative data rather than the literature.
Step 4a: theorising (iteration) – substantive theory
Informed by the analysis of selected data and having distinguished the way that older people engage
in medication management through their decisions, individual and shared, and actions or behaviours
at different but linked stages, the researchers identified NPT65,66 as a substantive theory to guide
further analysis of the data. Adopting this theory corresponded with highlighting implementation as a
key characteristic of medication management in terms of the work in introducing new medication
management practices, and making those practices routine in the day-to-day activities of older people
and informal carers.
Steps 3b/5b: further literature searches and review, interviews and evaluation (iteration) –
to focus on causality from integrated data sets
Here, the combined data were reviewed and evaluated for causal accounts to prepare for drafting
CMO configurations. Starting with the re-review of literature, configurations were set out in NVivo.
Each configuration was allocated to a node (n = 59) with associated child nodes, one for each context,
mechanism and outcome. Data were then abstracted from the interviews and mapped into the same
configurations, some of which were modified in the process and new configurations generated.
Progress on this configuring process highlighted the complexity of medication management. In light
of the breadth, volume and quality of data being generated, particularly from the interviews, the
researchers agreed to balance the need to understand the breadth of medication management with a
more detailed causal analysis focused on the reviewing/reconciling medications (Stage 5) [see Chapter 3,
Reviewing/reconciling medication (Stage 5)]. This decision was based on the potential significance of this
stage to the overall process for several reasons, including recognition of this stage’s importance in terms
of interpersonal decisions and actions, and relevance to Stage 2 in which the other interpersonal work
occurred when getting a diagnosis and/or medications. In addition, the researchers could establish
links between Stage 5 and Stage 3 in which changes would start to be implemented and Stage 4 in
which older people would continue to take their medications over time, and in which, in both stages,
non-adherence may emerge as an issue of concern. Finally, the researchers were aware of published
policy and guidance on the topic that could clarify standards of practice and their intended impact,
causally explained or not.
A key feature of realist approaches to literature searching is the enhancement of the original search
with core terms that had not been initially identified as important but whose centrality has emerged
during the preliminary literature analysis.52 Table 3 describes the supplementary searches on medication
review (2000–18). Consequently, the discussion paper was informed by a purposive literature search
for substantive literature relating to medication review, targeted at the MEDLINE database. A total of
244 review articles were identified and reviewed in relation to different configurations of medication
review, published between January 2000 and December 2018. A larger set of non-review articles
(3234 references) published over the same period was retrieved as a data set to support exploration of
specific issues identified from the initial review subset.
The Research Team chose not to add additional qualifiers beyond the concept of ‘medication review’ for
two reasons. First, the population seemed to be self-defining from the terminology (i.e. the large majority
of retrieved items referenced an aged population anyway). Second, the list of potentially qualifying
terms, such as polypharmacy, would be quite extensive and would be difficult to make sufficiently
exhaustive compared with the relative advantage of undertaking this sensitive search.
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Informing this step, the Research Team considered a discussion paper written by the Research
Associate that listed the full set of CMO configurations. It also included subsets of configurations for
reviewing and reconciling medications (Stage 5) and two areas of interest around risk identification and
individualised information that had emerged from the data and appeared to have the potential to
generate proposed interventions.
In addition to the involvement of the Research Team in these decisions, the Project Group also approved
this work, including the focus on reviewing/reconciling medications (Stage 5). The opinions of the
Stakeholder Group were also sought on emerging themes: medication management is not ‘one thing’;
older people’s goal about what they want from their medication and how, is very important to them;
family carers’ awareness of the responsibility and challenges when they support older relatives with
their medication; more and more practitioners, in different roles, from different organisations and with
different ways of working are involved in medication management. The Stakeholder Group discussions
enhanced the way that researchers understood these themes, supporting the analysis.
Work package 3: developing framework for intervention(s) and dissemination
Step 6: final programme theories
Final programme theory for a key stage in medication management is contained in Figure 5, based on
both evidence and experiential data.
Step 7: intervention proposals
The intervention proposals emerged from the data, with an evidence and experience base. The
Research Team identified the interventions most likely to improve medication management through
discussion and debate of the data analysis, themes and concepts. This took place at a face-to-face
meeting. Proposed interventions were prioritised as being most likely to bring about improvements in
medication management, directly relevant to the expressed needs of older people and informal carers
(individualised information) and improving practice (risk identification). They are reported in Chapter 3
and are considered in Chapter 4.
Having completed the account of the method underpinning MEMORABLE, the next chapter sets out
the results.
TABLE 3 Supplementary searches on medication review (2000–2018)
Search terms Articles
(Search 16) Search “medication review*” OR “medicines use review*” OR “medicines review*” OR (medicine
utilization review*) OR (medicine utilisation review*) OR (medicines utilization review*) OR (medicines
utilisation review*) Filters: Review; Publication date from 2000/01/01 to 2018/12/31; English
244
(Search 15) Search “medication review*” OR “medicines use review*” OR “medicines review*” OR (medicine
utilization review*) OR (medicine utilisation review*) OR (medicines utilization review*) OR (medicines
utilisation review*) Filters: Publication date from 2000/01/01 to 2018/12/31; English
3234
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Chapter 3 Findings
Using a realist approach and following the work packages and steps described in Chapter 2, thischapter sets out the findings from the literature and interviews in three sections.
1. Medication management: this section sets out how the data have been analysed and interpreted
to develop a series of subprogramme theories about aspects of medication management. These
subprogramme theories explain medication management in five ways: as a good practice, as a
complex intervention, as implementation, as burden and as experience. The breadth of this work
provided an explanatory structure of the complexity of medication management, necessary for the
identification and more detailed analysis of Stage 5 as a key and critical stage.
2. Reviewing/reconciling medication: this section is about Stage 5 of medication management in
which older people and practitioners are engaged, with or without the support of informal carers,
achieving personally meaningful outcomes while enabling medication adherence and medication
optimisation. This more in-depth work supported the generation of an explanatory theoretical
framework, conceptualised around burden.
3. Proposed interventions: selected for their potential to contribute to the improvement of
medication management.
¢ Risk identification of older people and informal carers who are not coping with the burden
of managing their medications. These are the people who might benefit from an additional,
needs-generated intervention such as a review.
¢ Individualised information about older people and their unique experiences of complex diagnoses
and treatments, developed collaboratively by them, their informal carers if they are actively
involved, and practitioners. This would be in an agreed format that encompasses their health,
multimorbidities and polypharmacy, situated in their day-to-day lives and reflecting their values,
goals and preferences. It would contribute to improved coping and self-management.
Reporting MEMORABLE’s findings begins with medication management.
Medication management
I think practice has improved. I think we are, we do more stuff than we used to. I think we sort of follow
guidelines a lot better than we used to . . . But you’re sort of, you’re juggling all these things of what the
textbook is telling me I should do, what is best for this 90-year-old person who’s on 1001 tablets already,
what is the benefit? Actually, is it going to help this individual?
P53 – general practitioner
Medication management is introduced from the perspective of good practice. It is then considered as
a complex intervention, as implementation, as burden and as experience. Understanding medication
management through the combined analysis of literature and narrative data are pivotal to the research.
Medication management as good practice
Good practice recommendations from medication management policy and guidelines informs
practitioners’ work, and the management and commissioning of the services in which they operate.
Policy and guidelines are generally aligned with preferred outcomes: adherence,12,72 in which the older
person’s actions matches the prescriber’s recommendations, informed by their involvement in and
agreement with decisions about their treatment, and optimisation33 that aims to ensure that older
people get the best possible outcome from any treatment. Reports from two organisations are noted
below, framing medication management practice.
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First, a formative WHO12 report endorses a behavioural approach to medication adherence, expressed in
an information–motivation–behavioural skills model. Behaviours are characterised by type, frequency,
consistency, intensity and/or accuracy. A broad level explanation of behavioural change and adherence is
contained in Annex 1 in the WHO report. Good practice is delivered through the practitioner’s clinical and
communication competencies, such as providing emotional support (empathy, validation, relationship
building); giving information (empowering, tailoring, supporting health literacy); asking adherence-specific
questions (monitoring, feedback) and; discussing therapeutic options, negotiation of regimen and discussion
of adherence (collaboration, shared decision-making). By pursuing this approach, the practitioner secures
the preferred change in the individual. Adherence is however subject to the caveat:
. . . almost everyone has difficulty adhering to medical recommendation, especially when the advice entails
self-administered care.
Reproduced from Sabate.12 This is an Open Access article distributed in accordance with the terms of the
Creative Commons Attribution (CC BY-NC 3.0 IGO) license, which permits others to distribute, remix,
adapt and build upon this work, for commercial use, provided the original work is properly cited.
See: https://creativecommons.org/licenses/by-nc/3.0/igo/
Second, turning to the evolving policy framework for medication management in the UK, 2009–2018,
NICE has published relevant guidance on adherence, optimisation and multimorbidity.33,41,72 It has also
issued several linked documents including a guideline and pathway for older people with social care
needs,71,83 a flow chart for optimisation,84 and a key therapeutic topic document on multimorbidity and
polypharmacy.29
The NICE guidance on multimorbidity and polypharmacy29,41 acknowledges the complexity of managing
future morbidity and mortality. NICE highlight two associated risks: first, in relation to multimorbidity,
for which multiple treatments may be recommended although the evidence base is specific to the
treatment of single conditions and, second, in relation to polypharmacy, for which benefits decrease and
the risk of harm increases with the addition of each medication. NICE also underscore the responsibility
of health-care professionals to make decisions appropriate to the circumstances of the individual patient,
in consultation with the patient. Good practice interventions accordingly include the need for:
l an individualised approach to accommodate needs, treatment preferences, lifestyle and concerns
through individualised and planned care, assessment and treatment;
l partnership with shared decision-making to ensure that there are informed discussions and
decisions in which the patient experience is understood; and
l outcomes that include not only clinical aspects of medication safety and effectiveness but also
the outcomes that matter to the individual, including improving quality of life and reducing
treatment burden.
Despite an extensive, supporting evidence base, the NICE documents do not explain how these
good practice interventions might work to enable practitioners to adapt them to local or individual
circumstances.85 Such an approach may appear to support the view that the act of ‘doing’ good practice
might suffice. In such circumstances, practitioners could struggle to make informed, individualised
decisions and assure good practice within the evidence available, noted by Hughes et al.86
To summarise, key elements of good practice from these strategic reports on medication management
have been mapped out in Figure 3, as a logic model: individual, interpersonal and system-level inputs,
individual and interpersonal activities, and expected impacts.
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Medication management as a complex intervention
Complexity and causality
A total of 24 articles containing rich conceptual data on medication management were identified through
screening the initial search results, prioritised because they appeared to have a causal account of how
medication management might work (Table 4). They were identified through the presence of the screening
terms ‘concept, framework, model or theory’ that might indicate a logic model, programme theory, or a
theory of action or change within them.74 Articles that included more than one of these screening terms
were categorised by the Research Team based on their primary focus.
Inputs Activities Impacts
Individual
Capacity and agency
Practitioner
Individualised approach to
practice (including reviewing,
deprescribing) and
communication
competencies: motivation
and information
Behavioural skills and change
Engaging motivation (affect),
knowledge (cognition), capability
(physical) and action (behaviour)
Adherence and
optimisation: improved 
quality of life by reducing 
treatment burden and 
minimising the risk of 
adverse events 
Practitioner and
individual
Partnership and continuity
Enabling relationship
System
Resourcing and access,
co-ordination and integration
FIGURE 3 Mapping generic factors informed by WHO12 and NICE.33,41,72
TABLE 4 Medication management articles identified for the presence of the terms ‘concept, framework, model or theory’
Authors Title Year Country Topic Method
Concept (n = 4)
Cheraghi-Sohi
et al.87
The influence of personal
communities on the self-
management of medication
taking: a wider exploration
of medication work
2015 UK Personal communities
involved in medication
work
Semistructured
interviews and the
construction of
network diagrams
Fried et al.88 A Delphi process to
address medication
appropriateness for older
persons with multiple
chronic conditions
2016 USA Translating framework
concepts into specific
strategies to identify and
remediate inappropriate
regimens, focusing on
deprescribing to reduce
medication burden
Modified Delphi
process: three rounds
of anonymised
web-based surveys
continued
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TABLE 4 Medication management articles identified for the presence of the terms ‘concept, framework, model or theory’
(continued )
Authors Title Year Country Topic Method
Naik et al.89 Patient autonomy for
the management of
chronic conditions:
a two-component
re-conceptualization
2009 USA Autonomy: decisional
(about treatment)
and executive (carry
treatment plan out) in
the context of multiple
conditions
Concept development
Upadhyay and
Joshi90
Observation of drug
utilization pattern and
prevalence of diseases in
elderly patients through
home medication review
2011 India Medication review by
pharmacists
Community-based
survey
Framework (n = 5)
aBartlett Ellis
and Welch91
Medication-taking
behaviours in chronic
kidney disease with
multiple chronic conditions:
a meta-ethnographic
synthesis of qualitative
studies
2016 Australia,
England and
the USA
Medication taking and
medication adherence
behaviours
Qualitative study
review
Boskovic et al.92 Pharmacist competencies
and impact of pharmacist
intervention on medication
adherence: an
observational study
2016 Croatia Results of pharmacists
intervention on
adherence in the
community
Observational study
Coleman93 Medication adherence
of elderly citizens in
retirement homes through
a mobile phone adherence
monitoring framework
(Mpamf) for developing
countries: a case study in
South Africa
2014 South Africa Intervention
development:
technology
Case study with
qualitative interviews
Schuling et al.94 Deprescribing medication in
very elderly patients with
multi-morbidity: the view of
Dutch general practitioners.
A qualitative study
2012 Netherlands Exploring experienced
general practitioners’
views on deprescribing
and involving older
people in these
decisions
Qualitative study
Yap et al.95 Medication adherence in
the elderly
2016 Singapore Systematic review
of the barriers to
adherence in the
elderly
Case study
Model (n = 9)
aDoucette
et al.96
Initial development of the
Systems Approach to Home
Medication Management
(SAHMM) model
2017 USA Systems approach to
safe and effective home
medication management
Model development
Hennessey and
Suter97
The Community-Based
Transitions Model: one
agency’s experience
2011 USA The acquisition and use
of health coaching
competencies in home
care clinicians at health
transitions
Model development
Jonikas and
Mandl98
Surveillance of medication
use: early identification of
poor adherence
2012 USA Identification of
population level
adherence and risk
of poor adherence
Model development
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TABLE 4 Medication management articles identified for the presence of the terms ‘concept, framework, model or theory’
(continued )
Authors Title Year Country Topic Method
Khabala et al.99 Medication Adherence
Clubs: a potential solution
to managing large numbers
of stable patients with
multiple chronic diseases in
informal settlements
2015 Kenya Assessment of the
people’s care through
nurse-facilitated
Medication Adherence
Clubs
Retrospective
descriptive study
aKucukarslan
et al.100
Exploring patient
experiences with
prescription medicines to
identify unmet patient
needs: implications for
research and practice
2012 Canada
and USA
Identification and
characterisation of
patients’ unmet needs
when taking prescribed
medication
Grounded theory
approach to interview
content analysis
aMcHorney
et al.101
Structural equation
modeling of the proximal-
distal continuum of
adherence drivers
2012 USA Identification of
adherence drivers
Model development
Lau et al.102 Multidimensional factors
affecting medication
adherence among
community-dwelling older
adults: a structural-
equation-modelling
approach
2017 China Multidimensional factors
affecting medication
adherence: measuring
medication adherence,
professional-help
relationship and
self-care abilities
Exploratory cross-
sectional approach
using interviews and
modelling
Milani and
Lavie103
Health care 2020:
reengineering health care
delivery to combat chronic
disease
2015 USA Modifying the health-
care delivery model to
include team-based care
in concert with patient-
centred technologies
Review
Shepherd
et al.104
Health services use and
prescription access among
uninsured patients
managing chronic diseases
2014 USA Identification of
relationships between
population characteristics,
health behaviour and
outcomes
Longitudinal quasi-
experimental design
with convenience
sample for assessment
and notes review
Theory (n = 6)
Geryk et al.105 Medication-related
self-management
behaviours among arthritis
patients: does attentional
coping style matter?
2016 USA Coping styles Internet-based survey
Haslbeck and
Schaeffer106
Routines in medication
management: the
perspective of people with
chronic conditions
2009 Germany Routines in medication
management along
chronic illness trajectory
Semistructured
interviews: initial and
follow-up
Laba et al.107 Understanding if, how
and why non-adherent
decisions are made in an
Australian community
sample: a key to sustaining
medication adherence in
chronic disease?
2015 Australia Intentional
non-adherent decisions
and behaviours
Semistructured
interviews and theory-
informed iterative
thematic framework
analysis
Marks108 Self-efficacy and arthritis
disability: an updated
synthesis of the evidence
base and its relevance to
optimal patient care
2014 n/a Self-efficacy, pain and
disability, adherence to
therapeutic strategies
and outcomes, applicable
to assessment and
treatment
Review and synthesis
continued
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Informed by the causal attributions in these articles, relevant factors and combinations of factors were
identified and coded into NVivo. The codes are listed in Appendix 2.
This analysis confirms that medication management aligns with the description of complex interventions
and their evaluation set out by the Medical Research Council:58,59 several interacting components, the
number and difficulties of behaviours among those involved, the number of groups or organisational
levels targeted by the intervention, and the number and variability of outcomes.
The following issues emerged from the analysis, associated with the two main groups: older people and
practitioners. Some additional articles have been added to the references in Table 4 where these have
augmented the understanding of particular factors:
l Older people: the way they manage the workload13–15 associated with their medications is influenced
by their diagnoses, including multimorbidities, symptoms and illness trajectories that overlay ageing
processes;11,12,78 the medications they take, including high-risk drugs, doses and complex regimens;89,91,111
and the relationship and interaction with the prescriber.112–114 Together, these affect behavioural
responses such as control, self-efficacy and coping styles87,89,91 through the adoption of routines106,115
that lead to the outcomes that matter to them. Cheraghi-Sohi et al.87 describe older people’s
individuality in the way that they manage their medication: ‘Medication-taking appears to be a
personalised, contingent and contextually situated type of work with participants developing highly
individualised routines and strategies’.
l Practitioners in health and care: doctors in particular87,89,103 as well as pharmacists92,94,96 and nurses87,91 are
identified as significant in medication management, following a patient-focused care model100,102,103 as
part of a health and care system in which there is co-ordination and continuity.100,103 The immediacy of
their work, face to face with older people, is highlighted in prescribing,88,90,91 deprescribing88,94 and
information-giving.91,94,97,100 Establishing a trusted therapeutic relationship89,91,100 enables practitioners to
extend their influence over older people’s medication management decisions and actions when they are
at home. Lau et al.102 highlight the importance of practitioners engaging with older people as individuals
to enable them to improve the way that they manage their medications: ‘Adherence interventions should
be tailored to the needs of a patient to enhance self-management capacity regarding medication use’.
TABLE 4 Medication management articles identified for the presence of the terms ‘concept, framework, model or theory’
(continued )
Authors Title Year Country Topic Method
Jorge de Sousa
Oliveira et al.109
Interventions to improve
medication adherence in
aged people with chronic
disease – systemic review
2017 USA, China,
Portugal
and Italy
Nursing interventions
to improve medication
adherence in older
people with chronic
disease
Systematic review
Skolasky
et al.110
Psychometric properties of
the patient activation
measure among
multimorbid older adults
2011 USA Patient activation
measure (Hibbard):
psychometric
properties and model
evaluation
Interviews+ completion
of measure. Cross-
sectional and latent
class analysis
n/a, not applicable.
a Articles containing more than one of the search terms.
Reproduced with permission from Maidment et al.67 This is an Open Access article distributed in accordance with the
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and
build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/
licenses/by/4.0/.
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These findings are supported by the interview data reported later in this chapter; see Medication
management as experience.
Structuring complexity
Medication management is often described in the literature as a single intervention. However, its real-world
complexity has been addressed in MEMORABLE by disaggregating it into stages differentiated by activities
and participants (Table 5):
l Activities – each stage has a distinct group of purposeful activities or work associated with it, such as
Stage 1: identifying a problem and Stage 4: continuing to take medications. However, stages are
linked and generative so that what happens in one stage informs another. For example, having
received a diagnosis and medications in Stage 2, an older person starts to take their new medications
in Stage 3 and continues to take them in Stage 4, making them part of their day-to-day routine.
l Participants – Stages 1, 3 and 4 are where an older person is managing their medications on their
own. This is indicated in Table 5 with a ‘(1)’ next to ‘older person’. However, the older person may
have the support of an informal carer depending on their particular needs, shown as (1 + 1).
Stages 2 and 5 are interpersonal stages where the older person and the practitioner work together,
shown as (1 : 1), next to ‘older person and practitioner’. Although informal carers were only
identified in association with ‘informal carer burden’ in the screened literature, they have been
included in the table to reflect their involvement, as described in the interviews.
Stages 2 and 5 are where good practice, discussed previously, is situated. Adherence on the other
hand can now be located in Stage 3, as an aspect of a single event when the older person is starting,
changing or stopping medications, or when continuing to take them in Stage 4, requiring repetition and
consistency. However, Volpp and Mohta116 indicate that the factors that initiate behavioural change are
different from those that sustain it although ‘human interaction and social support’ are noted as
significant to both.
TABLE 5 Five stages of medication management
Stage
Stage 1:
identifying
problem
Stage 2: getting
diagnosis and/or
medications
Stage 3: starting,
changing or stopping
medications
Stage 4:
continuing to
take medications
Stage 5: reviewing/
reconciling
medications
Who Older person (1) Older person and
practitioner (1:1)
Older person (1) Older person (1) Older person and
practitioner (1 : 1)
Older person may
be supported by
an informal carer
(1 + 1)
Older person may
be supported by
an informal carer
(1 + 1)
Older person may
be supported by an
informal carer
(1 + 1)
Older person may
be supported by
an informal carer
(1 + 1)
Older person may
be supported by an
informal carer
(1 + 1)
Doing
what
Older person
identifies
something is
wrong
Older person and
practitioner agree
what is wrong,
how to treat it.
A prescription is
issued and filled
Older person adjusts
daily medication
routine to include
new medication or
adjust or omits
current medication
Older person fits
new routine into
day-to-day life
Practitioner
confirms
medication safety
and efficacy
Older person and
practitioner agree
appropriateness,
adherence and fit
with day-to-day life
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Developing the stage structure further, Table 6 adds more detail to what is happening in each stage
and across stages, locating and linking decision-making and behaviours. The table confirms that the
older person (1) is self-managing in Stages 1, 3 and 4, although they may also be benefiting from
support with medication management through the involvement of an informal carer (1 + 1). These
stages are where the older person engages in individual decision-making to exert control or agency: in
Stage 1, when identifying that something is different and potentially problematic, and Stages 3 and 4,
when setting up and following routines. However, the emergence of a problem in Stages 3 or 4 may
result in a ‘disruption’ loop where the older person reverts to Stage 1 to address a concern.
Interview data confirm that a strong sense of control or striving for control supports adherence and
optimisation to get the best from medications that make a tangible difference in older people’s lives.
On the other hand, a strong sense of autonomy and weak external influence, such as ambiguity in the
advice from the prescriber about the importance of certain medications, could in some instances be
linked with an increased likelihood of intentional non-adherence. Media coverage about problems or
risks with certain medications, or trusted friends’ stories of their own bad experiences of particular
treatments, can compound the weakness of prescriber advice. As a result, older people’s decisions may
not always appear consistent as they try to fit medication management with the many other choices
and opportunities that they are exposed to on a daily basis. However, non-intentional non-adherence
appears to be linked more with occasional forgetfulness or cognitive decline. This suggests that an
effective approach to medication management may involve discussing how the older person fits this
complex staged work into their day-to-day lives, and copes with it, rather than focusing on more
abstract concepts such as adherence.
Turning to the interpersonal stages identified in Table 6, these are where decision-making is shared. The
first of these is Stage 2, where practitioners provide a diagnosis and medications. This stage is important
for what the practitioner does and communicates in an often time-limited event. Of equal importance
is the way these activities draw on older people’s needs and concerns to explain the problem as they
perceive it (Stage 1), together with experiences of coping with their medication routines day to day
TABLE 6 Five stages of medication management highlighting decision-making, behaviours and loops
Stage
Stage 1:
identifying
problem
Stage 2: getting
diagnosis and/or
medications
Stage 3: starting,
changing or stopping
medications
Stage 4:
continuing to
take medications
Stage 5: reviewing/
reconciling
medications
Who Older person (1) Older person and
practitioner (1 : 1)
Older person (1) Older person (1) Older person and
practitioner (1 : 1)
IDM: individual
decision-making
IDM
disruption loops
IDM IDM
Behaviours Self-management
(1)
Supported
management
(1 + 1)
Self-management
(1) Supported
management
(1 + 1)
Self-management
(1) Supported
management
(1 + 1)
SDM: shared
decision-making
SDM (1 : 1)
diagnosis loop
medication loops
SDM (1 : 1)
Reproduced with permission from Maidment et al.67 This is an Open Access article distributed in accordance with the
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and
build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/
licenses/by/4.0/.
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(Stage 4). Adding to the understanding of the way stages link and are generative, work in this stage also
feeds forward to influence what an older person does when they are back at home (Stages 3 and 4).
This is where older people, sometimes with the support of informal carers, may need to make changes
to what they are already doing to fit new medications into their routines and day-to-day lives.
The second interpersonal stage is Stage 5, a key stage in MEMORABLE, where practitioners are
reviewing or reconciling medications. This stage is where shared decisions are made between the
practitioner and older person about whether or not to continue with the existing medication regimen
as it is. In this case, the older person continues to self-manage as before (Stage 4). Practitioners and
older people might also decide to make changes to the medication regimen so that the older person
needs to adjust what they are currently doing (Stage 3) or, if there is a change in health status that
warrants a reassessment, to get a new diagnosis and/or medications (Stage 2). These medication and
diagnosis loops are shown in Table 6 that also highlights the interpersonal stages where older people
and practitioners are engaged in shared decision-making (Stages 2 and 5) and the other stages where
older people are making individual decisions (Stages 1, 3 and 4), distanced from but influenced by
engagement with practitioners.
Medication management as implementation
Having established the stages of medication management as a complex intervention, this subsection
addresses how medication management can be understood as a form of implementation involving
‘purposive and directed’66 work. As MEMORABLE is using realist methodology, the researchers
have drawn on Carl May’s65,66,117 work on NPT and particularly the article by May and Finch.66
This substantive theory was identified by the researchers during step 4a.
Normalisation process theory articulates the way new practices or activities are introduced and are made
routine or sustained through the work that is done by those involved. It identifies four linked areas of
work: coherence work to clarify what the new work is, relational work to build and sustain a network of
people to carry the work out, operational work to undertake it, and appraisal work to understand the
impact of what has been done. Normalisation process theory views this work as purposive, in other words,
outcome focused. As a substantive theory on implementation, NPT aligns with medication management as
a complex intervention, set out in Structuring complexity. It has been adopted here as an evaluative lens
because of the way that it provides a structure and process for understanding the work associated with
medication management, integrated across individual, interpersonal and system levels.
May et al.’s65,66,117 work initially focused on change implementation in organisations. Gallacher et al.,118
among others, have extended its application, using this theory to explain the workload and capacity issues
associated with the experience of stroke. They locate burden work in health-care settings and people’s
day-to-day lives. Gallacher et al.’s article118 is, therefore, referenced here for the way the authors apply
NPT to people’s experiences of health care. They also simplify NPT terminology. Accordingly, May et al.’s
terms have been revised as follows: coherence work to ‘sense-making’; relational work to ‘relationships’;
operational work to ‘action’; and appraisal work to ‘reflecting’ (associated with older people and informal
carers) and ‘monitoring’ (associated with practitioners).
Table 7 builds on Tables 5 and 6. Following the stages of medication management and focusing on the
older person and the core relationship between them and the practitioner, this version of the table
introduces NPT steps, distinguishing what is happening within and between stages:
l Stage 1: identifying problem – involving the older person (1) in individual sense-making about the
importance of the problem and what to do about it. Drawing on both knowledge and confidence,
choosing to act enables the older person to seek help, or not, while reflecting on the appropriateness
of that decision and action.
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l Stage 2: getting diagnosis and/or medications – within the relationship between the older person and
the practitioner (1 : 1), shared decision-making is located here as an action. This is because shared
decision-making is a type of work facilitated by the practitioner and contingent on them providing the
time and space for it to occur. The action extends as far as the plan to do something that is subsequently
initiated in Stage 3 and continued in Stage 4. The older person may reflect on their experience of the
encounter and the practitioner relationship, in that moment and as a longer-term, trusted collaboration.
Practitioner monitoring includes the performance elements of the work and the relationship, as well as
the anticipated clinical outcomes.
l Stages 3 and 4: starting, changing or stopping medications and continuing to take medications –
these stages are where the older person (1) makes sense of what they are doing in terms of the
information that they have been given, what they are currently doing and what needs to be done
to start and sustain a new routine. From this, the older person initiates (Stage 3) and follows that
routine (Stage 4) and reflects on it, for example thinking about the way the medication makes
them feel or the ease with which they can fit the new routine into what they do day to day.
l Stage 5: reviewing/reconciling medications – as with Stage 2, and the relationship between the
older person and the practitioner (1 : 1), shared decision-making located here as an action. Building
on Table 6, Table 7 also includes disruption, medication and diagnosis loops discussed previously.
TABLE 7 Five stages of medication management as implementation: NPT informed
Stage
Stage 1:
identifying
problem
Stage 2: getting
diagnosis and/or
medications
Stage 3: starting,
changing or stopping
medications
Stage 4:
continuing to
take medications
Stage 5: reviewing/
reconciling
medications
NPT steps Older person (1) Older person (1)
Sense-making IDM
Does this matter,
what, who?
disruption loops
[IDM]
IDM
What now, how
and why?
IDM
What now, how
and why?
[IDM]
Shared (1 : 1) Shared (1 : 1)Relationship
Action Do something
now SDM
Appears to be
this, so let’s try
that
Doing that once
SDM
Appears to be
this, so let’s try
that
Reflection/
monitoring
Is that right?
What effect?
How does that
feel or fit?
How does that
feel or fit?
How did it go?
What effect?medication loops
diagnosis loop
Older person (1) Older person and
practitioner (1 : 1)
Doing that
regularly
How did it go?
Older person and
practitioner (1 : 1)
Key (bold terms)
fit: between treatment/medications and day-to-day life.
IDM: individual decision-making by the older person (1).
it: relationship and conversation.
that: treatment/medications.
this: signs and symptoms.
SDM: shared decision-making between the older person and the practitioner (1 : 1).
Reproduced with permission from Maidment et al.67 This is an Open Access article distributed in accordance with the
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and
build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/
licenses/by/4.0/.
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The table highlights the way medication management can be understood using substantive theory as a
framework. Within the apparent complexity in this table, patterns of work can be identified that
contribute to explaining medication management including:
l The importance of sense-making and individual and shared decision-making from which actions are
generated within medication management. These actions include the way shared decision-making
might establish the choice architecture119 for older people’s day-to-day individual decision-making
at home.
l The amount of work older people are doing to start and to continue to take medications as they
make them routine, and fit that routine into their day-to-day lives. In this way, they experience and
value the control over what they do with medication, as with all other aspects of their lives.
l The limited but significant opportunities for practitioners to influence older people’s motivation,
knowledge and behaviours in the overall medication management process. Generally in NPT,
implementation networks and interactions are task-recruited and specific to the introduction of
new ways of working after which they may be disbanded. In medication management, although the
interactions between older people and practitioners align with Stages 2 and 5, the relationship
tends to be more enduring. It is valued for its consistency and qualities such as mutual trust.
This can be identified in the table where the final step involves reflection/monitoring. Here, the
question in Stages 2 and 5, ‘how did it go’ indicates the work being done to determine satisfaction
with the current or recent interaction and also whether or not to confirm continuing trust in
the relationship.
With medication management understood as a complex intervention and as implementation, structured
and detailed across Tables 5–7, the next subsection explores medication management as burden.
Medication management as burden
Burden was identified as an issue of concern during the research process in step 3a: further literature
searches and review (iteration). The Research Team were aware of Gallacher et al.’s118 research,
identifying treatment burden through the workload or demands of health care and people’s capacity or
personal resources to ‘manage health problems and follow treatments’, a workload-capacity dynamic
that is central to the concept of burden experienced by older people and informal carers.13–15 A search
for articles on burden was, therefore, carried out, linking it with multimorbidity, polypharmacy and
chronic disease. Three articles were initially identified: Mohammed et al.,78 Ridgeway et al.77 and
Sav et al.14 Several other papers were subsequently identified from included references: Demain et al.,13
Eton et al.,82,120 Katusiime et al.,121 Krska et al.,122 Shippee et al.123 and Tran et al.,124 informing
this subsection.
Illustrative examples of burden for each stage of medication management are set out in Table 8:
Examples of burden: workload and capacity in medication management. A more detailed analysis of
burden and coping is set out in Appendix 5, based on Mohammed et al.,78 Sav et al.,14 May et al.,39 Eton
et al.120 and Demain et al.,13 and in Appendix 6, drawing primarily on the work of Katusiime et al.121 and
Krska et al.122
Multiple factors inform workload and capacity: individually, these include the stability or instability of
diagnoses, side effects from medications or the total medication regimen; interpersonally, having a
consistent relationship with a practitioner such as a doctor, pharmacist or nurse that is founded on
mutual trust in which the older person feels confident; or at an institutional or infrastructural level,
accessing local services (e.g. being able to make convenient or timely appointments, transport or
parking) and information.
However, burden is an individual experience, noted by Mohammed et al.:78 ‘patients on the same
number of medicines may experience different levels and aspects of medication related burden’.
In addition, in as much as workload and capacity change, the experience of burden is not static and
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people’s response in terms of coping also fluctuates, as set out in Table 9. This table highlights the
relationship between increasing/high workload or capacity, and decreasing/low workload or capacity.
Decreasing or low workload and increasing or high capacity are likely to be experienced as no burden.
Where both workload and capacity are increasing or high, or both are decreasing or low, burden is
experienced. In these two burden situations, increasing or high capacity is likely to indicate coping whereas
decreasing or low capacity suggests not coping. Finally, increasing or high workload and decreasing or low
capacity is associated with high burden and not coping. Here, there are both workload and capacity risks.
The experience of low capacity was summarised in a practitioner’s interview:
Generally coping mechanisms, as in psychological, emotional coping. And we get people who, again it’s not
necessarily a diagnosis, but personality. They don’t sort of cope with things well and might need a lot of
support with relatively minor things. And that’s not a medical diagnosis. But they’re just sort of quite
dependent on professionals or support.
P53 – general practitioner
The way people experience burden-control is described by Mohammed et al.:78 ‘Patients tolerate,
control and adapt all events of a medication related burden until the cumulative effect of the burden
interference in day-to-day life exceeds their coping threshold and overcomes their controlling capacity’.
Older people and informal carers, who are not coping or at risk of not coping, need to be identifiable
to practitioners (see Proposed interventions).
Finally, Shippee et al.123 provide a compelling account of burden as a mechanism through which
‘complicating’ factors impact on outcomes: ‘a functional mechanism by which medical, social, and
personal factors translate into the patient’s experience’. Although this use of the term ‘mechanism’ may
not align with the way it is understood in realist terms, it does highlight people’s experiences, linking a
range of causal influences and outcomes. The Research Team therefore adopted it in this study by
conceptualising burden as a potential mechanism of interest. It has been mapped in to the analysis
framework in Appendix 7, enhancing the initial framework set out in Table 2. Nonetheless, the Research
Team also acknowledge that burden can also be a context or an outcome in the way medication
management is explained and experienced, day to day.
Findings set out above have confirmed medication management as a complex intervention, as an
implementation process and as burden. The final subsection below addresses the way it is experienced,
drawing on the interviews with older people, informal carers and practitioners from health and care.
TABLE 8 Examples of burden: workload and capacity in medication management
Stage
Stage
1: identifying
problem
2: getting
diagnosis and/or
medications
3: starting, changing
or stopping
medications
4: continuing to
take medications
5: reviewing/
reconciling
medications
Type of burden example
Workload
examples
Having a sense of
what it feels like
to be ‘well’ and of
sudden or lasting
changes that raise
concerns
Making and
attending
appointments
Reading and acting on
patient information
leaflets, remembering
and following
prescriber advice
Ordering
medications
regularly to ensure
a constant supply
Organising pre-review
tests, attending
face-to-face reviews
Capacity
examples
Knowledge: about
comorbidities to
be able to identify
new symptoms
Motivation: to
make and keep
appointments,
including tests
Flexibility: to adjust
medication routines
and daily activities
Organisation: to
stick to medications
routines
Memory: to recall
significant details
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Medication management as experience
Adherence and optimisation are emphasised as key outcomes in both policy and the literature reported
thus far, underscoring a practice-performance perspective. However, participant interviews provided
rich and more divergent causal accounts through descriptions of diagnoses, treatments and experiences
of managing medicines day to day and, finally, explanations of the way medication management works,
or not, for them.
Outcomes from medication management
Based on the realist interest in causality, interviewees’ outcomes are a useful starting point for analysis
(Table 10). Data are presented for each group of interviewees: older people were asked about what
they wanted from medication management, informal carers were asked about the outcomes for
themselves and for the older person they care for, and practitioners were asked about themselves,
older people and informal carers.
There is disparity in outcomes based on interests and role. Older people focus on the way medication
fits with and adds to their lives by keeping them as well as possible so that they can do what matters
to them. Informal carers identify with this on their relatives’ behalf. However, they also express
concerns about ensuring that the person they care for receives the best treatment that also maintains
or stabilises their health. This may reflect the way the different groups perceive their role and
responsibilities and how these are juggled to fit with other demands and priorities in their own lives,
juggling made easier when demands are known, stable and predictable. Practitioners’ outcomes are
about good practice and are typically role and performance defined, indicating the complex range of
factors that inform what they do: maximising benefit, minimising risk, ensuring safety, reducing cost
and sustaining relationships. Medical practitioners appear to accommodate the broadest range of
interests in their work. Other practitioners appear more limited by the scope of their role, as part of a
network of potentially complementary interests in medication management. Practitioners’ perceptions
TABLE 9 Exploring workload, capacity, burden, coping and risk
What capacity does the older person have (individual specific)?
Increasing/high capacity:
(examples)
l Increasing: regaining
confidence after acute
episode; and
l High: well-motivated and
resourceful, with strong
family support
Decreasing/low capacity:
(examples)
l Decreasing: feeling discouraged
by worsening health, increasing
cognitive impairment or frailty
l Low: depression, isolation
What is the workload (stage specific)?
Increasing/high workload: (examples)
l Increasing: additional medications started
(Stage 3) as a long-term diagnosis worsen
or in response to an acute episode, such
as an infection; and
l High: large number of medications being
taken in irregular patterns, several times
a day (Stage 4)
Burden: coping High burden: not coping – high
workload and low capacity risk
Decreasing/low workload: (examples)
l Decreasing: simplified medication
regimen becoming routine (Stage 4); and
l Low: minimal medication, regular pattern,
stable diagnoses (Stage 4)
No burden: coping Burden: not coping – low capacity
risk
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TABLE 10 Examples of interviewees’ medication management outcomes
Interviewees Outcomes
Older people Performance/clinical outcomes:
Well what I want is for them to maintain the healthy levels of whatever, my glucose or cholesterol . . .
And continue in good health, yes
OP4 – older person
Appropriate treatment:
I just want to stay as healthy as I am at the moment. Well, I’d like to be healthier than I am at the
moment but actually to be quite honest, I’m pretty good
OP8 – older person
The outcome that I would hope for would be that I don’t need them any more
OP28 – older person
Quality of life:
I can be normal and go out and do things and play with our grandson and cook meals and live a life
OP5 – older person
Just to remain as active and mentally active as I can be for as long as I can be
OP13 – older person
I’d like to feel better but I mean they can’t give me a tablet for that
OP21 – older person
Informal carers For themselves Performance/clinical outcomes:
I hope that it will prevent [my father’s] vascular dementia from getting
any worse
C9 – informal carer
I want them to keep his condition steady . . . I can cope with that . . .
And being safe
C14 – informal carer
Appropriate treatment:
In his best interests. I don’t want him to take anything that is irrelevant,
just for the sake of it. I just want it to be something that makes his
health and his life more comfortable and pain-free
C12 – informal carer
Quality of life:
I want to be able to keep [my husband] as well as we possibly can for long
as we possibly can. Basically it’s a question of maintaining quality of life
C11 – informal carer
It’s the quality of . . . being able to stay in vibrant relationships and you
know enjoy the things that are around you even though there are limits
to that [at 95 years old] . . . within the confines of what we are able to
offer when we go out or in the garden, you know he is able to enjoy,
physically and mentally enjoy the experiences
C46 – informal carer
What informal carers
think the older person
wants
Performance/clinical outcomes:
I think what she would like from her medication is the pain goes and she
has better mobility, that’s what she would want
C24 – informal carer
To keep her at home. As mobile really. And as functional really. Because. . .
we couldn’t cope if she couldn’t get out of bed really, I don’t think I could
C20 – informal carer
Appropriate treatment:
I don’t think he gives those things a thought to be honest. He takes it
because it is prescribed, and if it is prescribed then it’s something he needs
C12 – informal carer
Less of it
C26 – informal carer
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TABLE 10 Examples of interviewees’ medication management outcomes (continued )
Interviewees Outcomes
Adherence/non-adherence:
It’s just part of her routine I think now. I think her memory is getting
worse, she forgets why she has got to take things
C20 – informal carer
I don’t know that he thinks about it. He just takes them. Sometimes very
occasionally look through and ‘oh not all this lot’
C32 – informal carer
Ideally, it would be not to take it . . . Just to be able to, just take it and
forget about it
C15 – informal carer
Practitioners For themselves Performance/clinical outcomes:
No mistakes I suppose... no errors... in the meds reconciliation. So that we
are as accurate as we can be when they change care settings, from acute
or from the home to us, and then back to home
P1 – senior pharmacist
The best outcome for me with medication management is that our staff
made no errors
P38 – community health service manager
Appropriate treatment:
First and foremost that the patient is on the appropriate medication for
them. And that they understand why they are taking it. And are on board
and feel it is necessary. And are not getting side effects from it. And then
I guess finally that everything is clear and communicated and easy to
access in-patient, out-patient whatever
P6 – consultant geriatrician
People are taking medication appropriately. That it helps them. That it’s
not a hindrance. And that if it is causing any ill health or harm that we
make sure that we can do something about that . . . that it’s helping them
to live well and making sure that people have a good quality of life
P22 – social care manager
The patient still needs and is benefiting from that medication. Overall, it is
still hopefully doing more good than it is harm. I want to make sure that it
is still a medication that is based on current guidance . . . And also, I think
there is a role to play in ensuring that things are cost-effective, in terms of
a brand or generic prescribing. That there is an understanding that the
patient has the ability to kind of understand why they are taking it
P25 – general practitioner
And that they feel confident about it really, you know, they know what
they’re taking and why, and are happy to take it, rather than just saying
I take it because the doctor wants me to
P33 – specialist nurse
Quality of life:
People to be able to manage as independently as they want to
P18 – clinical pharmacist
I want [them] to be happy, I want them to be well. I want them to be
able to live their life as well as they can. So if that means them taking
their medication regularly then I’m going to sit there
P45 – formal carer
I mean patient satisfaction is probably the big driver really, you know.
They’ve got to leave here happy that what you’ve come up with is alright
for them . . . and making sure people aren’t on unnecessary medications,
it’s always nice if you streamline things and you’re on the most effective,
fewest most effective medicines
P53 – general practitioner
continued
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TABLE 10 Examples of interviewees’ medication management outcomes (continued )
Interviewees Outcomes
What practitioners
think the older person
wants
Performance/clinical outcomes:
To make sure, I would say, that it’s helping their condition, whatever it is
P22 – social care manager
They want to feel better, and they want to, they feel that either the GP’s
[general practitioner’s] listening, something’s being done
P33 – specialist nurse
To feel better I suppose . . . not be on stuff that’s sort of pointless and is,
you know, lots of preventative stuff that won’t make them feel better,
and actually might potentially be making them feel poorly
P53 – general practitioner
Appropriate treatment:
Most of them want to be on fewer medications. It might also be
exploring the route that is acceptable. So, patients often prefer a patch
over taking pills. Reviewing whether there are swallowing difficulties, if
we can switch onto liquids as opposed to tablets. Things like that can
make a big difference
P6 – consultant geriatrician
Not to take them. They don’t want to take them. They just don’t want to,
which is understandable. But I think I can sympathise with them, you
know. You don’t want to be taking 12 tablets every morning, five at
lunch, six at tea, 10 at bed, you know . . . you’re rattling
P45 – formal carer
So many people, I don’t think they necessarily want anything . . . I think
they’re just so used to be told this is what they need to take . . . People
want to have a bit more control over things sometimes, you know what
I mean. It feels that they are back in . . . control of it and able to manage it
P18 – clinical pharmacist
I don’t [know] if I am entirely clear on what they are hoping to get from it.
But I kind of imagine or sometimes I sense that it is benefit . . . I guess the
other thing is they also want to make sure they are not feeling any worse
taking them
P25 – general practitioner
What practitioners think
informal carers want
Coping experience:
Ease of supply to access the medicine from the chemist or delivery by
the chemist
P1 – senior pharmacist
Easy to take, not too many and noticing that it is making a difference.
I think they also really want to be listened to . . . They know the person
so much better than we do. And we do need to acknowledge that
P6 – consultant geriatrician
I guess they want it to be sort of hassle free. So, you know, nobody likes
the difficulties that some experience about getting medications on time.
I know that some people get a bit fractious when things look different as
well, it’s a different colour or it is not the brand I usually have
P25 – general practitioner
Convenience I think in terms of, you know, prescribing stuff that’s a bit
more straightforward
P53 – general practitioner
Just to keep that person as healthy as possible but doing it safely.
Informal carers quite often may be a bit concerned about how they’re
giving that medication . . . We’ve had some cases where people really
don’t want to do it all because of the responsibility of it
P18 – clinical pharmacist
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of older people’s outcomes make a distinction between those individuals who are perhaps trusting or
passive about taking medication ‘just as the doctor ordered’ and those who are more proactive in
seeking to minimise the burden of their regimen. Practitioners also acknowledge the importance
of individual outcomes to older people, including the benefits from medication. They also recognise
the value older people attribute to the interpersonal, therapeutic relationship and being listened
to within it. Aligned with informal carers’ outcomes, practitioners also appear to be aware of carers’
preference for medication management to be ‘hassle free’ as well as a similar need to be listened to in
the relationship.
Implementation work in medication management: focusing on older people
This section sets out interviewees’ descriptions of the way older people manage medicines day to day
as they seek to achieve outcomes and minimise burden, as well as the influences on what they do in
order to build explanations of the way medication management works, or not, for them. Literature
on emergent topics is also included for clarification. To aid navigation, the ‘dashboard’ (Table 11)
highlights key themes and the illustrative data extracts from narratives, located by box numbers.
Routines and control
Older people and informal carers devise routines to enable them to feel confident and in control
(see examples quoted in Box 1). Routines are the habitual behaviours that people adopt to carry out
regular daily activities, such as medication taking,115 in order to minimise cognitive demands and achieve
consistency. Initiating and sustaining stable routines contributes to burden management by maintaining
the balance between workload and capacity. Doing this successfully underscores a sense of self-efficacy
and agency119,125 through the experience of being in control: ‘Routines in medication management help
people to regain and to maintain control in their everyday life’.106
TABLE 11 Key themes: implementation work in medication management, focusing on older people
Routines and control: Box 1
Adjusting routines to maintain control: Box 2
Being informed: Box 3 Seeking treatment, and personalised
advice and support: Box 4
Practical concerns about
medications: Box 5
Cognitive concerns about
medications: Box 6
Future concerns
about coping: Box 7
Disruptions to routines and control
– new practitioners: Box 8
Disruptions to routines and
control – transitions: Box 9
Adherence to routines
through others: Box 10
BOX 1 Routines and control: older people and informal carers
I think I’m fairly confident that I’ve got things under control. And that I hope I’ve got future proof systems for
the drugs because I’m probably going to be on this regimen for a long time to come. Well, for ever.
OP8 – older person taking a complex regimen
I know what medication I get, I know that I can get it collected every month, and I’m the one who sticks it in
the boxes, so I know when to take it . . . I think the process is important and the routine is important – that’s
the key bit really.
OP10 – older person living with mild dementia
They come from the pharmacy in their original boxes. You put them into the dosette boxes. And all of the
family have them in the dosette boxes to make sure the routine is followed.
C11 – informal carer who cares for their mother,
supported by other members of the family
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Adjusting routines
Practices and routines do, however, have to be flexible as they need to be adjusted to fit with day-to-day
lives. Adjustments can occur when, for example, an older person’s capacity reduces, when there is a mismatch
between the quantities of pills provided and the equipment used to simplify medication taking, or when
organisational systems are not aligned or change (Box 2). This is confirmed by Haslbeck and Schaeffer:106
‘Not only a challenge to develop sustainable routines for daily medication management in the first place;
they also have to constantly readjust and change them – a task they have to deal with on their own’.
Being informed
The increase in complex polypharmacy makes it important for older people and informal carers to be
informed about their diagnoses and medications (Box 3). Personalised knowledge can then be built
into individual decision-making about routines, day to day: ‘to nudge people to make better choices’
(Thaler et al.119). Individualised information and collaboration with practitioners, based on shared
decision-making,42 are important aspects of this transactional work:
Patient participation in discussions about medicines and greater involvement in decisions was found to
lead to greater subsequent understanding of treatment, adherence, more satisfaction about both the visit
and doctor behaviour, and less regret about the treatment decision.
Stevenson et al.113
BOX 2 Adjusting routines to maintain control: older people and informal carers
The boxes used to be on the breakfast table and he used to take his tablets out of the box. And then it obviously
became apparent at some stage that he couldn’t do that or he wasn’t doing it. So it was easier for me to just
take what he needed out of the box, put it in a little dish, and if I put that little dish by his cereal bowl in the
morning and his orange juice and whatever else he has, then it was just a natural process for him to take it.
C12 – informal carer enabling her father
So, with the carousel, I mean, it’s good, it’s not perfect, but it’s solved a lot of problems in some respects. It’s
by his bedside, but he’s also deaf. So he’s totally deaf in one ear and has partial hearing in the other. So he
wears a hearing aid. But of course he doesn’t sleep in the hearing aid, OK? So the alarm goes off [on the
carousel]. That wakes mum up. She’s in her hospital profiling bed at the side of dad. When the carers leave
mum at night, they leave a walking stick across the bed and she gets the walking stick and prods him until he
wakes up and tells him his alarm’s going.
C09 – informal carer describing the night-time routine
for her father’s medication taking
Well, I have a box . . . where I put my daily meds in, my tablets. It’s actually a 7-day box but I use it as a 28-day
box because it’s got spaces for breakfast, lunch, dinner. So as I load that box . . . it takes two packets to fill the
box. But with this thing [in 10’s] it takes nearly three, and you know, that really is a pain. So when I order
3 months’ supply I always get the same quantity of everything but this, you can see how much this is built up.
OP28 – an older person with mild dementia trying to fit pills
that are dispensed in 10s into a 7-day box
I had real difficulty over the sharps bins [for two injected medications]. The Cimzia sharps bins, the [supplier]
take and they bring me a new one. The Methotrexate ones . . . [the local hospital] stopped dispensing them.
So, I was in trouble. Nobody seemed to know how I could get new sharps bins and dispose of them . . . But I
can now get that [Methotrexate] sharps bin prescribed by the GP but collected, whether they should do or not,
by [the local authority].
OP5 – older person
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Seeking treatment, and personalised advice and support
Where older people believe that they are not coping as well as they would like, based on their perception
of and emotional response to symptoms or changes, they seek help and support to regain control and
cope better, whether from partners, practitioners or technology. Examples are contained in Box 4.
Practical concerns about medications
Multiple risk factors may impact on routines and control. There are practical issues about being able to
distinguish different medications, described in the data extracts below (Box 5).
BOX 3 Being informed: older people and informal carers
I don’t think it’s difficult. And I think I quite understand a lot of my drugs as well which helps. I am quite
interested in the drugs in what they do and what they’re for. So because I understand them, that helps.
I read the leaflets, yes.
OP19 – older person
It’s just casually batted off during the appointment. And I think that more effort could be made to help
somebody that’s got all these conditions to understand not only the risk factor of not taking medication but
also what can be done additionally to help you get off that medication.
C26 – informal carer
Maybe as part of the discharge if they’d said OK this one is to do with protecting the lining of the stomach
and maybe you want to take it half an hour before. It’s just those little things that would have been helpful.
C15 – informal carer
BOX 4 Seeking treatment, and personalised advice and support: older people and informal carers
When I got rheumatoid arthritis, I was terrible. I was in a wheelchair. I couldn’t lift my arms up. I couldn’t
open doors. [My husband] had to prop the doors open when he went to work. I couldn’t walk anywhere
on my own. And I couldn’t pour kettles and . . . I was really bad. But I’m on the drugs now.
OP05 – older person
You walk into a pharmacy, there’s somebody there, you can have a chat and they’ll help explain. And I guess
the language issue obviously helps as well. So, the pharmacy obviously speak the native languages. So you
know, in that case, I wouldn’t necessarily have to go with mum and dad to the pharmacy.
C26 – informal carer
A lady that we saw who was in her 60s but was struggling to remember her medication. And when we looked
at different things, we realised that she needed something to prompt her. So, when we looked at her daily
routine and we talked about different things, it became apparent that the first thing that she did in the day
was to go on her computer and play a particular game. So, with the support of her husband, we put a screen
saver on the computer so that as soon as she turned it on in the morning, that had a prompt-reminder for her
medication. And then she then had to put a password in which was ‘tablets’ . . . And then we made sure that
her medication was accessible, near her computer . . . And then, when we did a follow-up a couple of weeks
later, we found that this had actually been really successful, and her blood pressure and her blood sugars were
much better controlled. And because of this she also felt much better. So she got that positive reinforcement.
P18 – practitioner describing the work they did to put a system in place once they realised
that asking her husband to prompt her didn’t work
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Cognitive concerns about medications
Older people may not cope as a result of cognitive decline (Box 6).
George et al.126 confirm this situation:
Polypharmacy, cognitive and functional decline, inadequate contact with health professionals, depressive
symptoms, poor social support and absence of assistance with medication administration are common risk
factors for medication non-adherence among community-dwelling elderly patients.
Future concerns about coping
Older people also have concerns about how cognitive decline or changes in the way that they manage
routines may affect their capacity to cope in the future (Box 7).
Disruptions to routines and control: new practitioners and transitions
Older people’s routines can also be disrupted by external factors such as a new practitioner reassessing
the need for certain medications (Box 8) or a care transition (Box 9). Both of these can lead to significant
adjustments to medication regimes. Disruptions can have positive outcomes, or not.
BOX 5 Practical concerns about medications: older people and informal carers
When you put the two side by side, yes, you can see there is a difference but again, somebody with poor
eyesight or slight confusion might not see that.
OP8 – older person
I’ve had three different colours of omeprazole.
C14 – informal carer
They are all little white pills.
C24 – informal carer
BOX 6 Cognitive concerns about medications: informal carers and practitioner
Well, he didn’t realise he was in difficulty with it. But he wasn’t taking his meds regularly. But he didn’t know
whether he’d taken something or not.
C09 – informal carer
My father was relatively on the ball. He knew what he was doing. But he was becoming frailer and had been
very dependent on my mother to help him manage his medication. But she was getting to a point where she
couldn’t. But nobody kind of realised and she thought she was still managing.
C11 – informal carer
It might be as simple as, you know, ‘am I supposed to continue this, how many times a day do I take it’ . . .
so just the processing of basic instructions of medications.
P53 – general practitioner
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BOX 7 Future concerns about coping
I mean it does worry me as I get older that I won’t be able to cope so well.
OP5 – older person
I’m also trying to put systems in place just in case I get Alzheimer’s. I’m hoping I won’t but you just never
know . . . because if you can put systems in place when you are totally compos mentis, that might help if you
are less so. Sort of future proofing really.
OP8 – older person
If certain things happen, if I become widowed or I become more demented, then obviously someone has to
take over those systems. So it’s my job to make sure the systems are as foolproof as possible, so that any fool
can do them so to speak, someone who doesn’t care as much.
OP28 – older person
BOX 8 Disruptions to routines and control: new practitioners – informal carers
Since we’ve been at the new place, they called him in for a review. And the doctor’s taken him off two, three,
I think, of the regular angina medicine that he’s been taking for quite a long time.
C09 – informal carer
He came to live here more permanently, registered with the doctor here, and then that’s when you know all
the, they reviewed all the medication and set him all up, set everything up here. And that’s when everything
became much more automatic and less complicated.
C46 – informal carer
BOX 9 Disruptions to routines and control: transitions – practitioners and informal carers
Some of our patients come in on so many different tablets that we need to review why they are on them, do
they need to continue on them, can we get them down to once daily dosing? . . . Are they actually taking
them? Are some drugs causing side effects which are then, other drugs are given for the side effects? So,
it is reviewing whether they need them and trying to stop them if they don’t. And you know, statins in
90-year-olds, is it appropriate? . . . But obviously you’ve got to discuss that with the patient when you are
making the decision as well, rather than just stopping things without telling them.
P1 – practitioner, senior hospital pharmacist
Especially when they go in and out of hospital and often their medication changes. And there can often be a
delay in the message getting back to the pharmacy or the GP. So we often have to chase that up’
C26 – informal carer
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Adherence to routines through others
Older people seek to overcome or compensate for physical and some cognitive difficulties with
equipment (Table 12 and Box 10). Functional capacity and the ability to cope will vary over a
potentially long trajectory of illness and is dependent on factors such as polypharmacy, increasing
frailty or cognitive impairment. Practitioners need to be able to identify older people and informal
carers struggling to cope. However, when adjustments cease to be effective or if the older person
prefers, they may make the decision to share the burden with informal and formal carers, potentially
increasing adherence:
Support from healthcare professionals and informal carers appear to be two independent predictors of
medication adherence . . .
Leung et al.128
Summary: older people
Within the complexity of medication management, routines appear to enable older people to control
and cope with balancing workload and capacity: their experience of burden. Setting up, following and
adjusting routines to fit with their lives (Stages 3 and 4) as well as resolving disruptions (Stage 1)
increase the workload on older people. Information can increase sense-making capacity, and when
older people identify problems they may seek personalised information, advice and support with
practicalities, mostly through contact with practitioners (Stages 2 and 5), so that they can improve
decisions from which action follows (Stages 3 and 4, as well as 1). When they feel that they are no
longer coping, older people may regain a sense of control of medication management through sharing
aspects or all of the burden with informal or formal carers. This can also help to ensure adherence.
Risks to coping can come from practical as well as capacity issues, such as cognitive decline or
increasing frailty. Older people may also experience disruptions to routines following contact with new
practitioners or at health or care transitions.
Implementation work in medication management: focusing on informal carers
The MEMORABLE study has identified a significant narrative about the experiences of informal carers,
summarised below. To aid navigation, the ‘dashboard’, Table 13, highlights key themes and the
illustrative data extracts from narratives, located by box numbers.
Increasing awareness of problems: gradually becoming an informal carer
Informal carers take on this role if asked to by an older person or practitioner, or if they become aware
that their relative or close friend is no longer coping with the burden of medication management,
highlighted by data extracts in Box 11.
Typically, this occurs gradually and involving small changes, such as starting to collect medications
because it is more convenient or putting out tablets because packaging becomes hard to handle.
However, it can also happen more suddenly if there is a disruptive event that adversely impacts on
the existing balance of workload and capacity or creates safety concerns, perhaps as a result of an
acute infection that causes weakness and confusion.
Learning by experience
Informal carers tend to learn by experience, have little if any access to training, and can end up taking
on more responsibility than formal carers (Box 12).
Learning by training and ongoing support: formal carers
The way informal carers learn about the complexities and risks of medication management as they go
along is significantly different from the way formal carers are prepared in advance and supported in
their role, as part of their service provision work (Box 13).
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TABLE 12 Medication management and changes to functional capacity
Functional capacity: coping independently to full,
formalised support (based on Functional
Independence Measure)127
Stage
1: identifying problem
2: getting diagnosis
and/or medications
3: starting, changing
or stopping
medications
4: continuing to
take medications
5: reviewing/
reconciling medications
No help: independent/
coping
Managing on their own Coping Collaborating: sharing
decisions and actions
Coping Coping Collaborating: sharing
decisions and actions
Managing safely and in
time, with equipment
Coping by, for example,
information seeking,
using prompts
Coping by filling own
pill box
Coping by filling
own pill box
Help: doing more than
half the task – coping
with increasing help,
including increasing
formalisation of support
Contributes with support
(e.g. verbal prompts,
encouragement/set-up,
equipment)
Coping with informal
carer/formal carer
identifying and
querying changes in
signs or symptoms
Collaborating: sharing
decisions and actions
with increasing informal
carer involvement and
increasingly formalised
support
Coping by receiving pre-filled pack, informal
carer/formal carer reminding/encouraging
to take
Collaborating: sharing
decisions and actions
with increasing informal
carer involvement and
increasingly formalised
supportContributes with support
(i.e. light-touch help)
Coping with informal carer/formal carer
setting up medication to take
Contributes with support
(i.e. some hands-on help)
Increasing informal
carer/increasingly
formalised support
with monitoring
multi-morbidities and
medications
Increasing informal carer/increasingly
formalised support with adhering to
medication routines (degrees of
institutionalisation/medicalisation)Help: doing less
than half the task –
dependent on more
formalised support
Contributes with a lot of
support (i.e. hands-on help)
Unable to contribute,
receiving full support
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Routines and control: informal carers
As with older people, informal carers rely on routines and making adjustments to them to cope with
the burden of medication management, responding to the older person’s changing needs (Box 14).
Risk awareness and stress: informal carers
A lack of expertise and an awareness of risk, anticipating the unknown, adds to the stress of the
informal carer role (Box 15).
TABLE 13 Key themes: implementation work in medication management, focusing on informal carers
Increasing awareness of problems: gradually becoming an informal carer – Box 11
Learning by experience: Box 12 Contrast of learning by training and ongoing support: formal carers – Box 13
Routines and
control: Box 14
Risk awareness
and stress: Box 15
Other medication management work
done by informal carers: Box 16
Role demands and
ambiguity: Box 17
What informal carers
give up: Box 18
Seeking recognition: Box 19
BOX 11 Increasing awareness of problems: gradually becoming an informal carer
Prior to things going wrong, he’d got a routine . . . it started to become obvious to me that there were tablets
lying around loose in the kitchen that he should have taken, and he wasn’t sure. Because I was only there
once a week, I wasn’t sure whether they’d been there just for that day, whether they’d been there for days . . .
C9 – informal carer
It’s sort of supervisory, to make sure he’s doing it without taking on the total responsibility.
C11 – informal carer
He relies on me for everything.
C14 – informal carer
BOX 10 Adherence to routines through informal and formal carers
At home we have a routine that we stick to, as I say, you know, a schedule.
C35 – informal carer
I manage her medication in the sense that we have a dosette box and I discuss with her GP what we’re going
to try next or whether or not things seem to be working and then I make up her dosette box every week. And
then four times a day, I actually have alarms, I have two alarms for lunchtime and teatime on my iPhone and
then that reminds me to get her meds out and stand over her while she takes them.
C43 – informal carer
And the person who is administering the medication is adhering to the principles and administering the
medication as prescribed by the relevant individual, i.e. GP or pharmacist.
P60 – practitioner: formal carer
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BOX 12 Learning by experience
The frustration of the carer that has learnt an awful lot and knows the picture – I’m not a doctor and I’m not
a nurse. But I’ve seen a lot and had to do a lot.
C32 – informal carer
I assumed that there would be a lot of information for me and this respiratory nurse, very pleasant, kind of
took me through it. And I watched him . . . We left with bags and bags and bags full of stuff . . . I had to swab
and check the line. I had to flush it – so I had to fill syringes with saline. And then I had to mix, it was a
powder I had to mix with, I can’t remember whether it was saline or what it was . . . And then I had to use
a syringe to get that. That then had to go into the line . . . And then I had to flush it out again. I made sure
I closed things. And make sure everything’s sterile . . . And I remember I was tired . . . I remember saying to
[the respiratory nurse], ‘I remember the sequence of what I had to do’ . . . he put it in writing, just as a letter
to the GP I think, that I had demonstrated I could do it. And like hell I’d demonstrated I could do it.
C32 – informal carer
BOX 13 Learning by training and ongoing support: formal carers
In terms of medication management for service users and administration, [formal carers] do a full day’s
training that is taught, is face to face. And then they’ll have a medication observation whilst they’re out on
district. And all staff get that at least once a year, if not twice. And all staff go on a 12-month refresher
for medication.
P38 – community service manager
Our medication training is amazing. It’s a full day. You’re there for seven to seven and a half hours. And then
once you’ve done your medication training, you actually come back to . . . where you work and . . . you’re
observed giving medication 10 times. If the supervisor’s happy, they’ll sign you off. If you’re happy, you’ll be
signed off. But if you’re not happy, yeah, for any reason, you will be then put back on 10 more observations . . .
as many observations as you like until you’re happy and you’re comfortable to administer medication on
your own.
P45 – formal carer
BOX 14 Routines and control: informal carers
At home we have a routine that we stick to . . . a schedule, I should say.
C35 – informal carer
What I do now is I’ve got little ramekin pots and I just put all the tablets in there . . . So at night, I set them
both up and I give him his evening tablets. But the ones in the morning are ready, for me. Just lift the ramekin
up and put it on his table, ready.
C32 – informal carer
So what I’ll do is I’ll take my dad to his appointment. As soon as I’ve dropped him off, l’ll sit down at my
mum and dad’s house and I’ll make the notes there and then. Think about what I need to do next. Stick it in
[my book] and then I can forget about it.
C15 – informal carer
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Other medication management work done by informal carers
Being an informal carer involves finding things out independently, being the link between practitioners
and joining the system together (Box 16).
Role demands and role ambiguity: informal carers
There is ambiguity in carers’ ‘informal’ role, including barriers to their involvement in practical aspects
of medication management, particularly when changes are gradual (Box 17).
What informal carers give up
Informal carers give up aspects of their own lives to take on this role (Box 18).
Seeking recognition: informal carers
Being an informal carer of an older person living with multimorbidity and polypharmacy is becoming
an increasingly expert and demanding role (Box 19). Informal carers seek recognition as an important
contributor to medication management, and health and care delivery.
BOX 15 Risk awareness and stress: informal carers
It’s quite a difficult position to be in as a carer to know whether, what to do, where to go.
C32 – informal carer
And I’m not an expert either . . . I guess it frightens me, you know . . . all these side effects . . . I don’t want to
misunderstand the information because I could misinterpret how to take them and I wouldn’t want to put my
dad in a dangerous position where I advise him to do something which compromises his health.
C15 – informal carer
Well I don’t think you actually realise because you’re just constantly adapting . . . You kind of get through that
week and then all of sudden you think ‘I am so tired’. And you think ‘why am I so tired? Oh, it’s because I was
physically exhausted, and mentally, last week just dealing with it.
C12 – informal carer
You can’t help but feel responsible even though I don’t know whether it is my job or not really, is it. Well it is
I know, but . . . People assume that you are going to do things you know. They assume that you can do it.
They don’t realise that perhaps sometimes you can’t cope . . . I don’t think they realise how much it affects
health, caring.
C20 – informal carer
BOX 16 Other medication management work done by informal carers
[For medication in liquid form to be given via per enteral gastrostomy] But they don’t supply the syringe.
It’s ludicrous. And then they’ll say, ‘Well . . . draw the liquid from the cup’. But the syringe is too big for the
cup . . . It’s very frustrating, actually, because, as I say, everybody passes the buck and we’re like, ‘We need a
syringe’. And, you know, we can’t get one from anywhere.
C35 – informal carer
I have to chase up an awful lot of stuff. So I’m chasing. And I mean, I don’t know what’s available. There’s
nobody overseeing it and drawing it together apart from me but without the professional experience or
knowledge of what might be available.
C32 – informal carer
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BOX 17 Role demands and role ambiguity: informal carers
It didn’t help that he refused to have them in the blister packs and the chemist won’t put them in the blister
packs unless you get his consent.
C14 – informal carer whose husband has dementia
I’ve been in contact with Social Services. But because he’s refusing any help, they won’t send anybody out
because he’s got to be engaged fully with the assessment. But I’m going to the GP’s next week with a view to
looking at how his memory is and whether he still actually has ‘capacity’ . . . But I’m stuck.
C14 – informal carer whose husband has dementia
The GP knows that they can give me information about my dad over the phone on his behalf [or] ring me to
say my dad needs a follow-up review . . . But that’s only recently . . . They did make it clear beforehand that
if I needed information on behalf of my dad then I would need to get a letter from my dad to do that . . .
I don’t think my dad has formally provided anything in writing to the GP. I think just through me attending
the appointments I think they see the value in me being there.
C15 – informal carer whose father has dementia
BOX 18 What informal carers give up
I wasn’t there every day but I was there 4, 5 days a week. I was staying at mum and dad’s for about 3 nights
a week or 4 nights a week and then going back [to my home 50 miles away] for 3 nights a week . . .
C9 – informal carer
[Gave up full time work because] they would need my undivided attention to be able to do all of that. And
that was because I wanted the best outcome. And I couldn’t trust with all due respect, even though there are
people out there, they would actually do this to my satisfaction.
C11 – informal carer for husband and mother, both of whom have dementia
I had to sell my house and move up here to be near him.
C14 – informal carer
BOX 19 Seeking recognition: informal carers
I think any carer, regardless of whether they’re professional or not, should get that [respect from practitioners]
because it becomes – you learn so much. You take so much on. You have to listen to the people that are there all the
time doing it . . . because there is a massive responsibility managing other people’s medications. It is such an issue.
C11 – informal carer
I know there’s time constraints on everybody. I do understand all that and there’s pressures on budgets and
stuff. But I’m just asking for somebody to communicate with me. Talk to me.
C14 – informal carer
I’ve walked out of the appointments feeling really sad, thinking ‘I’m really angry with the way I’ve been treated
and the fact that I let it go’ . . . If they [practitioners] could better understand my role, then I think they could
make the most of me and make sure that I know what I need to do so that when my dad leaves, he’s going to
do what he’s supposed to do.
C15 – informal carer
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Summary: informal carers
Within the complexity of medication management, informal carers gradually take on a role in
which they are trusted to meet the health and care needs of the older person they support, amid
assumptions about their ability to cope. Learning by experience, largely on their own, they take on
what can be an increasingly complex workload associated with setting up, following and adjusting
medication management routines and tasks (Stages 3 and 4), as well as identifying problems (Stage 1)
as the older person’s needs change. They can be pivotal to individualising health and care delivery,
linking with practitioners and joining up systems. They make compromises in their own lives to do this.
Stress associated with this role derives from factors such as a lack of knowledge, information, training,
or support. Amid varying experiences of ambiguity about their role, they seek recognition for the
complexity and burden associated with what they do.
This concludes the findings on medication management, highlighting the perspectives of older people,
informal carers and practitioners. Medication management is explained as a complex intervention, as
implementation through linked and iterative stages, steps and loops, as burden and as experienced. These
findings are the platform for a more detailed analysis of the key stage of the medication management
process: Stage 5 – reviewing/reconciling medications. Based on these findings, two possible interventions
have been generated: the identification of older people at risk in the way they manage their medications
and individualised information. These will be presented in Proposed interventions.
Reviewing/reconciling medications (Stage 5)
Medication reviews being a really critical part of good medication management. And, that could be either
at points of transition with people going backwards and forwards between different settings, particularly
on the return setting, coming back to you in general practice, or on the timed basis, whether that is a
6-monthly or a 12-monthly review that you have built into your system.
P2 – general practitioner
This section starts by exploring good practice in reviewing/reconciling medication, based on policy and
the literature, including articles identified through supplementary searches. It then explores reviewing/
reconciling medication and burden, synthesising data from the literature and experiential narratives
about older people’s, informal carers’ and practitioners’ experiences of this stage. CMO configurations
based on this combined data inform the understanding of burden in reviewing/reconciling medications
and ways of mitigating it, expressed in a framework (a programme theory).
Reviewing/reconciling medication as good practice
Reviewing/reconciling medications aims to optimise medication management and improve quality of
life in older people with long-term conditions requiring complex medication use.129 This has been
identified as Stage 5 in the medication management process, above.
The need for effective interventions to review or reconcile complex medication regimens and their use by
older people has increased because of the growth of polypharmacy, the variety of alternative medications
per diagnosis and the need to avoid the risks and costs associated with inappropriate treatments:130
The growing number of older adults who are prescribed multiple medications is at increased risk of
receiving PIMs (potentially inappropriate medications) and PIRs (potentially inappropriate regimens).
A major challenge in their care is the provision of medication reviews to identify these PIMs and PIRs.
Niehoff et al.131
Scoping good practice
There are three key interventions associated with reviewing/reconciling medications: a medication
review, a medication use review (MUR) and medication reconciliation.
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First, a medication review: in terms of definitions NICE33 scopes a medication review as:
A structured, critical examination of a person’s medicines with the objective of reaching an agreement
with the person about treatment, optimising the impact of medicines, minimising the number of
medication-related problems and reducing waste.
© NICE 2009. Medicines Optimisation: the Safe and Effective Use of Medicines to Enable the Best
Possible Outcomes. Available from www.nice.org.uk/guidance/ng5. All rights reserved. Subject to
Notice of rights. NICE guidance is prepared for the National Health Service in England.
All NICE guidance is subject to regular review and may be updated or withdrawn.
NICE accepts no responsibility for the use of its content in this product/publication
There are three accepted levels of medication review based on patient need, set out by Clyne et al.:132
l level 1: a prescription review – a paper-based, technical review, such as reviewing older people with
a less complex medication regimen, stable comorbidities or who are regularly seen and known to
practitioners as part of their on-going management
l level 2: treatment review – a medication review with full clinical notes but not necessarily the
person, an enhancement of level 1.
Levels 1 and 2 descriptors are applicable to reconciliations.
l level 3: clinical medication review – face-to-face review of comorbidities and medication with
the older person, such as regular reviews of older people on more complex medication regimens,
with unstable comorbidities or who may be regularly seen and known to practitioners as part of
their ongoing management but require a more comprehensive assessment of their overall
treatment, particularly if there are concerns about not coping, increasing risk or adherence.
Second, a medication use review: carried out by community pharmacists, these are generally considered
to be a level 2 review, but with the older person present. The Quality and Outcomes Framework (QOF),
the performance and reward system for primary care services in England, currently distinguishes MURs
as a complementary optimisation intervention.133 In these MURs:
The pharmacist reviews the patient’s use of their medicines, ensures they understand how their medicines
should be used and why they have been prescribed. The pharmacist will also identify medication problems
and will then provide feedback to the prescriber, if appropriate.
Reproduced with permission from the Pharmaceutical Services Negotiating Committee134
Thus, the pharmacist aims to improve the person’s understanding of their medication, identify side
effects and problems and agree solutions. This is often seen as a way of improving adherence and
reducing waste.
Finally, medication reconciliation: the NICE Medicines Optimisation guideline33 provides the following
definition:
Identifying an accurate list of a person’s current medicines and comparing them with the current list in
use, recognising any discrepancies, and documenting any changes, thereby resulting in a complete list of
medicines, accurately communicated.
© NICE 2009. Medicines Optimisation: the Safe and Effective Use of Medicines to Enable the Best
Possible Outcomes. Available from www.nice.org.uk/guidance/ng5. All rights reserved. Subject to
Notice of rights. NICE guidance is prepared for the National Health Service in England.
All NICE guidance is subject to regular review and may be updated or withdrawn.
NICE accepts no responsibility for the use of its content in this product/publication
DOI: 10.3310/hsdr08260 Health Services and Delivery Research 2020 Vol. 8 No. 26
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Maidment et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
47
Good practice in reviews and reconciliations is informed by guidelines, evidence and experience. NICE
guidelines address them as an element of adherence,72 optimisation,33,84 enhancing the management of
multimorbidity and polypharmacy.29,41 Good practice advice includes:
l aims: adherence;72 optimisation medication management through safe and effective medication use;33
optimising care through the reduction of treatment burden associated with, for example, multiple
medications and appointments for tests, consultations and reviews, as well as unplanned care41
l reviews: regular or as agreed, led by the most appropriate health professional, with technical and
therapeutic knowledge as well as communication skills33
l reconciliations: timed to coincide with health and care transfers, led by an appropriate health
practitioner such as a pharmacist, pharmacy technician, nurse or doctor33
l individualised, person-centred approach33,41 underpinned by shared decision-making33,41
l practice content: medication list;72 prescribing decisions;72 evidence base for decisions, including
using a screening tool for medication appropriateness such as STOPP/START (Screening Tool of
Older People’s Prescriptions/Screening Tool to Alert to Right Treatment),35 balancing evidence for
single health conditions in multimorbidity;35 addressing prescribing and deprescribing decisions to
include medication and non-pharmacological treatments35
l risk identification by the practitioner: need for adherence support,72 polypharmacy and high-risk
medications35
l older person information elicited by the practitioner: experience of medication use – knowledge,
understanding, concerns, needs72 as well as preferences, behaviours and risk,33 including risk
aversion;35 importance to them of treatments, health priorities, lifestyle and goals;35 right to
involvement in discussions and making informed decisions35
l informal carers: involvement33,41
l outputs: individualised action plan that addresses multimorbidity and subsequent polypharmacy,35
action plan for any non-adherence.72
Guidelines are supported by a growing body of research evidence on medications reviews129,135–137 and
reconciliations.138–140 Nonetheless, there is ambiguity about the impact of these interventions. On one
hand, there is good evidence of the benefits that accrue to individuals including reducing drug–drug
interactions, minimising side effects and addressing undertreatment or overtreatment of diagnoses:130,141
Medication reviews can reduce both polypharmacy and the use of inappropriate medications in the
elderly. Our findings support these previous findings and highlight the added likelihood of inappropriate
prescribing in the elderly and those with lower educational attainment.
Fletcher et al.135
On the other hand, however, there is less clarity about gains in terms of adherence, quality of life or,
at a system level, avoiding hospital admissions or securing cost savings.129,142
In addition to NICE guidelines, good practice is also framed by professional and task-specific advice,
reflecting practitioners’ roles and responsibilities. Examples in use during this research include the
General Medical Council’s Good Practice in Prescribing and Managing Medicines and Devices (2013),143
advice from the Nursing and Midwifery Council on medication management144 and record keeping,145
advice from the Royal College of Nursing on medicines management146 and nurse prescribing,147,148
and the Royal Pharmaceutical Society’s good practice guidance on medicines optimisation, 2013.149
Practice is also informed through more local organisations, including clinical commissioning groups’
policies, formularies, fiscal directives and incentives, as well as employer-related documentation,
induction programmes and training packages, including some associated with academic qualifications
that aim to ensure standardised, managed delivery and performance. Reviewing the substantial number
of locally relevant documents was beyond the resources or needs of this research.
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Interpreting and applying good practice
Despite both guidelines and evidence, good practice is open to interpretation, reflected in the
experience of one primary care practitioner:
Is a medication review, a GP sitting in the consulting room on their own looking at a list of the patient’s
medication? Or is a medication review, the patient sat in front of you and having a discussion about each
and every drug, the indication for it and are they getting any side effects?
P25 – general practitioner
According to Huiskes et al.,129 there is no gold standard for the way individual practitioners deliver
reviews and reconciliations: ‘different levels of medication review are applied in daily practice’.
This view is confirmed by the previous practitioner:
I think probably as variably as it is done in primary care, it is probably that the variation goes on in
secondary care as well.
P25 – general practitioner
In considering when reviews and reconciliation should be carried out, reconciliations are part and parcel
of transitional care, particularly when older people move into and out of secondary care. However, the
decision on an appropriate level, content and timing of a review appears to be determined by individual
practitioners within their own services, balancing the needs of the older person with resource limitations,
including their own capacity, and increasing demand:
Time is very pressured. So when people are booked in for their reviews, if you look at the amount of
information that you want to capture and outside of a medication review . . . so it is probably blood
pressure, weight, height, how much you drink, how much you smoke, giving appropriate lifestyle
information, recording a CHAD-VASc or a QRISK [standardised assessment and scoring systems], making
sure that blood tests are up to date if they are needed. There is so little time left to kind of do the very,
very thorough medication review, you know, the gold standard one.
P25 – general practitioner
In these circumstances, older people’s and informal carers’ experiences of good practice confirm
differences in the regularity, purpose and content of reviews, and the scope of the different practitioners
undertaking them. Not all those who meet the criteria for regular reviews receive them:
I suppose now, someday, it’ll happen. But I’ve never been to see anybody and they said ‘Oh well, why are
you on so much? And why are you doing this? And do you think we should change it or . . .
OP21 – older person
In addition, uncertainty about purpose and access to reviews in particular can create ambiguity around the
way in which older people value and subsequently contribute to them. Their value and usefulness may be
more limited when they are perceived as a discrete, performance and policy-driven aspect of health system
provision, formulaic in their application, rather than an integral, person-centred aspect of their care:
It’s usually 6 months now I think. Something like that . . . my next one is due in April. So I won’t be able to
get these [medications] again until I’ve been reviewed in April . . . When they say review, sometimes it’s
the pharmacist you see . . . not necessarily a doctor. In fact, well there’s a practice nurse and a practitioner
or there’s a pharmacist or a GP and you never know which one you’re going to get . . . I mean if you’re
taking things, you ought to be reviewed. But as far as I’m concerned, once a year is enough.
OP29 – older person
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This brief exploration of good practice sets out the guidance on what should take place in reviews or
reconciliations as well as experiences that highlight some difference in practice. However, this research
is concerned with how such interventions work as an aspect of the medication management process.
Accordingly, the next subsection reports findings that explore causality in reviews and reconciliations.
In particular, it focuses on explaining how burden might be understood and mitigated, as this is
fundamental to proposing interventions that are both evidence- and experience-based. It draws on
work included in Appendices 5–8.
Reviewing/reconciling medications and burden
Analysis and format of findings
The findings for this stage of medication management have emerged from the continued application of
a causal approach to the analysis of subsets of data, in this case centred on burden. Figure 4 sets out
the key concepts in the analysis, informed by NPT. The aim is to understand burden in this stage and
to identify potential contributions to its mitigation through implementation processes: sense-making,
action, reflection/monitoring and relationships.
Describing reviewing/reconciling medications
It has been established that in Stage 5, reviews are effectively non-acute interventions, proactively
instituted by the relevant practitioner. They provide an opportunity to consider older people’s medication
management burden: their workload, capacity and coping, extending to a wider review of needs, goals and
care. Typically, discussion largely centres on what is happening in Stage 4: continuing to take medications –
what are the medications doing, what effect the medications are having, how do they feel they are
managing their medications, what would make managing them easier? However, reconciliations are
typically more acute interventions to confirm the current medication regimen as a basis for treatment
planning, effectively a reactive process whenever there is change or disruption such as at transitions,
often from home to hospital and home again. There may be burdens associated with a transition, such
as from an acute deterioration in an older person’s overall health or increase in frailty; the stress and
anxiety about an acute illness and a hospital admission; or the loss of capacity from learned dependence
associated with the sick role and institutionalisation. These may be distinctly different from the underlying
burden that an individual has experienced day to day. On this basis, and having set out burden’s explanatory
potential in medication management, above, the workload-capacity dynamic of burden is assumed to be
transferable to reviews and reconciliations as a key stage.
Older people living with multimorbidity and polypharmacy
Informal carers and practitioners
Stage 5: reviewing/reconciling medications
(linked to Stage 4: continuing to take medications)
Understanding burden
Workload Capacity
Sense–making Action Reflection and monitoring
Relationships
FIGURE 4 Structure of the analysis of Stage 5: reviewing/reconciling medications – understanding burden.
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Describing burden in reviews and reconciliations: from the literature
Good practice guidelines from NICE72 on adherence do not refer to burden and, on optimisation,33 they
briefly mention burden in terms of adverse events impacting on the NHS. Guidance on multimorbidity
and polypharmacy36 acknowledge both ‘treatment burden’ from multimorbidity and the ‘pill burden’ from
polypharmacy. These are generalised references and not specific to this stage in medication management.
Findings from the searched literature on burden have been discussed previously: seeMedication management
as burden, highlighting important links between workload, capacity, burden, coping and risk, again in
generalised terms.
Describing burden in reviews and reconciliations: from interviews
Focusing on reviews and starting with the workload indicative of potential burden, older people and
informal carers have described a range of specific tasks associated with this stage, such as:
l having to make and attend appointments, including travel arrangements
l in advance of the review, organising blood tests so that results will be available in time
l preparing for the review by reflecting on their current medication and noting any feedback or
concerns that they want to raise
l contributing to the discussion and decisions, including considering the options and adjustments that
will be required when back at home
l needing to contact the pharmacy about new prescriptions and dispensing adjustments, especially
where they have blister packs, disposing of discontinued medications, reading and acting on new
patient information leaflets and developing a new routine to accommodate any stops, starts or
changes to dosages.
Informal carers may gradually become more involved in these tasks, particularly if the older person is
becoming increasingly frail or cognitively impaired. Informal carers may start by providing transport
and arranging review appointments. However, they may eventually become a key participant, reflecting
their contribution to managing their relative’s or friend’s medications on a day-to-day basis.
The workload for practitioners might include:
l setting up a recall system
l generating invitations to attend a review and following up non-responses
l agreeing a convenient date and time to fit with older people’s travel arrangements and practitioner
commitments, such as routine and emergency appointments
l facilitating discussion and decision-making
l agreeing plans and next steps
l communicating outcomes to other practitioners involved in the older person’s medication management
l acting on any plans such as requesting further blood tests, generating new and cancelling previous
prescriptions, and making referrals to other practitioners.
Following on from workload and tasks, the other aspect of burden in this stage is capacity. Capacity
can be domain-associated: physical such as dexterity, vision, hearing or stamina/fatigue; affective,
particularly the personal motivation and confidence to be engaged in the process; and cognitive,
including memory and executive function that are important to effective communication, decision-
making and action. Capacity can also be externally generated as part of a ‘compensation’ strategy
such as by getting encouragement, help and support through the involvement of informal carers.
Explaining reviewing/reconciling medications and burden
The subsections that follow set out the findings on reviewing/reconciling medications and burden,
highlighting key themes that have explanatory value in understanding the complexity of burden in this
stage and contributing to the framework in Figure 5. To aid navigation, the ‘dashboard’ (Table 14)
highlights themes and the subsections in which they are set out, burden types and key steps.
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Subsections explain each theme, setting out summary CMO configurations evidenced with extracts from
the literature, as well as from interviews. CMO configurations are prefixed with RR as an abbreviation
for reviews/reconciliations in this stage of medication management. This causal analysis supports the
stratification of burden into five types: ambiguity, concealment, unfamiliarity, fragmentation and exclusion,
locating these burdens as mechanisms. The researchers acknowledge that if this stratification was applied
more widely to the analysis of data, as opposed to identifying the way that the identification of these
burdens evolved, burden in general as well as specific burden types could also be contexts or outcomes
in more generative explanations of the way medication management stages work.
Illustrative quotations have been selected to provide a rich and insightful example of interviewees’
experiences or because they make a unique but important contribution to understanding the topic.
They add to the understanding of each subsection through subtle nuances, often lacking in the
literature, that explain the interviewee’s experience of burden, directly or indirectly. The number of
data extracts under any configuration does not imply a greater weight of evidence but illustrates
its range, highlighting, for example, the difference between the perspectives of older people and
practitioners, or the particular experiences of informal carers. CMO configurations contribute to
explaining the stage and the burden within it.
Despite focusing on reviewing/reconciling medication (Stage 5), theorising about this stage contributes to
confirming, refining or refuting the candidate programme theories on medication management as a whole
that were set out at the start of the research (see Step 4: candidate programme theories and substantive
theory). Figure 5 summarises the implementation steps within reviewing/reconciling medication (Stage 5)
and, for each step, CMO configurations that describe and explain the researchers’ causal claims. Figure 5,
therefore, represents a detailed subsection of the research’s emerging programme theory, focused
specifically on Stage 5. This will be considered in Chapter 4.
Knowing about medication reviews and reconciliations: ambiguity
Purpose and content of reviews/reconciliations
Validating the work on generic ‘good practice’ set out in Describing burden in reviews and reconciliations:
from the literature, the literature highlights the importance of reviews, reconciliations and an individualised
approach as a way of influencing older people’s experiences in Stage 4: continuing to take medications:
Patient-focused, structured and collaborative health care service provided in the community setting to
optimize patient understanding and quality use of medicines.
Basheti et al.130
In the process of medication review, healthcare professionals can assess the need for changes in
medication, ensure patients’ understanding of the medication regimen and provide review for patients
who are at risk, while patients can discuss their perception regarding adverse effects or effectiveness of
the prescribed medication.
Leung et al.128
TABLE 14 Key themes: reviewing/reconciling medications and burden
Key theme Burden type Key step
Knowing about medication reviews and reconciliations: purpose and content, timing,
practitioners’ experience and expertise, home-based reviews, reconciliations
Ambiguity Sense-making
Having personalised, meaningful information Concealment Sense-making
Continuity and mutual trust Unfamiliarity Relationships
Addressing complex needs as a whole Fragmentation Action
Recognition and engagement Exclusion Action
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Reconciliation process at discharge, with individual attention and subsequent monitoring at the patient’s
home could ensure appropriate compliance with chronic treatment, with a consequent reduction in
medicines errors and adverse effects.
Marmesat et al.150
Medication improvement strategies to shift from a system repairing overdue maintenance to a more
individualized approach . . . related to a patient’s use of medication in the context of his medical
condition. For instance individualized medication coaching consults with non-adherent patients or patients
experiencing drug-related problems or adverse events.
Huiskes et al.129
Informed by the literature, work on the initial CMOs identified the way, for example regular medication
reviews and transition reconciliations by experienced practitioners optimise medication management
by minimising the risk of treatment-related problems [Lit (literature) CMO 05] or when practitioners carry
out a medication review in an older person’s home, they are more likely to identify medication-related
problems because they understand people’s lived experiences and they take more time (Lit CMO 06).
Interviewees, however, present a less consistent picture of their experiences of reviews, with older
people and informal carers describing uncertainty about purpose and content. They struggle to reconcile
having a review of their medication, separate to a review of a single diagnosis from the many that they
have, such as a diabetic or cardiac review, when they are living with multimorbidity. Some reviews are
also perceived as being undertaken to fulfil practitioner/service performance requirements rather than
to meet their needs (Box 20).
BOX 20 Purpose and content of reviews and reconciliations: older people’s and informal carers’ perspectives
After a blood test. So it’s a review of your bloods and what I would expect to be a review of medication.
I don’t actually think it is a review of medication. It’s a review of your blood test. It’s also apparently now,
also a dementia review.
OP10 – older person
Regular reviews of parent’s medications with the GP or pharmacist? No, not particularly . . . because there’s
such a high frequency of contact.
C26 – informal carer
Because of his diabetes and that gets reviewed when he has his annual diabetes review . . . specialist nurse . . .
to be fair I don’t know how his asthma’s going to be reviewed. I guess that would be done through his GP now.
C15 – informal carer
We get more discussion, support etcetera, and reviewing, through the research program. And that’s when
[my husband’s] overall review comes. Because they take bloods forever. They weigh you. They examine you.
You have your blood pressure taken. They talk to you. They ask you questions ‘til you’re blue in the face.
OP10 – older person whose husband is participating in research
Getting an appointment with him is more difficult, except when they ring up and say they want me to go and
see him and he’s sitting behind his desk fuming because it’s one of these national, government sort of things
that he’s got to do.
OP13 – older person
DOI: 10.3310/hsdr08260 Health Services and Delivery Research 2020 Vol. 8 No. 26
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Maidment et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
53
Practitioners appear to recognise the value of medication reviews, if not always their potential (Box 21).
The evidence highlights ambiguity in the purpose and content of medication reviews, in particular.
Timing of reviews
Box 22 highlights significant variation in the older people's and informal carers' experience of the timing
and regularity of reviews. Practitioners also acknowledge potential differences in the interpretation of
‘good practice’ (Box 23). This evidence underscores ambiguity about timing.
BOX 21 Purpose and content of reviews and reconciliations: practitioners’ perspectives
It would make my life a lot easier if everybody was reviewed, every medication had a really good review as to
why they are on it. Because that would save so much time . . . you know . . . looking at do they really still need
it and what the evidence base is for them still needing it.
P1 – practitioner, senior pharmacist
We had someone the other day . . . I’ve been dealing with seeing every couple of weeks . . . rang the chemist to
say, ‘Oh, can you just slow down the delivery of my dosette boxes because I’ve got quite a backlog?’ . . . And he
had a months’ worth of dosette boxes that he was sort of picking and choosing from. Some were half empty.
Some were full . . . So what we thought was happening and what was actually happening were just very
different things.
P53 – general practitioner
People that go out in the community and look at what patients have got. And you know stop re-issuing things
that (a) shouldn’t be prescribed anymore and (b) that they have got you know a 10-year supply of. And it just
becomes beyond a joke. I mean there is just so much waste . . . We could save millions in the NHS if we just
monitored medication properly.
P30 – practitioner, specialist nurse
BOX 22 Timing of reviews: older people and informal carers
Dad has reviews every 3 months . . . by the GP.
C14 – informal carer
It’s a 6-monthly review, yes.
OP19 – older person
The GPs insist once a year that I go and have a review for my rheumatoid arthritis.
OP5 – older person
If she does go to the doctor, which isn’t very often, they probably do do a review then. But it’s not done on a
regular basis, I assure you of that.
C35 – informal carer
I can’t remember the last time we had a review.
C12 – informal carer
I suppose I have to be proactive in requesting an annual review.
C46 – informal carer
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Practitioner experience and expertise
The combination of professional requirements, experience and expertise required to carry out
reviews and reconciliations is available among doctors, nurses, pharmacists and pharmacy technicians.
However, evidence exists in the literature of the development of an enhanced role for pharmacists to
carry out reviews and reconciliations because of their particular knowledge and skills. However, there
is also evidence of significant variation in the range of activities already undertaken by pharmacists in
carrying out this work, from simply providing a record of medications dispensed, to more collaborative
interventions that directly engage with and support older people and practitioners with complex
medication management.151
Community pharmacists could be more involved in medication review interventions for older adults,
with their contribution extending from identification of DRPs (drug related problems) to a more holistic
contribution to medication therapy management.
Kallio et al.151
Interventions involving pharmacists in medicines management, such as medicines reviews (with positive
effects on adherence and use, medicines problems and clinical outcomes) and pharmaceutical care
services (consultation between pharmacist and patient to resolve medicines problems, develop a care
plan and provide follow-up; with positive effects on adherence and knowledge).
Ryan et al.111
Important role of pharmacists in taking accurate medication history across various hospital transitions.
Pharmacists’ increased knowledge and acquaintance with the medications allows them to extend support
to other healthcare professionals including doctors and nurses by acquiring precise and complete
medication histories from the patients.
Cheema et al.138
Active interventions by pharmacists including medication reconciliation, tailored patient counselling, and
provision of telephonic consultation with patients following hospital discharge were associated with
clinically important reduction in medication discrepancies.
Cheema et al.138
BOX 23 Timing of reviews: practitioners
A regular, by which at least yearly review of patients who are on multiple medications, so that’s usually older
patients. It could be by a doctor, pharmacist, nurse with a view to check that all medications are currently
still indicated, that there isn’t inconsistent prescribing or multiplication of drugs or prescribing something to
counter the side effects of another medication. And just rationalise what’s being prescribed. And confirm that
the patient is taking it. And whether they are taking any additional over-the-counter medications as well.
P6 – practitioner, consultant geriatrician
I think it was that medication reviews would generally be about 6 monthly [under QOF]. And also, that
would apply to patients taking maybe four or more medications. But if you had less than that then I think
the requirement could be kind of annually. And then somewhere along the lines it was actually felt that face
to face would be sufficient annually and maybe the 6-month interim, could just be, may not be face to face.
So, it may be just sort of the scenario that I described, where you are looking and saying ‘Oh yes, everything is
up to date and yes that seems appropriate, we will go on until the next face-to-face review’. And I think that
was got rid of in QOF some years ago but I think practices, well certainly our practice, still use that kind of
framework in terms of medication reviews currently.
P25 – general practitioner
DOI: 10.3310/hsdr08260 Health Services and Delivery Research 2020 Vol. 8 No. 26
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Maidment et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
55
Impacts on cardiovascular disease and diabetes were the most frequently reported clinical outcomes.
Pharmacist services in these therapeutic areas may be particularly valuable because warfarin,
insulin, oral antiplatelets and oral hypoglycemics are implicated in up to two-thirds of hospitalizations
linked to ADEs.
Jokanovic et al.152
High levels of workload are perceived as a major safety concern in UK general practice, and one
of the main policy drivers of pharmacist role development is to free clinical and administrative
time for GPs.
McNab et al.139
Interviews confirm the diversity of practitioners involved in reviews and evidence the increasing
contribution of pharmacists, supporting general practitioners (GPs), described in Box 24.
The evidence highlights ambiguity in the roles, experience and expertise of those likely to be
undertaking medication reviews, in particular potentially exacerbated by workforce innovations in
accessing appropriate knowledge and skills in line with the complex needs of older people.
BOX 24 Practitioner experience and expertise
We always see the GP themselves.
OP19 – older person
I have once or twice had reviews of my medication with the pharmacist. Certainly not frequent. The prescriptions
always say ‘to be reviewed by the GP’, of course, on such and such a date. And everyone ignores those. So some
of those dates are a year late . . . But the pharmacist is supposed to review, and one is supposed to say to a
pharmacist ‘I’m feeling a bit funny about this new med’ and they’re supposed to advise you, aren’t they?
OP28 – older person
The pharmacist did pick up on the fact that I was a patient with lots and lots of drugs – and ‘Come and have a chat’.
OP8 – older person
I wouldn’t hesitate to talk to the pharmacist, because they really are very helpful.
C12 – informal carer
Pharmacists in GP practices, I think there is a big role there isn’t there for reviewing medication.
P1 – practitioner, senior pharmacist
We have three practice-based pharmacists . . . CCG [Clinical Commissioning Group] employed . . . they do a
number of audits including safety audits . . . they will inform us if there has been a hospital admission that
could have been linked to a medication – [they do] a kind of root cause analysis on that . . . But they also
have an extended role . . . assist us with medicines reconciliations . . . Also, if there are any clinic letters
coming from consultants . . . they also assist in on those changes and liaise with community pharmacists . . .
For the housebound patients . . . they have additional expertise in the over 65s.
P25 – practitioner, GP
I give them about a fortnight because as I say I’m due for the review and then the appointment arrives and
you never know who you’ll see whether doctor, pharmacist or nurse.
OP29 – older person
FINDINGS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
56
Home-based reviews
Conducting medication reviews in older people’s homes is seen as an effective way of undertaking a
comprehensive assessment and planning interventions that fit with older people’s day-to-day lives,
as well as being effective for post-discharge reconciliations. Communicating the outcomes with those
involved and the wider multidisciplinary team is an important part of the review or reconciliation:
It is necessary to visit patients in their own homes to get the complete representation of a patient’s
medication regimen.
Basheti et al.130
For some patients, the home setting can be a suitable venue for medication review and education after
discharge from hospital.
Kogut et al.140
Older people and informal carers value being reviewed at home, where the reality of managing complex
regimens and fitting them into day-to-day lives can be better understood and those at risk identified
(Box 25). Home-based reviews appear to be particularly effective for identifying adherence issues.
The evidence highlights ambiguity between the known benefits of and preferences for home-based
medication reviews, and the resources available for this work.
BOX 25 Home-based reviews
It would be very nice to be able to access somebody who perhaps will come and see you at home, as I used to
do for people for 26 years, if we needed to . . . And sometimes it’s better to have people at home because
you’re in your own environment – you feel in control . . . It’s a shame really, because they should come and see
how it affects your day-to-day life but they can’t.
OP10 – older person
The relatives are sometimes there when I go out to see a patient at home and can certainly help with, you
know, advice as to whether they’re taking what’s prescribed or whether they’re not . . . It certainly helps me
though in terms of when they say, ‘Oh this isn’t working, this isn’t working’. ‘Well actually you’re not taking it?’.
And little voice pipes up from the kitchen saying, ‘Yes’.
P30 – practitioner, specialist nurse
If we refer somebody to [our practice-based pharmacists], then they will come into the practice, review their
medical record and then they will go out to see them in their own home. And then depending on their level of
experience, they will come back in and say ‘I think we should stop this, this, this and this’ or ‘I think we should
start that’ or ‘We need to get a blood test done on this’ . . . That has been really beneficial because there have
been incidents when they have gone out and they have found boxes of stock that would make your eyes
water, like 17 salbutamol’s in a cupboard or boxes of insulin in the fridge.
P25 – practitioner, GP
Often, even when [GP’s] are doing home visits, they may not be aware of those adherence issues or patients
are very reluctant to open up to them to say that they’re struggling with their medication because you know,
they’re the ones that have provided it. Whereas going in a lot more neutral like we do, and with that non-
judgmental thing, people tend to open up to you a lot more about how they are or not coping.
P18 – practitioner, clinical pharmacist in a community team
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Reconciliations
Reconciliations are purposeful and time specific:
Transitions of care between hospital, GP and care home are points of particular vulnerability to
medication error. There is some evidence that a pharmacist review of medication may improve the use of
appropriate medication in these circumstances.
Centre for Policy on Ageing.136 Reproduced with permission
from the Centre for Policy on Ageing, London, UK
The process of medication reconciliation should account for any alterations made in the medications
taken by patients and should make sure that patients or their carers have been made aware of
these alterations.
Cheema et al.138
Practitioners acknowledged the contribution of reconciliations to medication management at times of
significant risk (Box 26).
Everybody that’s referred to the service is offered a domiciliary visit if that’s appropriate . . . And do a full
review . . . We would still always look at if there’s an adherence issue, if there’s any clinical issues that can be
optimised. And also if there’s any cost-saving initiatives that can be done as well . . . We would do that review
in the home . . . we did have a gentleman recently who, once we looked in his house with his consent, and
looked at the medication quantities in there, he’d obviously struggled with adherence for quite a long time . . .
was having very variable blood pressure, we think, because of this. He was having a lot of falls. And whenever
the surgery were checking his blood pressure, it was quite high. So they were just adding and adding
treatment. But the rest of the time obviously he wasn’t taking it.
P18 – practitioner, clinical pharmacist
BOX 26 Reconciliations
We do meds reconciliation when they first come in to us, so we are checking that their medication is correct
and tallies up with the GP print out if appropriate or with the print out from the acute trust. Speak to the
patients. Try and sometimes reduce the tablet burden, with a view to them going home . . . But we will be
reviewing their medication whilst they are in hospital and checking things like compliance, why they are
on things.
P01 – practitioner, senior pharmacist
[Practice-based pharmacists in primary care] assist us with medicines reconciliations. So if somebody has gone
into hospital. Maybe they have had their medicines changed or reviewed in hospital, or quantities need
altering etcetera. They pretty much do that.
P25 – practitioner, GP
BOX 25 Home-based reviews (continued)
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This subsection highlights ambiguity between the knowledge, practice and experience of medication
reviews in particular. Ambiguity covers purpose and content, timing, practitioners’ experience and
expertise, home-based reviews and reconciliations. This is explained in the following CMO:
When practitioners carry out medication reviews and reconciliations in ways that are not consistent with
guidelines and good practice, integrated within the wider processes of complex health management with
older people living with multi-morbidity and polypharmacy (C), individualised (C) and involving their
informal carers where relevant (C), they do not engage older people and informal carers effectively in this
key intervention that supports their health and wellbeing (O), and waste time and other resources (O),
because they generate ambiguity (M).
RR CMO 01
Ambiguity requires clarification of all aspects of reviews and reconciliations set out above, initiated in
and contributing to sense-making.
Having personalised, meaningful information: concealment
Practitioners draw on evidence from published sources as well as that gained through continuing
professional development opportunities to inform and substantiate their practice. However, there can
be tension between guidelines and experience, and the degree to which more powerful practitioner
groups or individual practitioners feel confident to adapt them to meet the individual needs of an older
person (Box 27), as well as limitations in the scope of some guidelines, such as those only relating to
single rather than multiple pathologies.
Older people’s and informal carers’ contact with practitioners provides them with an opportunity to
receive individualised information that addresses their own combination of multimorbidities and
polypharmacy. The exchange of information enables them to be more equally involved in shared
decision-making in this stage and potentially influences and informs day-to-day, individual decision-
making and actions at home, supporting self-management and coping. The knowledge, understanding
and confidence that come from information sharing contributes to increasing control and collaborative
capacity, whether sourced from evidence or experience. Conflicting information is disruptive and has
an impact on their confidence in practitioners (Box 28).
A few older people and informal carers seek information from other sources such as newspapers and
websites despite not being sure about quality. In some cases, it is sufficient to feel that the information
they find is useful whether or not it is derived from a safe or trustworthy source.
This subsection highlights concealment of information. Findings are summarised in the following CMO:
When practitioners do not provide information in ways that are personalised, meaningful and consistent
(C), they do not engage older people and informal carers effectively in this key intervention that supports
their health and wellbeing, including self- management (O), and waste time and other resources (O),
through concealment (M).
RR CMO 02
Concealment can be addressed through the exchange of information, generic and individualised,
ensuring that it is understood and useful, to support sense-making.
Continuity and mutual trust: unfamiliarity
Mutual trust is an emergent property of the relationship between the older person, the informal
carer and the practitioner. It is central to practice.148 Once established, continuity enables trust to be
sustained. Furthermore, it engenders loyalty in older people and informal carers towards individual
practitioners, especially GPs and their decisions. However, there are also risks that it can also be
frustrated or irreconcilably lost.
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BOX 28 Conflicting information provided by practitioners to older people and informal carers
The one who was adamant about him coming off the lorazepam had this one mind set. And the other one
who said ‘Well actually, I think we should keep him on it because I’m quite happy’ . . . The hospital and one GP
having one attitude and other GPs having other attitudes . . . 30 or 40 years he’s been on it.
C14 – informal carer
Some of them say don’t take with your antacids. Some say take before food. Some say hours before or
minutes before or, so and after . . . And it seems to be regardless of what it actually says from the pharmacy
about ‘do take with this or don’t take with that’.
C24 – informal carer
BOX 27 Sources of practitioner information
We’d follow NICE guidance with a view to what medication our elderly patients should be on . . . Then we
have got an area prescribing formulary as well, so we’d adhere to that . . .I think we probably just stick to
guidelines wouldn’t we more, just because we would want the evidence as to why we have done something . . .
other healthcare professionals are more likely to follow guidelines than perhaps the [more senior doctors], just
because it is their patient at the end of the day isn’t it and they would expect everyone else probably to justify
why they are making the decision and that’s the evidence isn’t it.
P1 – practitioner, senior pharmacist
We have the Medication Administration Policy which is the trust policy and we work to that. And obviously
with the NMC [Nursing and Midwifery Council], we have guidelines on the administration of medicines and
prescriptions which again is something we draw upon as well. But most of the trust guidelines are in line with
the NMC guidelines anyway.
P30 – practitioner, specialist nurse
We’ve got formulary . . . which tells us what we should prescribe. You’ve then got your personal experience and
preference of drugs and obviously that’s influenced by I gave this person this drug once and it, they were
really ill so I won’t use that again. Sort of like sample size of one . . . And also just sort of less obvious stuff,
you know, I’ve used this quite a lot and actually I think I probably do prefer this other one, I find that people
respond better to it. And so yeah, the personal experience and preferences. You’ve . . . well obviously you use
the various guidelines and NICE and [Clinical Commissioning Group] guidance in terms of in what order to
prescribe drugs . . . that sort of pretty much frames what we do.
P53 – practitioner, GP
I do a lot of going to conferences, you know, the primary care conferences – British Geriatrics Society . . . I’ll
read information that comes through . . . I give all the NICE guidelines and all those sorts of things out to
[staff] . . . I also organise training days . . . We’ll also get people in, so we have clinical meetings every quarter
and I try and get a speaker. It’s great for us because it means that we’re constantly updated.
P22 – practitioner, manager of supported care facility
We have got this array of single-disease guidelines and the majority of patients do not have a single disease.
They have multiple long-term conditions.
P25 – practitioner, GP
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Trust develops over time, from seeing the same practitioner in whom they are confident, underscoring
the importance of continuity of care to practice and practitioner relationships:153–157
The patient–provider relationship is the fundamental starting point for patient centred care delivery.
Central to the patient–provider relationship is trust.
Murray and McCrone157
Across diverse clinical settings, patients reported to be more satisfied with treatment, to show more
beneficial health behaviours, less symptoms and higher quality of life when they had higher trust in their
health care professional.
Birkhäuer et al.112
Continuity of care is a long-standing feature of healthcare, especially of general practice. It is associated
with increased patient satisfaction, increased take-up of health promotion, greater adherence to medical
advice and decreased use of hospital services.
Pereira Gray et al.114
We know that hospital admissions are often undesirable for patients, and there is some evidence
that if GP care is managed by the same practitioner over a long period of time, patients have fewer
emergency admissions.
Stafford et al.6 Reproduced with permission from The Health Foundation
The experience of mutual trust and consistency is described in Box 29.
BOX 29 Knowing through consistency and building trust
I just think that they know who you are. They don’t to need to read . . . it’s all very well saying oh yes you’ve
got to read this but I mean, they can read what you came for last time yes, but that doesn’t give you the
overall picture does it . . . of your patient? I mean if you’re a doctor and you see the same person you know,
you pretty well know why they’ve come. So I think it’s better for them.
OP21 – older person
We’ve got at least five GPs, maybe six. It’s a training practice and you can always get an emergency
appointment on that day. If you want to see a particular doctor you may have to wait but if you were in an
emergency you’ll see anyone, won’t you?
OP19 – older person
In terms of decision-making, you’re the person best placed to make decisions, if you would recognise things
that another clinician might not. That whoever it is I’m seeing in front of me just isn’t quite right today . . .
normally they would be bright as a button. But I’m seeing them today and I can – they’re just not right, you
know? So recognition of what this person’s normally like or how they normally would present. The sort of
situations where we’ve been here before . . . If you’ve seen that person a lot you’ll remember that and you’ll
remember how you managed it last time. And the medical records don’t give the story. Reading the records
isn’t the same as actually going through it and the nuances of sort of experience with this individual, knowing
how people respond . . . how to package management plans.
P53 – practitioner, GP
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Disruption to services and practitioners is experienced negatively by older people and informal carers,
even generating avoidance. This is illustrated in Box 30.
Disruptions in staff and services are also problematic for practitioners, arising from reorganisations,
financial cuts and new initiatives, occurring in succession and, increasingly, together (Box 31).
This subsection explores unfamiliarity. Findings are explained in the following CMO:
When there is change and inconsistency in services and practitioners (C), older people, informal carers
and practitioners do not establish and sustain mutual trust and confidence that comes from enduring
relationships (O), and the foundations for shared decision making (O), as well as the co-ordinated
management of complexity and risk (O), because of unfamiliarity (M).
RR CMO 03
Unfamiliarity can be addressed through interpersonal work to build and sustain relationships,
supported by systems that ensure space, time and stability in which this work can occur.
Addressing complex needs as a whole: fragmentation
The health and care needs of older people and informal carers living with multimorbidity and
polypharmacy are best addressed by a co-ordinated network of practitioners. Responsibility for
carrying out medication reviews is increasingly being shared by doctors, nurses, pharmacists and
pharmacy technicians across a number of organisations and sectors. Effective medication review is
reliant on good interprofessional communication to bridge gaps and reduce any tension between this
multiplicity of teams, staff, the older person and any informal carers involved:
Medication reviews, generally performed by physicians, are increasingly involving pharmacist and nurses
as well.
Kallio et al.151
Benefits of face-to-face ‘case conference’ communication between pharmacists and GPs as part of
medication reviews.
Jokanovic et al.152
BOX 30 Disruption of consistency and trust perceived by older people and informal carers
[At the other place I lived] the pharmacist, I’d go in: ‘hello [name], here’s your stuff’ and all the rest of it . . .
and they might well have picked up on something unusual. I can’t guarantee it but . . . I always felt they might
have done. Whereas here, because it’s a biggish [pharmacy], there’s fluctuating staff . . . unless someone’s
checking the paperwork, they might not pick up on something unusual.
OP8 – older person
They didn’t know him [my father] . . . because they have all just recently changed, which is a bit unfortunate . . .
And he said ‘They don’t know me. They don’t listen to me. They don’t ask me how I am. So I am not going to sit
there and tell them how I am feeling when they know nothing about me’.
C12 – informal carer
At the GP level, it just seems to be churning patients and numbers, you know. There’s so many appointments in the
day. There’s only so much time per appointment. You can only discuss one issue at a time. You go in and you spend
half of the time trying to work out what happened on the last occasion and who was the last GP to see the patient.
C26 – informal carer
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Value of a multidisciplinary approach to preventing adverse drug events is widely acknowledged.
Collaboration and teamwork between patients, general medical practitioners (GPs) and pharmacists is
important to achieving the safe and effective use of medications.
Jokanovic et al.152
BOX 31 Disruption of consistency, trust and working relationships perceived by practitioners
We used to have a woman [smoking cessation] that did the whole of [the city] and she was based at a
hospital . . . and she would take all the referrals, and arrange appointments and things like that. But for
whatever reason, 3 years ago or so, that funding was pulled and the service was disbanded.
P33 – practitioner, senior community nurse
The feedback that we [a pilot] got everywhere was sort of, ‘Yeah, but in 6 months you’re going to be gone, so
what’s the point of us using this service?’. Yeah they’re used to pilots coming and going and things. So actually
to have, still, 3 years down the line, still be here they’re like ‘Oh, you’re still going, oh right, we can use this
then’ . . . I’ve spoken to other people that have done sort of community work similar to this. It does take a long
time to gain those peoples’ sort of trust and you know, respect in the service.
P1 – practitioner, senior pharmacist
We’ve had quite a lot of pharmacy changes. We had a couple of Vanguards. And one of the Vanguard’s
involved having a particular company coming in and supply pharmacies into a number of GP practices. So we
kind of linked with those initially and now that again has finished now and they’ve all come out. But they’re
now trying to, through the CCG [Clinical Commissioning Group], introduce another GP pilot of pharmacies
working in the primary care.
P1 – practitioner, senior pharmacist
One CCG [Clinical Commissioning Group] . . . they’re doing, it’s [area wide] . . . they want this all singing,
dancing respiratory service [for] admission avoidance and stuff like that. But actually what they’re talking
about, rapid response already do [but in the] rapid response team no-one knows anything about it. So they
want a service that is already there . . . And actually, patients with comorbidities, if they’re breathless and
they’re cardiac, I mean it’s not patients’ responsibility to know whether they’re cardiac or respiratory that’s
causing them to be acutely unwell – who do they contact if you’ve got two separate services?
P33 – practitioner, senior community nurse
Initially started with six practices in one network and then expanded to other networks but then since then,
as typical in sort of CCGs [Clinical Commissioning Groups], the networks are not networks any more, they’re
federations and they’ve changed about three times since.
P1 – practitioner, senior pharmacist
The thing is it’s knowing what facilities and who’s available out there, I mean coming into the community
I’m finding people that I didn’t even know, and their roles, existed . . . But then nobody talks and checks
upon each other unless you go to sort of a national conference or somebody just happens to find out.
P33 – practitioner, senior community nurse
It’s like we’re sitting on these, doing these sort of workshops. And it’s almost like, God, what goes around
comes around . . . we sat and did this 25 years ago. There was certainly a lot of good stuff we did that
I think’s got lost over the years . . . And we’ve got those good relationships now but they’re not as close
as they were. I think we’ve lost, you know, a lot of good working really.
P38 – practitioner, community service manager
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Delivery models for health largely support specialisation and centralisation. Models for community
teams are emerging that augment the range of knowledge, skills and practices in ways that are more
local, integrated and complementary. Nonetheless, there needs to be one practitioner who retains
responsibility for oversight. For reasons legal accountability, the primary health role is vested in
the GP, although there can be positional ‘deference’ or uncertainty, leading to inertia between primary
and secondary care. In addition, older people and informal carers feel that they are not understood nor
that their complex needs are addressed as a whole, when they are seen by separate practitioners and
across diffuse services114 (Box 32).
Practitioners adopt ways of working together to overcome diffusion and address complexity (Box 33).
Access to quality information supports practitioners in reviews and reconciliations, although there are
issues with accuracy, delays and the completeness of the picture, partly as a result of disconnected
care pathways and practitioners working in silos. This impacts adversely on co-ordination within and
across services (Box 34).
In the UK, there is a political appetite for closer working across health and care being enacted through
policy on more integrated delivery systems. However, in practice it appears that economic drivers for
efficiency, opportunistic and transient initiatives, and clinical agendas around specialisation may be
undermining these aspirations. Practitioners compensate for a lack of integrated health and care by
working in formal and informal networks. Older people and informal carers also make significant
efforts to navigate and bind disparate practitioners and services together to reflect their needs.
This subsection addresses fragmentation. Findings are explained in the following CMO:
Increasing specialisation and centralisation (C), and extending responsibility for reviewing and reconciling
medications to multiple practitioner groups (C), results in older people and informal carers having
multiple, discrete contacts with services (O), limiting the way they are understood and their needs
addressed as a whole (O), including the co-ordinated management of complexity and risk (O), because
of fragmentation (M).
RR CMO 04
Fragmentation can be addressed through relationship and action work at inter- and intra-agency levels
to build and sustain operational and strategic networks.
BOX 32 Addressing complex needs as a whole
I know one person can’t do everything, just to be able to understand right OK, so when I turn up to an
appointment they’ll know right my dad’s got diabetes, asthma, and he’s got a heart condition . . . so how does
that [new problem] then affect the other conditions? Not just look at that symptom specifically on that day.
C15 – informal carer
You’ll have one specialist for this, one specialist for that, one specialist for something else. And they all add in
all of these drugs. The GP then says, ‘Oh no, I can’t change that because the specialist gave them that’.
P22 – practitioner, community service manager
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BOX 34 Information, communication and decision-making
It just feels like everybody’s working in isolation but the time it takes to communicate what’s going on with an
individual, it almost feels like it’s caused other problems. So it almost feels like you’re causing more harm to
my dad by not talking – keeping your communication systems up to date. Because if you don’t know what’s
happened and you’re relying on my dad to tell you, you’re not going to get anywhere.
C15 – informal carer whose father has dementia
Patients come in from a variety of sources. So, some would be, come in from the community directly. In which
case, if it is via the GP they would usually have a GP summary with a list, which would include a list of
medication; that is, acute and long-standing prescriptions. Some have been admitted from the community
directly by an advanced nurse practitioner, or a case manager, in which case it is usually a hand-written note
which ideally would include a list of medication. A lot of patients also come from the acute sector . . . in which
case they come with a discharge letter. We would then routinely try and marry up to check that the
information we have got on medication is right.
P6 – practitioner, consultant geriatrician
BOX 33 Ways of working together
Generally what we would do is we would refer to the GP for [someone identified as not coping and at risk] and
request a medication review. And generally the district nurses then work with the GP about how they can do
things . . . the actual medication changes would be done through the GP and indeed, the pharmacist that
sometimes gets involved as well with this. So it’s sometimes a three-way thing.
P30 – practitioner, specialist nurse
Multidisciplinary team meetings. So myself and the consultant from the hospital, because we’re like secondary
care into primary care. We’re doing a pilot project . . . We go through their patients. Like a virtual ward . . .
So it is the GP, it’s the consultant, me. We try and get the practice nurse or practice nurses in, and we are
trying to get the community case managers in as well, you know, those that do actually the community
long-term management for the chronic conditions.
P33 – practitioner, specialist nurse
We’ve got the [service] that covers physiotherapists and occupational therapists. We’ve got community
matrons and staff nurses. We’ve got the social workers and then we’ve also got the voluntary sector [for older
people, for informal carers]. We’re all in the same office. So of those core ones . . . we have what we call a
stand-up meeting every morning . . . I think it’s very much about collaborative working as well . . . even though
we’re kind of a really small [pharmacy] service, it’s just trying to make sure that that’s not an isolated service
and it feeds into the bigger picture really.
P18 – practitioner, clinical pharmacist
But it’s just everybody talking to everybody isn’t it. And I think the beauty of being in the hospital is that we
have easy access to everybody. In a GP environment is not so easy, is it? Hopefully with practice pharmacists,
that will improve.
P1 – practitioner, senior pharmacist
The whole idea of health and social care integration which, OK, it’s on the agenda, a government policy to
bring that into play. It’s been on the agenda for a long time, although seemingly that hasn’t come to the
fruition as yet. But still, I think there is an appetite to do that.
P60 – practitioner, social worker
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Recognition and engagement: exclusion
As established previously in this report, older people and informal carers develop expertise in the
day-to-day management of their health, diagnoses and medications (see Medication management).
Their experience and expertise can make a useful contribution to decisions and actions about their
health and care. This includes when reviewing and reconciling medications. In this type of interpersonal
work, shared decision-making is a well-established part of collaborative working. It is underpinned by a
substantial body of evidence42,158–164 and support for its use in practice:33,41,165
Achieving shared decision making depends on building a good relationship in the clinical encounter so
that information is shared and patients are supported to deliberate and express their preferences and
views during the decision making process.
Elwyn et al.164
Face to face interactions, permission and space to discuss options, and continuity of patient-professional
relationships are key in supporting older people with complex needs to engage in shared decision making.
Bunn et al.159
Shared decisions based on what is important to each person in terms of treatments, health priorities,
lifestyle and goals.
NICE.41 © NICE 2016. Multimorbidity: Clinical Assessment and Management. Available from www.nice.
org.uk/guidance/ng56. All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the
National Health Service in England. All NICE guidance is subject to regular review and may be updated or
withdrawn. NICE accepts no responsibility for the use of its content in this product/publication
Older people and informal carers value recognition and engagement in decisions and actions affecting
their health and medication (Box 35).
Changes which we make on in-patient medication would be relayed to the GP via the discharge letter. And, on
the back page of our in-patient drug chart, there is a space for recording any changes and then that can just
be incorporated in the discharge letter . . . so that the changes continue to happen . . . A good discharge letter
would account for those changes and explain . . . for example reduced the dose of the antihypertensive
because of the side effects . . . but that is not always the case.
P6 – practitioner, consultant geriatrician
I find that even with the consultants here, who you think would be up for reviewing everything wouldn’t you –
And I still think there is reluctance for them to stop anything that the GP started. And I think that the GPs
are reluctant to stop anything that the consultant started. And it’s because they don’t know why.
P1 – practitioner, senior pharmacist
I know that sometimes that will just be that they just carried on things, the patient has been a bit ill and they
go ‘Well, we just carried that on because the GP has carried it on’. So, there are still opportunities for them as
in-patients to have their medications reviewed. But I have spoken to a consultant about it, probably about a
year or two ago. And he said ‘Well actually, sometimes there just isn’t the time. Because we try and turn
around patients very quickly. And, we just expect it to be picked up again in the community’.
P25 – practitioner, GP
BOX 34 Information, communication and decision-making (continued)
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Practitioners also value their input and ways of securing the involvement of older people and informal
carers (Box 36).
Box 37 draws on more general evidence about the need for time and space for this interpersonal work
to evolve that can be translated to reviews and reconciliations.
This subsection addresses exclusion. Findings are summarised in the following CMO:
When older people and informal carers are not recognised and engaged with practitioners in shared
decisions about their health, diagnoses and medications (C), the individualised basis for decisions is
limited (O), older people and informal carers are less likely to apply what has been agreed (O), and their
relationship with practitioners is undermined (O), because of exclusion (M).
RR CMO 05
BOX 35 Recognition and engagement: older people and informal carers
And he sat with me and he, well he said ‘What do you think it might be?’, to me just like that. And I know he
wasn’t meaning for me to diagnose myself but what he was sort of saying in a roundabout way was what was
are you worried about.
OP19 – older person
We have discussed whether we should look at some of the biologics – that there’s an increased risk of breast
cancer if you take it . . . But they know [my rheumatoid arthritis] is progressing because my hands are getting
worse. They had wondered – but because of the increased risk, there’s no argument to me. I’d rather have
kinky hands than cancer.
OP8 – older person
So the doctor and I will discuss things over the phone, and because we’ve built up a good relationship, trust
one another.
C32 – informal carer
You have to listen to the people that are there all the time doing it’.
C11 – informal carer
BOX 36 Collaboration and shared decision-making: practitioners
Keep the information you tell the patient as basic as you can, in terms that they will understand. I know
sometimes it takes a bit of time to get to know the patients doesn’t it and build up a bit of a rapport with
them. Which you can if you are seeing them quite regularly.
P1 – practitioner, senior pharmacist
You’re not going to build up a good relationship with that person if you’re spending half an hour bombarding
them with information about all their tablets when really they didn’t want to know that . . . we do our reviews,
the patient – the person is very much involved in that. And that’s quite a concordant discussion.
P18 – practitioner, clinical pharmacist
So that’s always slightly tricky [best treatment, failed treatment and cost], but I usually involve patients with
that in terms of the decision-making.
P53 – practitioner, GP
DOI: 10.3310/hsdr08260 Health Services and Delivery Research 2020 Vol. 8 No. 26
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Maidment et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
67
Exclusion can be addressed through action work using shared decision-making to benefit from the
individualised expertise and experience of all those most involved.
Summary: burdens in reviewing/reconciling medications
Reviewing and reconciling medications is a key, complex interpersonal stage in medication management.
Using a realist approach, MEMORABLE has stratified this complexity by identifying five burdens that
could be addressed through mitigation work in this stage, influencing what is done in other stages:
l The ambiguity burden about reviewing/reconciling medications within medication management –
this involves sense-making by clarifying the purpose and content of medication reviews
and reconciliations.
l The concealment burden due to a lack of information-giving that prevents older people and informal
carers from understanding, personalising and using what they want or need to know – this is also
about sense-making and establishing meaning through information to increase personal efficacy,
agency and control.
l The unfamiliarity burden arising from not seeing the same practitioner consistently – this is about
establishing continuity and mutual trust in relationships as the foundations for interpersonal work.
l The fragmentation burden limits the way older people and informal carers are understood and
their needs addressed as a whole when they are seen across a range of services – this is about
the importance of inter- and intra-agency collaboration in operational and strategic networks.
l The exclusion burden when older people and informal carers are not recognised for their experience
and expertise, nor fully or effectively engaged in decisions that affect their health and care – this is
about action and enacting collaboration through shared decision-making.
These findings are summarised in Figure 5, which highlights several key elements:
l Identification of those involved in Stage 5: reviewing/reconciling medications – older people,
informal carers and practitioners, and their association through multimorbidity and polypharmacy.
l Complexity is acknowledged and accommodated.
BOX 37 Time and space for collaboration
So if I said to her I do have a problem, I think it needs some sort of medication. I guess, I might have
researched it, she would do whatever I thought, I think. Or she would say ‘Well I’ve found that this one is
better in this condition’. She’s good but you know, it’s a partnership I think.
OP28 – older person
With the previous doctor I did eventually sort of build a relationship with the doctor where I felt that he was
actually sort of listening to me and accepting that they were reasonable questions I was asking.
C9 – informal carer
I know GPs are constrained but it takes just like 10 seconds for my dad to just get his bit out, it doesn’t take minutes,
it only takes a short moment . . . And then we can just then look to try and resolve whatever the problem is. But she
just managed it really well. And I felt confident knowing what I need to do to help him going forward as well.
C15 – informal carer
We have all got to speak to the patient haven’t we at the end of the day, and include them in any decisions
for anything that is prescribed. Because you might sometimes be surprised about what their priority is
compared to what the prescribers priority is . . . I still think old people get a raw deal with an assumption that
nobody needs to talk to them about anything or it’s going to be very difficult because they are a bit deaf or
they might not understand. Well, have a go.
P1 – practitioner, senior pharmacist
FINDINGS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
68
l Burden issues are highlighted – ambiguity, concealment, unfamiliarity, fragmentation and exclusion.
l Work to mitigate burden is associated with sense-making, relationships and action as linked
implementation steps (NPT) in this and each of the five medication management stages. This includes
the way steps interact across stages in the medication management process. These generative links
are suggested by arrows that overlap the perimeter of the box.
l Enduring relationships are emphasised as foundational to the work that is done.
l Important elements of sense-making and action are highlighted.
l Reflection/monitoring are included as part of the implementation process, although it was only
implied in the data rather than specified.
l Indicative but important outcomes of burden and risk management, and sustaining coping and
control are included.
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experience and expertise
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FIGURE 5 Summary of findings for Stage 5: reviewing/reconciling medications, mitigating burden.
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Based on these findings, the figure also identifies proposed interventions generated within this stage:
l Risk identification as a point of access from Stage 4: continuing to take medications, signifying its
contribution to identifying those who are not coping and should be offered further evaluation or
review rather than waiting for a planned review.
l Individualised information is located centrally to emphasise its importance to sense-making, action
and relationships.
Details of the proposed interventions are set out below.
Proposed interventions
This section sets out two proposed interventions from the findings: risk identification and individualised
information. They emerged mainly from the experiential data. They were subject to discussion and debate
by the Research Team and subsequently endorsed by the Project Group and the Stakeholder Group.
However, before describing these proposed interventions, two issues need to be considered. The first issue
is the type of intervention that might be proposed. The researchers acknowledged that, despite having
established the complexity of medication management and of the stages involved in it, a complex intervention
may not be appropriate or implementable across health and care. The researchers could envisage difficulties
with standardisation and fidelity across multiple practitioner groups as well as with trying to introduce
another ‘innovation’ to practitioners already overburdenend by initiatives. There would also be unacceptable
cost implications attached and sustainability issues. This issue is explained by Santo et al.:166
. . . interventions to improve adherence to medications . . . are mostly complex. The disadvantages of
complex interventions are that they are difficult to compare and be replicated, thereby possibly increasing
costs and making implementation in routine practice difficult. Our results showed that simple interventions
might be as effective as more complex ones.
Thus, discussions in the Research Team initially explored the findings from the analysis of burden,
whilst seeking ways to respond to what older people and informal carers were requesting, directly
and indirectly. These discussions focused on identifying simple interventions that would potentially
have a high impact, such as risk identification.
The researchers also resolved that any proposals needed to:
l be sensible, practicable and novel
l address multimorbidity and polypharmacy directly
l have potential to engage older people, informal carers, practitioners and others in developing these
ideas into something practicable, collaboratively
l have a clear route to introduce such an intervention through which it could be disseminated to
those who would benefit most
l accrue significant gains directly to those involved.
Based on these criteria, risk assessment and a more ambitious proposal for individualised information
were agreed.
The second issue involves the level of detail in the specification for each intervention to be included
in this study. The consensus among the Research Team, the Project Group and the Stakeholder Group
members was that, although the findings substantiated the need for these proposed interventions,
and that the need to establish the framework for proposed interventions fully met the research aim,
it was beyond the scope of this research to provide a detailed specification for these follow-on studies.
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Indeed, those involved in these discussions agreed that this work should be undertaken collaboratively
by users and beneficiaries as well as by others who might be able to provide expertise to turn proposals
into practice and subsequently evaluate the way they work, or not, following a similar realist approach
to this work. Therefore, the proposed interventions are briefly described below, at a level of detail
sufficient for this research.
Risk identification (linking Stages 4 and 5)
Older people and informal carers who are not coping and are at risk may not be readily visible to
practitioners. There needs to be a simple and easily implementable way of identifying older people and
informal carers who are not coping and then, having done so, to enable them to access appropriate
help and support through a more detailed follow-up, such as a review. Many older people and informal
carers have multiple contact points with health and care and therefore, one way of identifying those
at risk would be to have simple ‘Whooley-type’ questions [URL: https://whooleyquestions.ucsf.edu
(accessed 10 December 2019)] that could be used by any practitioner. These screening questions
would be burden focused, one on workload and one on capacity with two ‘no’ answers indicating no
significant burden at this time and one or two ‘yes’ answers requiring further evaluation.
Risk identification could be undertaken at any contact point or time in Stage 4, while older people and
informal carers are continuing to take medications as a way of fast tracking them to further evaluation,
help and support, or to a medication review (Stage 5).
Individualised information (linking Stages 5 and 2 to Stages 1, 3 and 4)
McHorney et al.101 state: ‘people can only do what they understand’. Despite good information on single
diagnoses and single medications, there is limited information, if any, that encompasses the unique
combination of multimorbidities that increasing numbers of older people live with, as well as the
complex polypharmacy regimens they are prescribed. Older people and informal carers stated that
current information does not reflect the uniqueness and complexities that each individual experiences.167
Learning how to manage this ‘by doing’ is inadequate and fraught with risks, including following
routines that could be mistaken in their underlying assumptions about when and how to take certain
medications. Making individual decisions on a day-to-day basis, without adequate information, adds to
that risk. In addition, the way older people and informal carers have to repeat the same information
about themselves to practitioners is burdensome, time-consuming and may inadvertently lead to
them not divulging the way that they are actually managing or mismanaging their medications.
In this case, the proposed intervention is for older people and informal carers to have individualised
information that they can use and share, tailored to their particular preferences, needs and experiences
of living with several long-term conditions and taking many medications. The format, content and ways
of using this individualised information would be developed collaboratively by working with those
groups most directly involved, as with this research, as well as with others with expertise to turn
proposals into practice.
Both proposed interventions would be pursued using realist methodology.
These findings are discussed in Chapter 4.
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Chapter 4 Discussion
The aim of MEMORABLE was to undertake a realist synthesis ‘to develop a framework for a novelmulti-disciplinary, multi-agency intervention(s), to improve medication management in older people
on complex medication regimens resident in the community’.30 This aim has been met through the
combined analysis of literature and narrative data on medication management and subsequently
focusing on reviewing/reconciling medications (Stage 5). By theorising about causality, an understanding
of what works, for whom, why and in which circumstances was generated: realist methodology’s four
‘W’s.49–53,55,56 Findings confirm the complexity of medication management, understood through stages
and steps, and, furthermore, the complexity of burden as a significant, multifaceted experience within it.
This research has established the need for simple, but effective improvements in risk identification
by practitioners, and the development of individualised information that reflects the experiences and
addresses the day-to-day needs of older people and informal carers living with multimorbidity and
polypharmacy.
This chapter draws out salient points from this study that the researchers believe have the potential
to inform and improve practice, or warrant further research. Sections cover medication management;
reviewing/reconciling medications; proposed interventions: risk identification and individualised
information; and the research methodology. Each section considers the results and the implications
for practice. The chapter concludes by addressing the strengths and weaknesses of the research.
Medication management (see Chapter 3, Medication management)
Complexity in medication management: stages and steps
Much of the existing literature identifies medication management as a single intervention. Policy
and guidelines are often based on good practice. Evaluation is based on describing cause and effect168
rather than explaining real-world complexity. Policy and practice are typically aligned with issues
of medication adherence and optimisation, with a behavioural underpinning to achieving both of these
aims. The message is that these ‘betterment’ goals, optimisation and adherence, can be secured
through various forms of behavioural incentives, disincentives and evidence-based advice.
Advancing this understanding, MEMORABLE views medication management as a complex intervention,
aligning with the Medical Research Council58,59 definition, engaging older people, informal carers
and diverse practitioners across health and care. Medication management is also an implementation
process, operating across five linked stages with four implementation steps and three loops in each
stage. This process structure offers a framework for understanding the generative and serial dynamics
of real-world complexity within which individual and interpersonal work is carried out (NPT).65,66
Stages 1, 3 and 4 involve older people doing work on their own: identifying problems (Stage 1);
starting, changing or stopping medications (Stage 3); or continuing to take them (Stage 4). In some
instances these stages may be supported by an informal carer, typically a family member, or a formal
carer, assuring adherence and minimising risk.
Routines are fundamental to what older people and informal carers do, emerging from sense-making,
action and reflection, and founded on key relationships, from which they exert agency and control.
Routines are flexed to minimise burden and accommodate short-term and longer-term change.
Examples of routines include linking medication taking with mealtimes and keeping pills in the kitchen
as a prompt, organising regular pharmacy pick-ups as part of trips to the shops or arranging doctor’s
appointments well in advance to ensure that older people see their preferred practitioner. Thus, older
people and informal carers cope by fitting the practicalities of medication management into their day-
to-day lives to achieve the outcomes that matter to them. Medication management plays a part in this,
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but is not an end in itself; adherence is only part of their narrative. Accordingly, practitioners need to
address routines, outcomes, coping and burden in their contacts with older people and informal carers
to ensure a purposeful and productive alignment between their agendas and to ‘nudge’ adherence
within those discussions.
Difficulties in Stages 3 and 4 can provoke a ‘disruption loop’ when a problem occurs (Stage 1).
Sustaining stable medication management, coping and optimisation in Stage 4 appears to be desirable.
Frequent jumps from Stage 4 to Stage 1 may indicate a lack of coping and risk, particularly if red flag
issues arise in Stage 1 and the older person or informal carer does not contact a practitioner for help
and support. Red flags might include consistently not keeping enough tablets at home or stockpiling;
muddling up tablets that look similar but which should be taken for different reasons; or avoiding
taking particular tablets because of attributing undesirable or inconvenient side effects to them, but
not seeking help to identify an alternative. Practitioners need to be able to identify those at risk and
provide older people and informal carers with accessible, personalised information that enables them
to be confident in determining the significance of problems and how best to resolve them, on their
own or by accessing appropriate and timely support.
Stages 2 and 5 are where older people and informal carers engage with practitioners, typically in a
clinical or formal setting. These two interpersonal stages are where they are getting a diagnosis and/or
medications (Stage 2) and reviewing/reconciling medications (Stage 5). Stage 5 may trigger a ‘medication
loop’ to Stage 4 where older people simply continue to take medications as before or to Stage 3 if they
are advised either to stop, adjust doses or start something new, which then becomes part of their
regimen in Stage 4. In addition, Stage 5 may trigger a ‘diagnosis loop’ where concerns are raised about
their health, addressed in Stage 2. Shared decision-making is a key aspect of both stages.
Time-limited, interpersonal contact points are where information about older people’s and informal
carers’ experiences of making medication management work day to day is exchanged, shared decisions
are made and actions taken that influence what happens in the other three stages. Based on the
research findings, shared decision-making provides an opportunity to establish the details and
acknowledge the importance of the routines that older people and informal carers follow to feel that
they have control over medication management in their lives and to achieve meaningful outcomes.
Quality collaboration, with practitioners, optimises older people’s and informal carers’ intrinsic
motivation and better informs the individual decisions they make at home. Alongside assuring safety
and effectiveness, addressing these issues of ‘fit’ may have greater resonance and leverage in the
decisions and actions of older people and informal carers about what medications they take, how and
when. Supporting them to make medication management one of the many activities that they choose
to engage in, day to day, may prove more enabling than emphasising practice-defined aims of
adherence or optimisation.
The MEMORABLE Research Team identified that there were advantages in understanding medication
management as a complex, dynamic stage, step and loop implementation process. First, it enabled them
to work with its complexity, at a level that was manageable. Second, it provided a structure to identify
and characterise key stages, steps and loops in the process, framing the data. Having set out this
process early in the research and refining it as the research progressed, it proved to be useful in
discussions about the direction of the literature search, in focusing the interviews and in interpreting
and applying findings from the data from a consistent perspective.
The Research Team acknowledge that one of the tensions in medication management as an intervention
is how to view it as a discrete aspect of the wider and complex processes of care involving older people
with multimorbidity and polypharmacy,9 to underscore its importance and ensure that appropriate
practitioners such as pharmacists are involved and their work co-ordinated. However, it also needs to
be integrated within the wider health and care process, acknowledging that medication is increasingly
important in the treatment of chronic diseases. To contribute to this, the Research Team recommend
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that further research is undertaken to extend the application of this stage, step and loop approach to
complexity in medication management, underpinning it with a more substantive evidence base and
causal account of each stage and extending across stages, to support the development of policy and
practice in this field.
Outcomes in medication management
Medication management guidelines emphasise adherence and optimisation as outcomes. The literature
on medication management provides an extensive and growing evidence base for both.
The MEMORABLE study’s interviews identify an extended range of outcomes that interviewees attach
meaning to or want to achieve. Older people’s outcomes generally appear more diverse, purposeful,
functional and qualitative than the role-informed outcomes of practitioners. As the key beneficiaries
of medication, there is an embedded friction between minimising the number of medications older
people have to take while achieving the effects that enables them to do things that matter to them.
There is a reciprocal tension for practitioners as they mediate between criteria in guidelines that
inform good practice on which their performance is assessed and the older person’s expressed wishes.
There is some degree of convergence in the outcomes identified by informal carers and practitioners
attached to their roles in medication management, perhaps reflecting the way informal carers feel
responsible for ‘good practice’ and adherence. There is also divergence in the outcomes informal carers
and practitioners identify for others, highlighting the tension between personal and role-based agendas.
Early in the research, the researchers agreed that adherence and optimisation were important practice
outcomes in MEMORABLE, acknowledging the importance of taking medications as prescribed and
agreed (adherence) to achieve the best outcomes (optimisation). However, the researchers extended
the range of outcomes by sourcing them from the literature, set out in the analysis framework (see
Table 2 and Appendix 7), and populating them from the research interviews. By asking interviewees
about the outcomes that they derived from medication management and then what had brought these
about, the researchers identified outcomes occurring at different stages or levels, and evolving over
time, as well as identifying the contexts and mechanisms involved. These causal accounts resolved
explanatory gaps in the literature and informed the writing of CMO configurations.
The Research Team recommend undertaking further research on outcomes in medication management,
involving older people, informal carers, and health and care practitioners. This could contribute to
developing a vocabulary and possibly a decision support tool for practitioners to better engage older
people and informal carers in discussions about what matters to them and the routines they might use
to ensure that these outcomes are achieved. These outcomes would be documented as part of their
individualised information.
Informal carers in medication management
Although the main focus in MEMORABLE has been on older people and medication management,
the role and contribution of informal carers has emerged as an important topic. MEMORABLE, in line
with other research, found that the depth and breadth of support informal carers provide to older
people with multimorbidity and polypharmacy is increasing, many taking on a pivotal role and making
significant personal sacrifices as a result.21–25 The outcomes informal carers want from medication
management highlight the tension that exists between the responsibility of being a care provider, in
which they seek to adhere to the practitioners’ directions, and their identification with the wishes of
and for that older person, based on familial ties and personal knowledge.
Informal carers experience role-creep as they become more engaged in the older person’s medication
management and a time lag in acquiring the information and the increasingly specialist knowledge and
skills that they need, which are largely gained by experience. With many taking on more responsibility
and more complex tasks than paid carers, they nonetheless lack equivalent training or support.
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Informal carers can also lack recognition from health and care practitioners or within health or care
systems, arising from legalities around the older person’s ‘capacity’ as defined by mental health
legislation. In circumstances when an assessment of ‘capacity’ may be borderline, an older person may
nonetheless be failing to cope with the complexities of medication management. As a result, informal
carers may be taking on a significant part of the workload, yet be excluded from key shared decision-
making opportunities.
The Research Team recommend that further research is needed on the role of informal carers in
supporting medication management. MEMORABLE will publish a paper on the research findings for
informal carers to contribute additional evidence to the debate on this issue.
To conclude, medication management is a complex intervention and, therefore, improvement proposals
need to engage with that complexity. MEMORABLE has developed a five-stage implementation process,
causally focused and evidence and experience based. However, MEMORABLE remains a formative
study. Accordingly, the researchers believe that framing medication management as a five-stage,
four-step, three-loop process merits further exploration and critique to advance its contribution to
research and practice.
Reviewing/reconciling medications [see Chapter 3, Reviewing/reconciling
medication (Stage 5)]
Complexity in reviewing/reconciling medications
Reviewing/reconciling medications are the interventions associated with Stage 5 of the medication
management process. It is an interpersonal stage where older people and practitioners collaborate, as
with Stage 2: getting diagnosis and/or medications. Informal carers may also be involved. It involves
regularly reviewing the way in which older people are continuing to take medications (Stage 4) or
reconciliation at a health or care transition. As a result of what is decided in Stage 5, older people may
continue to take their existing medications (medication loop to Stage 4); they may start, change or stop
medications (medication loop to Stage 3); or they may need an assessment for a new diagnosis and
medications (diagnosis loop to Stage 2). This process is illustrated in Table 6.
Reviewing/reconciling medications (Stage 5) was selected for more detailed analysis, as it was judged
to be a key stage and an exemplar within medication management. This decision was made during the
iterations of work packages 1 and 2, steps 3b/5b, based on:
l the emerging significance of this stage to the overall process
l its immediate links to Stage 4, where older people are continuing to take their medications and
where non-adherence may emerge as an issue of concern
l the way it is understood through policy and guidance that could clarify standards of good practice
and their intended impact, causally explained or not
l its importance in the way it focuses on interpersonal decisions and actions, and, therefore, its
potential relevance to Stage 2, where the other interpersonal work occurs when getting a diagnosis
and/or medications.
There are, however, important distinctions between the two interventions that make up this stage:
reconciling and reviewing medications.
The first intervention is reconciling medications. It is associated with transitions between settings,
the accuracy of medication lists and risk minimisation, such as avoiding drug–drug interactions or
prescribing two medications with similar actions for the same or similar symptoms. Medication
reconciliations are perceived as more straightforward than medication reviews. In the interviews,
prescribers commented on the importance of having accurate information about the medications older
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people are taking, who prescribed them and why. This information is essential in treatment planning,
including rehabilitative work to support older people to regain their independence in managing their
medications when they return home from hospital. However, practitioners commented on problems
with the quality and speed of communication needed to carry out reconciliations or act on results.
The second intervention is reviewing medications. MEMORABLE has identified three issues in the way
medication review is understood and practised.
The first reviewing issue is about ‘what is done and when’. The researchers’ interpretations of the data
indicate variation in older people’s and informal carers’ experiences of the content and timing of
reviews. There are three accepted levels of medication review based on patient need. Policy, and
associated funding, require MURs to be carried out by community pharmacists, with the older person
present. Elsewhere, practitioners currently determine which level is most appropriate for any
individual, acknowledging the resource limitations in the system.
It appears from the interview data that older people who are coping and whose condition is stable may
have 6-monthly or annual reviews reflecting the practitioner’s perception of relatively low risk. Older
people with less stable conditions and who are not coping appear to be having reviews as part of
regular contact with practitioners. Their formal reviews are then often carried out as level 1 or 2 at
which they are not present.132,169 However, MEMORABLE has established that, despite contact with
practitioners as part of ongoing medication management, older people and informal carers who are
not coping and are at risk are not being identified or their needs addressed. Risk may be exacerbated
by waiting for a planned review. MEMORABLE proposes that older people and informal carers whose
day-to-day medication routines are breaking down and who are not coping need to be identified at any
point of contact with a health or social care practitioner so that they can be offered further evaluation
and support. Risk identification is discussed in Proposed interventions/future research.
The second reviewing issue is about ‘who’. The legal accountability for health care is held by the GP in
primary care. However, the development of professional roles and multidisciplinary team working has
resulted in pharmacists and nurses taking on additional responsibilities for prescribing and reviewing,
building on their specialist knowledge, skills and supplementary training. Specialist nurses contribute to
the management of specific long-term conditions, such as respiratory or cardiac, and community matrons
support older people and informal carers living with complex long-term conditions in the community.
Pharmacists increasingly work with GPs in reviewing medications. Both the literature and interview
data, describe a variety of effective pharmacy service developments in primary care where the specific
expertise and experience of pharmacists is valued. Developments do, however, appear to be patchy
and sometimes transient, subject to local sign-up and funding uncertainties. With clarification of roles
and responsibilities that integrate pharmacists within the primary care team, improved information
that gives them access to patient notes, and improved communication systems that would come from
co-location, it appears that pharmacists could contribute to more effective service delivery, quality and
impact, increasing capacity and reducing workload for GPs.170,171 Thus, potentially, MEMORABLE found
some support for the developing role of practice-based pharmacists.
The third reviewing issue is about ‘where’. There is no need for home-based reviews for all older
people with multimorbidity and polypharmacy. However, the potential advantages of reviewing older
people and informal carers who are not coping, at home, are clearly made when the focus of the
review encompasses the fit between the demands of medication management and older people’s
day-to-day lives. Practitioner interviews confirmed the success they have in identifying and resolving
risks in the home setting where older people’s and informal carers’ routines can be demonstrated and
discussed. It is harder for older people and informal carers to indicate that they are coping, perhaps
out of a misplaced loyalty to the practitioner, when there are boxes of pills randomly scattered about
the house, a litter of old prescriptions or a muddled store of medications, some of which are long out
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of date. Support to regain control of the situation and to re-establish routines that fit with day-to-day
lives is readily available from practitioners once the issue becomes known. As another aspect of the
risk issue, risk identification is discussed in Proposed interventions/future research.
Causality in reviewing/reconciling medications and burden
By focusing in detail on this stage, MEMORABLE has extended the understanding of reviewing/
reconciling medications within medication management. It has scoped and identified tasks associated
with good practice. Using a realist approach has enabled the researchers to explore how implementation
work is done and with what effect.
From the many lenses the researchers could bring to this analysis, they chose to conceptualise burden as
a potential mechanism of interest, based on an initial assumption and subsequent validation of the need to
mitigate burden in medication management. To do this, they drew on the evidence, experiential accounts
and theorising processes within realist methodology, basing analysis on subsets of CMO configurations,
and used the additional analytic lens afforded by NPT. The findings on reviewing/reconciling medications
therefore have a robust evidence and experience base to inform intervention proposals.
Conceptualising burden as a mechanism of interest has assisted data analysis thus far. In doing this, the
Research Team acknowledge that it is also possible to locate burden as an outcome from the work done
in any stage, as well as a context to what is being done. The value of this generative, terminological
fluidity is acknowledged by Manzano,75 enabling analysis to reflect individual experiences of medication
management and changes to those experiences from, for example, acute exacerbations of a particular
diagnosis or combination of diagnoses, disease progression or age-related issues such as increasing
frailty or cognitive decline.
Realist analysis of the complexity inherent in reviewing/reconciling medications has enabled the
researchers to theorise about this stage in ways that are potentially transferable to other stages and
circumstances based on the assumption that the same mechanisms may be in operation. In addition, the
use of a realist approach has increased the understanding of the influence of contexts–mechanisms on
outcomes, potentially contributing to better tailoring of medication management in different contexts.
Understanding burden mitigation in reviewing/reconciling medications
The MEMORABLE study has identified five burdens associated with reviewing/reconciling medications
that are experienced primarily by older people but also by their informal carers: burdens of ambiguity,
concealment, unfamiliarity, fragmentation and exclusion (see Chapter 3, Reviewing/reconciling medications
and burden). Mitigation of these burdens occurs through implementation work, primarily involving
sense-making, action and relationships. Reflection/monitoring were not identified directly from the
interviews or the literature but are acknowledged as important aspects of implementation in this and
all other stages. An absence of data in this aspect of the programme theory would be addressed in
further research. Ways of mitigating specific burdens are discussed in the following paragraphs.
Mitigating ambiguity: knowing about medication reviews and reconciliations,
sense-making – clarification (RR CMO 01)
The researchers found that the scope of reviews and reconciliations needs to be more clearly and
effectively communicated to older people and informal carers, enabling them to prepare and participate
more effectively. It would also help older people and informal carers make sense of these interventions
in relation to what happens in other stages of medication management so that they can link what
is decided in the review or reconciliation with what they do at home. Better general information on
reviewing and reconciling medications could be personalised in any invitation sent to older people and
informal carers to attend reviews, in particular. This might include questions to think about in advance
to help them reflect on their routines and their experiences of the burden of medication management,
and what might decrease the work they have to do, or increase their ability to do it, enhancing their
feelings of control and coping.
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Mitigating concealment: having personalised, meaningful information, sense-making –
information (RR CMO 02)
Older people and informal carers struggle to make sense of poor information, particularly when it is
impersonal, lacks meaning for them and is inconsistent or conflicting. Generalised information that
focuses on a single diagnosis or medication is valued but of limited use when older people’s lives
involve multimorbidity, polypharmacy and their unique experiences of both. Overcoming a lack of
information adds to their workload, whereas poor information reduces their capacity to engage fully
or as they might choose if better informed. It can exacerbate uncertainties when they are managing
medications at home, undermining self-management. The use of the internet as an information source
is growing, although there are concerns about how to access trustworthy websites and evaluate the
information on them. Older people and informal carers are asking for reliable and readily accessible
information that helps them to cope. The intervention proposal for individualised information is an
attempt to address this issue (see Proposed interventions/future research).
Practitioners also receive poor information, particularly around medications and the reasons for
prescribing and deprescribing so they can make sense of the individual they are seeing, and may not
have seen before, their diagnoses and treatments. This is made worse by delays in communicating
between organisations, further exacerbated by communication by letter or fax. This points to wider
information sharing and communication issues across health and care that lie outside the scope of this
study. Nonetheless, practitioners may benefit from accessing the individualised information held by
older people and informal carers, proposed in Proposed interventions/future research.
Mitigating unfamiliarity: continuity and mutual trust – relationships (RR CMO 03)
Continuity elicits mutual trust and loyalty. It is a desirable in the contacts between older people and
practitioners, including informal carers where they are involved. This is particularly the case when
sharing decisions about the long-term, often progressive and increasingly complex, nature of the
diagnoses, treatments and associated burdens older people are living with. Consistent relationships
with GPs in primary care and secondary care consultant physicians, who specialise in the health care of
older people, are valued because they retain oversight of this complexity. GPs are seen as having more
enduring relationships overall.
Mutual trust is a well-established aspect of interpersonal relationships in health and care according to
the literature112,114,153–157 and confirmed in the research interviews. Accessing named practitioners with
expert clinical and communication skills, and the sense that they are acting as allies in the best interests
of the older person and their informal carers, builds and sustains the trust that is foundational for the
effective interpersonal work required for medication optimisation.
In as much as systems permit, older people and informal carers who are struggling with routines and
the burden of their medication, and for whom continuity is important, need to be able to identify and
access preferred and trusted practitioners, particularly in primary care.
Reflecting on relationships within NPT, it is important to recognise that this substantive theory was
initially developed to explain the implementation work associated with new practices; introducing
them and making them routine. In NPT, relationships are only established to achieve short-term
delivery goals. In Stage 5: reviewing/reconciling medications, MEMORABLE confirms that sustained
relationships are key to mutual trust, and to safe and effective medication management across the
whole process. This finding also confirms the usefulness of this substantive theory in explaining
implementation and the work associated with it.
Mitigating fragmentation: addressing complex needs as a whole, action –
collaboration (RR CMO 04)
Serial health and care reorganisations increase practitioners’ workload on sustaining collaborative
networks during change. Some practitioners stated that it was difficult to know about new initiatives or
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where projects have ceased because of funding being withdrawn. Networks break apart, taking with
them established, effective and trusted working relationships, the additional capacity they provide, and
systems and practices associated with unified and integrated working. These networks are often replaced
with increasing specialisation and centralisation, intended to achieve system efficiencies. However, this
results in the complexity of older people’s health and care management being distributed across multiple
sectors and organisations. Individual practitioners work to bridge these system-initiated discontinuities.
Partnership working between practitioners, systemically supported, brings access to a greater range
of knowledge, skills, experience and expertise as a way of addressing the complex needs of older
people living with multimorbidity and polypharmacy, as a whole. Longer-term strategic planning and
funding streams need to enable this approach in future system reconfigurations, addressing workforce
and practice.
Mitigating exclusion: recognition and engagement, action – shared decision-making
(RR CMO 05)
Gaining traction as a skill set and evolving as a broader approach to collaborative care, shared
decision-making is most effective when it is embedded as a routine behaviour by an expert and
experienced practitioner. Older people and informal carers need to be recognised and engaged for
the value of their own experience and expertise rather than being defined by their diagnoses or the
content of their prescriptions, or left feeling overlooked as an individual when practitioners increasingly
focus on single specialisms. MEMORABLE endorses shared decision-making as a way of enacting
collaboration. Through it, workload can be reduced by, for example, enhancing effective and meaningful
communication in a more mutually trusting therapeutic relationship. In addition, capacity can be
increased, because the older person feels more confident in managing their medication.
By facilitating shared decision-making, practitioners can generate benefits in other stages by being
able to make more effective adjustments to medication regimens to get a better fit with older people’s
and informal carers’ day-to-day routines and not merely deprescribing for adherence;168 increasing
motivation through feelings of control; and raising older people’s and informal carers’ confidence to
make safer, more informed and effective choices about medications when at home.
Proposed interventions/future research (see Chapter 3, Proposed interventions)
The findings from MEMORABLE are potentially broad ranging. Several lie outside the direct scope or
capacity of this study, such as the need to improve the speed and accuracy of communication about
older people’s medication regimens between primary, secondary and social care sectors.
Two specific interventions have been proposed from the analysis of the evidence, considered by the
Research Team to have practical application that might contribute to an improvement in medication
management within a reasonable time frame, mindful of the following caution from a Cochrane
Review:111
There are many different potential pathways through which consumers’ use of medicines could be
targeted to improve outcomes, and simple interventions may be as effective as complex strategies.
However, no single intervention assessed was effective to improve all medicines-use outcomes across all
diseases, medicines, populations or settings.
Risk identification
The MEMORABLE study has established the need to identify those who are not coping with medication
management and who are at risk. From the literature and the interviews, this intervention should be
a brief, simple and targeted risk assessment at any of the multiple points of contact with different
practitioners that older people have as part of the medication management process. MEMORABLE found
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that this screening assessment should focus on identifying who is or is not coping with the burden
of medication management, rather than assuming that all older people and informal carers are at risk.
This needs to be a simple tool, with questions focused on the workload experienced by older people
and informal carers and their capacity to cope with that workload. Such a tool would enable scarce
health-care resources to be directed to the older people and informal carers most in need of support.
As it is only possible to outline this proposed intervention in MEMORABLE, it is recommended
that scoping the detail and developing, implementing and evaluating a trial of risk identification is
progressed through collaborative research to follow this study (MEMORABLE2). Involving all those
with an interest, knowledge and skills in this area in realist evaluation would ensure the generation of
an evidence and experience base on which development and roll out could be implemented.
Individualised information
The MEMORABLE study found that older people, informal carers and professionals need access to
individualised information in an accessible format that can be shared by these key groups. It would
provide a reference point to support older people’s and informal carers’ day-to-day decisions and
actions, and increase the sense of control that they have over their medications. As a personalised
working document, it could include, for example, a short summary of the older person’s values,
preferences and goals; integrated and individualised information about their diagnoses and medications,
individually and together, including links to trusted resources; their medication routine; key practitioners
and contact information. It could be held in paper and electronic format, to be shared and updated
as and when required. However, deciding on the most useful content and format would need to be
co-created by those involved, with the input of others with expertise in how to make such systems
practicable, such as through smart phone app (application) design.
As with the risk identification discussed above, it is recommended that, following co-production
principles, future research should scope the detail of the required individual information, and then
develop, implement and evaluate the tool, as part of follow-on research. This would be a significant
amount of work, including determining lines of responsibility and accountability that would need to be
completed before any trial.
Research methodology (see Chapter 2)
This section considers the contribution of the research approach to MEMORABLE, including the
implications for researchers or others seeking to use the same approach to understand how complex
interventions work.
Combining review and evaluation
The MEMORABLE study is a realist synthesis, integrating a review of the literature with an evaluation
of the primary interviews, described in Chapter 2 and Figure 1. This combined approach is gaining
popularity among researchers. It enables secondary and primary evidence to be brought together,
facilitating the search for and the resolution of resonance and dissonance in their causal explanations
of complex interventions. In MEMORABLE, the richness of the interview data was invaluable in
supporting explanatory reasoning about the literature.
The MEMORABLE study benefited from the way the synthesis supported understanding of real-world
complexity, being theory driven and purposefully evidence generating. In the research, preliminary
analysis of the literature was used to inform discussion and debate by the Research Team. This guided
further work on the literature review, including extending some of the search activity to address
emerging themes and flexing interview schedules to gather interviewees’ opinions on the way
medication management was beginning to be understood in the study.
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Involvement of the Project Group and Stakeholder Group brought scrutiny and expertise to discussions
of progress and the consideration of findings. In this way, the research progressed deductively by
considering how the researchers thought medication management might work and then refining those
ideas through data, as well as inductively by looking at emerging patterns in the data and generating
theory from them. These processes were augmented by accessing the experience and expertise in the
Research Team and in both groups to gain consensus on data-informed, causal explanations of patterns
in the data. The iterations and associated opportunities for combinations of reasoning across a broad
spectrum of experience and expertise provide a robust platform for researching real-world complexity.
Evidence and experiential data
An additional benefit of this combined approach to the research was the added value of interrogating
secondary and primary data, moving backwards and forwards between them to ensure that one informed
the other. In MEMORABLE, secondary sources provided access to broader, relevant and substantive data
whereas primary sources illuminated the subject with finer-grained experiential perspectives.
Interviewing older people, informal carers and practitioners brought real voices directly into the research,
informed by years of personal experience and expertise engendered by those experiences. This supported
the co-creation of evidence. However, these interviewees were not a sample in research terms but
contributed to theorising through their explanatory narratives. Their value was in what they described
and explained, rather than who they might represent. In this type of real-world research, gaps can be
identified between the way interventions are supposed to work, or are described as working when
generic good practice is adhered to, and the way in which individuals actually experience them working
in terms of the uniqueness of their own situation. Diverse data contribute directly to the analysis, its
structure as well as its content. They also contribute indirectly by constantly challenging the researchers’
assumptions and methodological practices in the steps and iterations within the research process.
Qualitative data have strengthened MEMORABLE’s findings. A range of interviewees were invited to
take part, reflecting the breadth of those involved in day-to-day medication management: older people,
informal carers, practitioners from all sectors of health and care, including doctors, nurses, pharmacists,
pharmacy technicians, social workers, and managers to front-line staff. The structure of the interview
schedule enabled interviewees to describe their own experiences of multimorbidity and polypharmacy
and to account for the way in which medication management worked for them at that time, and how it
might work better in the future.
Approximately 60 hours of audio-recordings were collected and analysed in combination with the
literature. From these, 59 initial CMO configurations were developed as well as five additional CMOs
explaining burdens in reviewing/reconciling medications, informing a framework for burden mitigation
(programme theory). Data saturation was achieved and no new themes were generated from the last
two or three interviews. The realist analysis, subsequently conducted, confirmed that data saturation
had been obtained.
The MEMORABLE study has accumulated a rich, qualitative data resource. In addition to writing up the
research, its methodology and findings, the researchers intend to revisit it with a view to publishing
additional articles that explore multiple themes of interest such as perspectives on the emerging role of
pharmacists and the experiences of informal carers.
Theorising about causality
Theorising about how interventions work is central to realist methodology. In MEMORABLE, this involved:
l setting out candidate theories (see Chapter 1, Step 4: candidate programme theories and
substantive theory)
l using substantive theory (NPT) to inform the analysis (see Chapter 3, Medication management
as implementation)
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l generating CMO configurations to explicitly and transparently account for the multiplicity of ways
interventions work for some people under certain conditions (see Chapter 3, Medication management
as experience and Reviewing/reconciling medications and burden and Appendix 8)
l developing a more narrowly focused final programme theory from a subset of those CMO
configurations to explain Stage 5: reviewing/reconciling medications (see Figure 5).
Although substantive theory brings an additional analytic ‘lens’ to the synthesis, theorising in realist
methodology is undertaken flexibly. In this way, it supports rather than controls analysis. Programme
theory is set out to be confirmed, refined or refuted through the research process. CMO configurations
are modifiable as meaning becomes clearer; one person’s outcome can be another person’s context and,
even for one individual, contexts, mechanisms and outcomes can shift as the intervention process
advances. This can feel messy and daunting.
In MEMORABLE, having a clear process, the work packages and steps by which the research
progresses, was important. Process iterations occurred in response to the data with the Research Team
mindful of the overall structure and the place of theorising within it. Having a methodology workshop
at the start of the research was key to developing a shared knowledge base and an appreciation of
realist methodology in the Research Team and Project Group. However, for theorising, having access
to high-level realist knowledge and skill in the team and group, and regular meetings where data
interpretations and analyses were discussed and debated, has been invaluable and are processes that
should be considered by all realist research teams.
Strengths and limitations
Strengths
As far as the Research Team is aware, this is the first realist synthesis of medication management
combining realist review and realist evaluation to understanding this key clinical area. As part of the
research process, MEMORABLE has developed two key outputs:
1. a five-stage, four-step, three-loop medication management process that provides a structure to
address intervention complexity, highlighting the cycles of interactions between individual and
interpersonal stages (see Table 5, further developed in Tables 6 and 7)
2. a more detailed and focused programme theory of Stage 5: reviewing/reconciling medications that
sets out the way that this key stage can be understood as implementation as a burden, explained by
the evidence and informing proposed interventions (see Figure 5).
In addition to these outputs, the researchers have also obtained rich, qualitative data from diverse
interest groups: older people, informal carers and health and care practitioners. They have set out an
evidence-informed analysis framework to support their use of a realist logic of analysis and integration
of data from the literature and interviews. They have also demonstrated the way substantive theory
(NPT) has added explanatory value to the analysis. Analysis has generated proposed interventions
that are evidence and experience based, and theory informed.
The MEMORABLE study has demonstrated the value of following a clear research process that enacts
the research methodology, while maintaining the flexibility to respond to emerging topics of interest.
It has also shown how the structures, processes and broad membership of Research Teams and groups
supports accountability and transparency in decisions and in the scrutiny of outputs at key stages. This
study has also added to practitioner capacity in realist methodology and is already being disseminated
as an example of the application of that methodology.
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Limitations
Few studies directly address the complexity of medication management as a process and how it works.
Therefore, the researchers had to draw more heavily on primary data to validate causal attributions
being made in the analysis and in the generation of programme theory. As a formative piece of
research, grappling with that complexity proved time-consuming. As a result, the researchers decided
that addressing causality across the whole medication management process was likely to be beyond
the scope and resources available to them. The researchers had to make judgements on which of the
stages of this process were more important to focus on. Analysis was, therefore, not extended or
integrated across all five stages of the medication management process. Extending the analysis in the
future would build useful knowledge of medication management and the development of evidence- and
experience-based interventions that might bring about improvements. In addition, as acknowledged
earlier, the framework for the interventions requires further development.
The decision to focus on Stage 5: reviewing/reconciling medications was not taken until part way
through the research. This was because the researchers needed to have worked through what data
were available to them before identifying that reviewing/reconciling medications (Stage 5) was the key
part of the process to focus on. This ‘delay’, caused by a need to refocus a realist review, or evaluation,
is a potential challenge for realist researchers and can have an impact on the conduct of a project. In
this project, the impact was to delay the search for literature on these interventions and limit the
opportunity to focus some of the interview questions on this stage.
Other limitations include that the search was limited to English-language literature, the research
focused on non-institutionalised populations and the search had a broad definition of ‘older people’.
Furthermore, only a relatively limited number of people with mild dementia were interviewed.
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Chapter 5 Conclusions
The MEMORABLE study
The MEMORABLE study has explored the complexity of medication management through a realist
approach involving the synthesis of rich data from evidence and experiential accounts. It has set out a
five-stage, four-step, three-loop medication management process and, through a more detailed analysis
of Stage 5: reviewing/reconciling medications, has identified five burdens experienced by older people
and informal carers: ambiguity, concealment, unfamiliarity, fragmentation and exclusion. Drawing these
strands together, MEMORABLE has generated an evidence- and experience-based programme theory,
set out as a theoretical framework. This framework begins to explain the real-world complexity of
medication management as it affects older people, informal carers and practitioners. Informed by the
framework, MEMORABLE has proposed two interventions: risk identification and individualised
information to assist older people living in the community to manage their medication.
This realist approach, and the theoretical framework and intervention proposals generated through it,
demonstrate the way evidence and experience can be synthesised to explain complexity and inform the
development of practice.
The MEMORABLE study affirms the place of older people at the centre of medication management,
through their experiences and the outcomes that matter to them. The research has underscored their
individuality, ingenuity and sense of purpose in the routines that they use to cope with the burdens of
living with multimorbidity and polypharmacy.
As the number of older people in the population continues to grow, and, in parallel, multimorbidity and
polypharmacy among them, so do the medication management challenges that they experience. These
challenges are also experienced by informal carers and the health and care practitioners, services and
systems that older people access, underscoring the need for further translational research in this area
leading to more effective, evidence- and experience-based interventions to improve outcomes.
The key message for practitioners from MEMORABLE is that medication management for and with
older people living with multimorbidity and complex regimens can be very burdensome, for different
reasons, even if older people appear to be coping. Informal carers also experience burdens. These
burdens are often hidden from practitioners. When prescribers start or change a medication they often
think of the side effects that an older person might endure. They must equally consider their actions in
terms of burden.
Future research
The researchers recommend three areas of research arising from MEMORABLE.
First, MEMORABLE has established a substantial evidence and experience base to inform two key
proposed interventions: risk identification and individualised information. The principles of both
interventions have been validated by the Project Group and the Stakeholder Group. Future research
should be undertaken to translate these proposed interventions into practice. To be credible, it would
need to be collaborative, with design and trialling co-produced with stakeholders.
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Second, there needs to be further work to extend the understanding of medication management as a
complex intervention and as implementation, pursuing a causal approach to it and on burden mitigation
within it. This would extend the understanding of medication management stages, steps and loops by
setting out a fully integrated, causally explained process. This is believed to have conceptual as well as
practical value.
Third, the researchers see potential in linking to and extending MEMORABLE’s data through a study
to clarify the outcomes that older people, informal carers and practitioners want from medication
management. Such research would improve understanding of the goals and motivations that inform the
decisions and actions of those involved in medication management.
CONCLUSIONS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
86
Acknowledgements
General
The researchers would like to express their thanks to all those who took part in research interviews,
for their time and for their invaluable contributions to this study.
The researchers would also like to thank the members of the Stakeholder Group for sharing their
experience and expertise.
The researchers would like to acknowledge the contributions of recruitment sites (alphabetical order):
Aston Research Centre for Healthy Ageing; Birmingham Community Healthcare NHS Foundation Trust;
Bournville ExtraCare Village; Eve Hill Medical Practice; Join Dementia Research; Midlands Partnership
NHS Foundation Trust; Sheffield City Council (Communities Commissioning).
Contributions of authors
Ian D Maidment (https://orcid.org/0000-0003-4152-9704) (Chief Investigator, Reader in Clinical
Pharmacy): responsible for leading and delivering the research, ethics and governance. Lead of the
Research Team. Chairperson of the Project Group and co-chairperson of the Stakeholder Group.
Sally Lawson (https://orcid.org/0000-0003-0793-5645) (Research Associate): responsible for
delivering the research. Member of the Research Team, the Project Group and attendee at the
Stakeholder Group.
Geoff Wong (https://orcid.org/0000-0002-5384-4157) (GP, GP Trainer and Clinical Research Fellow,
Realist Approaches): specialist contributions in medicine, research and realist approaches. Member of
the Research Team and Project Group.
Andrew Booth (https://orcid.org/0000-0003-4808-3880) (Reader in Evidence Based Information):
specialist contributions in information science, literature searches, research and realist approaches.
Member of the Research Team and Project Group.
Anne Watson (https://orcid.org/0000-0001-9264-4847) (Medicines Management Research Lead):
specialist contributions in pharmacy and research. Co-chairperson of the Stakeholder Group and
member of the Project Group. Facilitated site recruitment.
Jane McKeown (https://orcid.org/0000-0003-2920-4931) (Lecturer/Senior Nurse Service User and
Carer Involvement): specialist contributions in nursing, research, and PPI. Member of the Project Group.
Facilitated recruitment.
Hadar Zaman (https://orcid.org/0000-0002-4252-2822) (Lecturer in Pharmacy Practice): joined
MEMORABLE in February 2018, specialist contributions in pharmacy and research. Member of the
Research Team and Project Group. Facilitated recruitment.
Judy Mullan (https://orcid.org/0000-0003-3772-7986) (Associate Professor, Director of the Centre for
Health Research Illawarra Shoalhaven Population): specialist contributions in pharmacy, research and
international perspective. Member of the Project Group.
DOI: 10.3310/hsdr08260 Health Services and Delivery Research 2020 Vol. 8 No. 26
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Maidment et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
87
Sylvia Bailey (Retired Practice Manager with direct experience of challenges associated with medication
management in older people): specialist contribution in PPI. Member of the Project Group and PPI lead.
Facilitated recruitment.
Publications
Maidment I, Booth A, Mullan J, McKeown J, Bailey S, Wong G. Developing a framework for a novel
multi-disciplinary multi-agency intervention(s), to improve medication management in community-
dwelling older people on complex medication regimens (MEMORABLE) – a realist synthesis. Syst Rev
2017;6:4–11.
Maidment I, Lawson S, Wong G, Booth A, Watson A, Zaman H, et al. Towards an understanding of
the burdens of medication management affecting older people: the MEMORABLE realist synthesis.
BMC Geriatr 2020;20:183.
Data-sharing statement
This is a qualitative study and, therefore, the data generated are not suitable for sharing beyond those
contained within the report. Further information can be obtained from the corresponding author.
Patient data
This work uses data provided by patients and collected by the NHS as part of their care and support.
Using patient data is vital to improve health and care for everyone. There is huge potential to make
better use of information from people’s patient records, to understand more about disease, develop
new treatments, monitor safety, and plan NHS services. Patient data should be kept safe and secure,
to protect everyone’s privacy, and it’s important that there are safeguards to make sure that it is
stored and used responsibly. Everyone should be able to find out about how patient data are used.
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Appendix 1 Pilot search
Overview
The information specialist (AB) and the research associate (SL) carried out a pilot search on MEDLINE,
using the following combined search terms (including a cut-off date of 2009 and in English):
l ‘aged’ (65 years >) and ‘aged, 80 and over’ (Protocol 60 years >);
l ‘medication management, medicines optimisation/optimisation, concordance, compliance/patient
compliance, adherence, health services misuse or inappropriate prescribing, deprescribing’;
l ‘chronic disease’; and
l ‘regime or regimen/regimes or regimens’.
There were 160 articles identified.
The research associate read all article abstracts. This provided a ‘sense’ of the data while adding to her
understanding of the research topic. The task was then for her to identify and report:
l relevant articles – by date and by content
l additional terms not included in the pilot search
l sift criteria to be used in future searches, as well as a data extraction form based on those criteria.
Initial analysis and results
These are summarised below.
Relevant articles: by date and content
Additional terms identified from the remaining records
The 35 abstracts were then mapped onto an Excel database (AB/SL Search Database, tabbed Pilot
Search), identifying the record number from the search, author, title, topic, design, number of subjects
and country.
The contents of each abstract were then analysed for additional terms that added to the scope of
the original four search terms noted above or because they appeared to have explanatory or causal
significance in relation to the research topic. These were identified in the content of the abstract and
TABLE 15 Relevant articles by date and content
Records N Criteria
Abstracts identified through pilot search:
MEDLINE on 10 July 2017
160 Search criteria listed in Overview
Screened by date (2009>): records removed (n = 92)
Screened by relevance (excluding ‘not relevant’ because of e.g. focus on the
action of medications, other treatments/interventions, protocol/study
design only, duplicate records): records removed (n = 33)
Remaining records 35
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the key word listing. As a result, the four combined search terms were expanded to 56, and grouped in
three ways: those associated with individual experiences, whether older people and carers, or practitioners,
and those associated with health and care practice and systems that were often highlighted in the articles’
recommendations (as below).
The following bullet points provide a sense of the data, setting out the top three clustered terms
occurring in each group:
l Individual experiences (older people and carers)
¢ High risk patients/Health status and complications/Chronic diseases/Chronic conditions/Long-
term conditions/Co-morbidity/Multimorbidity/Progressive/Diagnoses/Other health conditions/
Disability/Chronic illness trajectory/Restrictive health care conditions (n = 32)
¢ Medication adherence – nonadherence: (n = 22)
¢ Complex medication regimens/Dosing frequency/Schedules of medication-taking events and Pill
burden/Frequent changes/New medications/Inconvenience/Taking and timing adherence/
Adjusting routines (n = 21).
l Individual experiences (practitioners)
¢ Drug therapy (unnecessary, ineffective, incomplete)/Dosage/Pharmaceutical preparations/
Medication therapy management (n = 6)
¢ Discussion/Shared decision-making/Effective communication/Decision-making/Time/Priority
reconciliation/Health professions interest-disinterest in balancing diagnosis, regimen and
life (n = 6)
¢ Collaborative approaches/Patient centred care (n = 5).
l Health and care practice and systems
¢ Person centred approach/Decision support systems/Patient care/Personal support/
Patient–provider relationship/Teach-back methods/Coaching (n = 6)
¢ General practitioners/Physicians practice patterns/Socio-economic influences/Doctor-patient/
Physicians role (n = 6)
¢ Community pharmacist/Professional role/Pharmacist (n = 4).
Sift terms and a data extraction form
Based on this analysis, an indicative (rather than definitive) list of terms is proposed below, identifying
those associated with inclusion as well as exclusion.
Under inclusion, these are grouped under core terms and supplementary terms. The core terms reflect
the scope of the research to ensure that abstract content aligns with the research topic. This frames
the search. The supplementary terms encompass the different levels, interests and perspectives within the
research: individual older people and carers, individual practitioners, and health and care practice
and systems. Applying these permutations enabled further searches to explore different aspects of
the literature, following separate but integrated lines of thinking about this complex topic (e.g. core
terms + combined older person/carer perspective terms to explore their perspective and experiences;
or core terms + shared decision making and decision aids/decision support systems; or core terms +
deprescribing to focus on particular interventions that might be included in the final research output,
i.e. the framework to support improved medication management).
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Inclusion [based on the pilot search: note not all MeSH (medical subject
heading) terms]
Core terms
l aged; aged, 80 and over; independent living; home/community
l chronic disease; comorbidity; long-term conditions; multimorbidity
l polypharmacy; multiple prescribed medications
l complex medication regimens; schedules of medication-taking events
l medication management; medication compliance; medication adherence; medication concordance;
medicines optimisation; patient compliance.
Supplementary terms: individual – older person/carer perspective
l patient acceptance of health care; health literacy; health belief model; belief about medications
l self-care; self-management; self-administration; medication knowledge
l physical/cognitive/emotional capacity; motivation; intentional/unintentional nonadherence
l social support (family/friends); interpersonal relationships
l treatment burden/pill burden; medication related health regimens; lifestyle changes
l patient reported adverse reactions/events/intolerance; drug/treatment related side effects; safety
l patient goals/outcomes; lived experience; life style; sense of normality; goal conflict with clinicians
l medication-related A&E visits/hospital admissions or re-admissions/length of stay.
Supplementary terms: individual – practitioner perspective
l evidence based medicine; practice guidelines/guideline directed interventions; cumulative treatment
recommendations; risk benefit comparison
l patient centred care; shared decision-making; decision aids/decision support systems; patient
information/education; coaching; practitioner/professional role/relationships
l medication errors; inappropriate prescribing/dosing
l Home Medication Review; home visits; telephone interviews
l deprescribing
l health related quality of life; treatment outcome/adverse health outcomes; outcome data
l general practitioner; practitioner practice patterns
l nursing staff/nurse practitioners; community matron
l community pharmacist; pharmacist
l home care/aides.
Supplementary terms: health and care practice and systems perspective
l continuity of care (records, plans, medication, team approach); transitions; medication reconciliation
l telehealth; personal health applications.
Exclusion
l < 2009
l aged below 60 years or mixed age cohorts that include ages below 60 years
l limited-generalisable race/ethnic groupings to England, for example Asian American/Pacific Islander,
Hispanic, Mexican American
l in-patient or in-care settings
l non-medication interventions, for example screening programmes
l single medication or treatment, or assessment or trial protocols or evaluations
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l cost, funding or insurance determinants of health behaviours in privately funded health-care
systems e.g. cost-related non-adherence/Medicare/Medicaid beneficiaries/USA
l duplicate records.
A data extraction form was set up by the research associate combining the record identifiers (i.e. the
record number from the search, author, title, topic, design, number of subjects and country) with
inclusion terms, once these terms had been agreed within the Research Team. This was used to inform
the analysis of outputs from searches within work package 1.
As each search was undertaken, identifiers for each abstract were listed on the data extraction form
and the occurrence of core and supplementary terms recorded where these were identified in the
body of the abstract or as key words at the end of it. Associated terms identified in the abstract that
enhanced the understanding of the listed terms were assigned to existing terms to which they relate.
New terms were highlighted so that they could be assimilated into further searches as necessary or
used to inform the development of programme theory/ies and CMO configurations.
Further terms were identified through the expertise and experience available through the Research
Team Project Group, the work of the steering group or through the interviews in work package 2.
These were added to the evolving list in order to clarify, for example, the contribution of secondary or
social care, or to refine or focus the search on selected factors that warrant exploration (e.g. specifically
medication review) because of their criticality to the causal processes within medication management
for and with this group of older people. These cumulative, iterative processes were aligned with
accepted approaches to realist methodology and served to enrich the findings.
Next steps
Once agreed, the preliminary list of terms was circulated to the rest of the Research Team Project
Group for information and comment.
APPENDIX 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
104
Appendix 2 Node summary (research
process step 3: further literature searches
and review)
TABLE 16 Node summary
Nodes\\Health and Care
Nodes\\Health and Care\Access
Nodes\\Health and Care\Beliefs about patients
Nodes\\Health and Care\Care co-ordination Care Planning Team based infrastructure Continuity
Nodes\\Health and Care\Care model Patient focus Personalisation
Nodes\\Health and Care\Coaching Behavioural interventions
Nodes\\Health and Care\Doctor GP
Nodes\\Health and Care\Healthcare practitioners system organisation
Nodes\\Health and Care\Information giving
Nodes\\Health and Care\Nurse
Nodes\\Health and Care\Pharmacist
Nodes\\Health and Care\Prescribing Deprescribing
Nodes\\Health and Care\Psychosocial support
Nodes\\Health and Care\Quality Safety
Nodes\\Health and Care\Relationships Trust Respect
Nodes\\Health and Care\Remote monitoring of meds and diagnosis
Nodes\\Health and Care\Risk assessment Decision support tools
Nodes\\Health and Care\Social worker Care manager
Nodes\\Health and Care\Time and expertise Experience and expertise Competence Professionalism
Nodes\\Health and Care\Timing
Nodes\\Health and Care\Treatment choices
Nodes\\Health and Care\Workforce learning and development
Nodes\\Health and Care\Workload
Nodes\\Medication Management
Nodes\\Medication Management\1 Identifying problem
Nodes\\Medication Management\2 Getting medication
Nodes\\Medication Management\3 Starting medication
Nodes\\Medication Management\4 Continuing to take medication
Nodes\\Medication Management\5 Reviewing medication
Nodes\\Medication Management\6 Changing or stopping medication
Nodes\\Medication Management\Adherence and non-adherence
Nodes\\Medication Management\Interventions
continued
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TABLE 16 Node summary (continued )
Nodes\\Medication Management\Specific medications
Nodes\\Older people
Nodes\\Older people\Ageing and age
Nodes\\Older people\Beliefs about medicines, diagnoses, health
Nodes\\Older people\Beliefs about self + Identity
Nodes\\Older people\Informal carer burden
Nodes\\Older people\Coping styles Control Self efficacy Self-management
Nodes\\Older people\Decision making Autonomous SDM Collaboration
Nodes\\Older people\Diagnoses Symptoms Illness trajectories Comorbidities
Nodes\\Older people\Drug alternatives
Nodes\\Older people\Drug dosage Regimes
Nodes\\Older people\Drug interactions Side effects Drug burden
Nodes\\Older people\Drug packaging Drug labelling Drug information
Nodes\\Older people\Functional status Dexterity Swallow Cognition Emotion
Nodes\\Older people\Health and care experiences
Nodes\\Older people\Health burden Illness and medication work Self-rated health status
Nodes\\Older people\Health literacy Expert patient Health behaviours
Nodes\\Older people\Help seeking
Nodes\\Older people\Home and social environment
Nodes\\Older people\Information seeking
Nodes\\Older people\Outcomes Goals Goal directed behaviour Benefit
Nodes\\Older people\Relationship and interaction with doctor-prescriber
Nodes\\Older people\Relationship and interaction with formal carers
Nodes\\Older people\Relationship and interaction with nurse
Nodes\\Older people\Relationship and interaction with pharmacist
Nodes\\Older people\Relationship and interaction with social networks
Nodes\\Older people\Relationship and interaction with spouse partner family friends
Nodes\\Older people\Remembering Reminders
Nodes\\Older people\Routines Roles Everyday life
Nodes\\Older people\Self-monitoring Self reporting
Nodes\\Older people\Social norms
Nodes\\Older people\Socio-demographic characteristics Culture
Nodes\\Older people\Technology Tools
Nodes\\Older people\Transitions Change Certainty-uncertainty
Nodes\\Other External Factors
Nodes\\Other External Factors\Evidence Guidelines Standards Protocols
Nodes\\Other External Factors\Policy Finance
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Appendix 3 Interviewee profiles
TABLE 17 Interviewee profiles
Category Characteristic
Older people (n= 13) Age: range 60–84 years, mean 73 years
Male: 7; female: 6
Living with mild dementia (and living with informal carer – spouse): 2
Number of diagnoses (multimorbidity): range 3–6, mean 4
Number of different medications (polypharmacy): range 5–15, mean 9
Informal carers (n = 16) Male: 5, female: 11
Black, Asian, and minority ethnic: 4
Caring for someone living with memory problems/dementia: 7
Caring for more than one person living with dementia: 2
Practitioners (n= 21) Doctors: 2 consultant geriatricians, 2 GPs
Nurses: 5, including a nurse manager, specialist nurses, community matrons
Pharmacists: 3, including head of service, a clinical pharmacist, pharmacy technician
Social worker: 1
Care providers: 7, including managers, assessors, team leaders and front-line staff
Strategic manager (health and care): 1
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Appendix 4 Interview schedules: common
content of the interview schedules (research
process step 5: interviews and evaluation)
1. Participant identifiers: confirming participant and interview details, including unique code used to
anonymise the participant.
2. Baseline demographic data: (for monitoring purposes) including ethnicity.
3. Pen portrait: home circumstances, community circumstances, access to and use of technology,
functional status relevant to medication management – sight, hearing, swallow, dexterity, mobility
(indoor/outdoor), health and medication.
4. Finding out about the general experience of medication management:
Process of managing medication:
l (exploring the intervention): understanding of medication management (reference to five stages),
key people involved and doing what
l (exploring what works, for whom, why and in which circumstances): what currently makes
medication management easier/more difficult (with how and why for explanatory detail),
what would make it better or easier in the future (solution focus, with how and why for
explanatory detail)?
Outcomes from taking medication:
l (generating explanatory accounts, working back from outcomes): what are the outcomes that
matter to that individual, are they achieved, who or what makes it easier/more difficult to
achieve those outcomes (doing what, how and why for explanatory detail, anything else), who
or what would make it better or easier in the future to achieve those outcomes (solution focus,
with how and why for explanatory detail, anything else)?
5. Eliciting responses to explaining experiences of medication management: (responses to candidate
programme theories): ‘You have told us about your experiences of . . .’ (summarise to bridge to
programme theory) > ‘In the Research Team we have been thinking about . . .’ (describe programme
theory in detail appropriate to that individual and their experiences) > ‘What do you think about
this (summary title of programme theory)? When does it affect you most (enable discussion of
detail: what, who, why and in which circumstances)?’
6. Anything else arising from the interview.
Note that the schedules for informal carers and practitioners shared this common content but
were flexed:
l Informal carers provided data on themselves as well as the person they cared for.
l Practitioners scoped their role, expertise and experience, and what informed their practice and
provided data on themselves and the older people and/or informal carers they work with.
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Appendix 5 Initial mapping of burden:
from a Research Team working paper
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TABLE 18 Initial mapping of burden: form a Research Team working paper
‘Patients on the same number of medicines may experience different levels and aspects of MRB 
(medication related burden).’77
‘Patients tolerate, control and adapt all events of MRB (burden) until the cumulative effect of the burden 
interfere in day-to-day life exceeds their coping threshold and overcomes their controlling capacity.’77
Consequences/outcomes can become antecedents/contexts: burden is dynamic, cyclical14
Contexts   
(presence or lack of) 
Mechanism Outcomes
Individual Medication/polypharmacy:78 
treatment characteristics:14
to change the disease’s course
or ameliorate its effects14
routines: complex, 
inconvenient/interfering,
inflexible, changes78
medication 
characteristics: 
formulations (size, shape, 
taste), number, 
frequency, brand changes,
packaging,13,39,78,82,120
information on
medications: inadequate, 
conflicting, contradicting
on medications and lack 
on managing and
integrating medications in
daily life78
side effects: nature,
severity, frequency13,39,82,120 
adverse events: nature,
severity, frequency78 
devices, equipment78
lack of support78
perceived meaning about 
number of medications, 
effects14,78 
social impact78
Increasing/high  workload13
(ageing and health trajectory 
+ diagnoses and treatment 
burdens): disruption to daily
Increasing or 
high burden on
older person
(minor and
manageable vs.
extensive and 
awkward,
specific or
extensive,73
avoidable/ 
unavoidable7) 
NB up to a 
threshold14 
‘Overburdened patient’39 
(high or low workload, low 
capacity: individualised)
Impacting on resilience77,
functioning and wellbeing78
Poorer adherence 
not taking medication as 
prescribed: trialling, 
juggling, experimenting,
skipping, stopping78
less satisfaction with 
medicines,120 perceived 
lack of efficacy14
self-prescribing
alternatives78
[Poorer health literacy73] 
Poorer quality of life
physical/mental
exhaustion120
risk of iatrogenic 
outcomes from
polypharmacy39
risk of undertreated or
over-treated conditions 
worsening, with relapses, 
reduced survival14
worse/decline physical
and mental health14,120
more hospital admissions82
treatment
intensification120
lower self-efficacy/agency120
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life14 through increasing time, 
effort and inconvenience of
workload39
co-morbidity/ 
multi-morbidity: the 
natural history of
underlying illnesses,14,39,77,78  
physical and psychological
diagnoses concurrently,14
poor symptom control,14
new diagnoses77 (longer
duration14)
illness work: making,
getting to, attending
medical appointments
with different 
practitioners82
polypharmacy work: 
organising, planning, 
taking, adjusting, 
monitoring13,39,82,120  
responding to changes14
self-care/medications
self-management work:82,120 
learning about
treatments and
consequences, engaging 
with others and 
mobilising support, 
adhering to treatment 
and lifestyle changes and
monitoring treatment14
wellbeing work: 
diet/food, exercise, 
health plans76,82,120 
lack of fit with daily life 
and routines: lifestyle, 
social, work77,82,120 leaving 
less time for meaningful 
activities13
economic burden14,77,82 
time burden78
Decreasing/low capacity13
Coping threshold78 (workload,
capacity + prior experiences):
personal and social
resources77 
social roles: lost or
limited78
Poorer performance
therapeutic goals/  
expectations not met, lack 
of efficacy14,78 
undesirable effects78
damage to health78
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Cognitive
knowledge/ 
understanding: 
confusion82,120  about 
information and advice14,
39,78,82,120 and changes120
scepticism: about 
medication and
information78
Psychological/emotional78
buy-in, ownership,
motivation: lacking38,82,120  
negative emotions: 
distress, concern/ 
‘bothered by’ (anxiety,
fear, anger, frustration7), 
sense of stigma, guilt, 
secrecy13,39,78,82,120, 
self-efficacy/agency: 
reduced77
stigma, isolation:78 
feeling
beliefs from experience: 
own and others’ about 
medication, including
long term use and 
dependency, risk/benefit 
of medication and
illness,78 social norms78
Physical, physiological77 
physical skill: lack39
pain120
Behavioural78 
health seeking78 
information seeking78
help seeking13
trade off: functional
performance for QoL,13
less efficacy for less
burden14
Other issues
age and gender (F>M)14
lack of transport78
(lack of access to or skill
with IT)
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Loss of identity13/impact on
daily life78
meaningful activities, 13
meaningful life: 78
restrictions
losses: autonomy,
control,78,82  resilience,13
freedom, 13
independence, 13
increasing dependence120
change: self perception78
isolation: from family, 
practitioners13,14
challenge: being a patient 
in a complex health-care 
system: obstacles, 
relationships, costs, 
time78
Interpersonal
[interdependence 
–family (legal
status of
involvement if
older person has
capacity but may 
not consent if
they do not agree 
there is an issue 
to be solved
together such as
forgetting meds) 
and practitioner 
support and 
collaboration can 
minimise burden]
Fractured care
1:1 practitioner
continuity: lacking for 
older people with 
complex needs78
information on services: 
lacking78
Poor care
older person’s lived 
experiences, needs and 
life impact of diagnoses
and treatment: not 
considered14,78
partnership relationship: 
lacking78
consultation styles:
unacceptable,78 with lack
of explanation, 77
treatment information, 14
poor communication
about treatment and
adherence14
time: lacking78
Family/social issues
reliance on (extended14) 
family: emotional and 
practice support14,77,78 
relationship tension: 
conflict, lacking family
support78 (and wider 
social network13), lacking
Over-treatment 
continued prescribing of
ineffective or unnecessary 
medications 
unnecessary additional 
prescribing: treatment
intensification39,120 
increased risk of side
effects and drug-drug 
interactions39
Undermined therapeutic 
relationship (1:1)39 
lack of confidence
lack of trust
guilt14
hopelessness14
fear14
secrecy 
[dissatisfaction] 
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understanding, strain,13,14, 
82,120  distress flowing 
between person and
caregiver14 
support for family: to
understand,
communicate and
participate in treatment 
decisions14 lacking
role/meaningful, social
activity: limitations13,120 
financial worries13
Institutional/  
infrastructural
(system obstacles) 
Fractured health and care
multiple services for 
multiple diagnoses: 
increasingly community-
led by different 
providers,39 more
specialised care across
multiple providers, 77  not 
networked for older 
people with complex 
needs78
continuity/co-
ordination: lacking
between services39
provider criteria and 
service systems: different
sites, clinic timing, making 
and attending
appointments, travel/ 
parking, assessments  
and treatments, 
communication (between 
practitioners, services, 
and with older person)77,
82,120
sharing assessments and 
care plans:120 lacking
information and advice:
conflicting,78,82,120  lack of14 
disease-specific 
treatment guidelines,39
management protocols
(appointments, tests, 
treatments)77 
delays120
Fractured support/info 
health (services,
practitioners13), diagnosis 
or treatment 
Wasted resources 
increased treatment costs 
from unnecessary 
polypharmacy39
reduced scheduled care,
avoidable increase in
unscheduled care14 
(does this add to                              
inco-ordination?) 
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information:82,120  difficult 
to access
trusted information 
sources/websites:82 
lacking
Key: tentative links taken from selected articles:
Mohammed et al.78
Sav et al.14
May et al.39
Eton et al.120 
Demain et al.13 
NB: Eton et al.:82 some duplication and Ridgeway
et al.:77 more solution focus
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Appendix 6 Dimensions of burden:
workload and capacity
TABLE 19 Dimensions of burden: workload and capacity (developed from Katusiimi et al.121 and Krska et al.122)
Burden Dimensions Contexts
Workload Increasing burden
(increasing/high workload)
Day-to-day life: life revolves around using my
medicines and affects daily tasks, social
relationships, social or leisure activities, driving,
sexual life (increases workload)
Medication:
polypharmacy
and treatment
characteristics
Side effects: bothersome, interfere with
day-to-day life, sometimes worse than the
problem (increases workload)
Practicalities: participant identifiers – confirming
getting prescriptions from doctor/pharmacist
(increases workload)
Health and care
system
Practicalities: regimen needs planning and
thought, difficulties using medicines (increases
workload)
Identity and
day-to-day life
Participant identifiers: confirming payment,
choice between essentials and medicines
(increases workload)
Decreasing burden
(decreasing/low
workload)
Greater likelihood
of coping
Patient–doctor relationships and communication
about medicines: me and my medicines known
enough by my health professionals, listened to
by doctor and concerns taken seriously, have
enough information, trust (reduces workload)
Health and care
relationships and
communication
Practicalities: easy to keep to regimen, timing
(reduces workload)
Identity and
day-to-day life
Autonomy/control of medicines use: choice of
whether to take or not, can vary dose/times
(reduces workload)
Capacity Decreasing burden
(increasing/high
capacity)
Medication effectiveness: medicines working,
live up to expectations, prevent condition
getting worse, side effects worth the benefits,
able to live life as wanted, satisfied (increases
capacity)
Medication:
polypharmacy/
treatment
characteristics
Increasing burden
(decreasing/low capacity)
General concerns about medicines: long-term
damage, interactions with other medicines/
alcohol, reliance, polypharmacy, lack of
information/choice (reduces capacity)
Identity and
day-to-day life
Side effects: adversely affect my well-being
(reduces capacity)
Practicalities: concerns about forgetting
(reduces capacity)
Cost-related burden: worry about paying
(reduces capacity)
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Appendix 7 Revised analysis framework
conceptualising burden as a potential
mechanism
TABLE 20 Revised analysis framework conceptualising burden as potential mechanism
CMO
configuration
Level
Contexts:
factors that contribute to
increasing/high
workload (W) or 
decreasing/low capacity
(C)
Mechanism:
response to the resources
Outcomes
Individual
Diagnoses:
multimorbidity
Medication:
polypharmacy and
complex regimen
Identity and
day-to-day life
Burden
(potential mechanism)
(workload + capacity)
Coping
experience
Health literacy
Appropriate/
inappropriate
treatment
Quality of life
Performance/clinical
outcomes
Adherence/
nonadherence
Interpersonal Health and care
relationships and
communication
Family and social 
relationships
and communication
Health and care
relationships and
communication
Family and social
relationships and
communication
Institutional/
infrastructural
Health and care
system
Support systems 
and information
Resources
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Appendix 8 Initial list of context–
mechanism–outcome configurations from
the literature and interviews with older
people, practitioners and informal carers
TABLE 21 Initial list of CMO configurations from the literature and interviews with older people, practitioners and
informal carers
Literature
Literature CMOs C+M>O short form Source
Lit CMO 01 Older people are at increased risk of an
adverse drug event (O) when they are taking multiple
medications and certain high-risk drugs (C) because of
age-related changes (M)
Polypharmacy and high risk drugs +
physiology of ageing > increased risk
Lit, OP
Lit CMO 02 Older people who have informal carer or
formal carer support with managing their medications (C)
are more likely to be adherent (O) because they have
given control to the person that supports them (M)
Support + control > adherence Lit, C
Lit CMO 03 Individual practitioners who are treating older
people with multimorbidity following disease-specific
guidelines (C) are more likely to contribute to
polypharmacy (O) because of adherence to evidence-based
rather than person-centred practice (M)
Guidelines + evidence than person
> polypharmacy
Lit, P
Lit CMO 04 When practitioners carry out a medication
review using an evidence-based review tool (C), they
are more likely to identify and discontinue high-risk
medications and simplify regimens (O) because they are
confident making decisions (M)
Evidence-based tool+ confidence
> deprescribing/simplifying
Lit, P
Lit CMO 05 Regular medication reviews and transition
reconciliations by experienced practitioners (C) optimises
medication management (O) by minimising the risk of
treatment-related problems (M)
Regular reviews and experienced
practitioner+ risk minimisation
> optimisation
Lit, P
Lit CMO 06 When practitioners carry out a medication
review in an older person’s home (C), they are more likely
to identify medication-related problems (O) because they
understand people’s lived experiences and they take more
time (M)
Home-based review+ understanding and
time > identify problems
Lit, P
Lit CMO 07 Pharmacists carrying out a home medication
review (C) are more likely to identify and resolve
medication-related problems (O) because of their
particular expertise and experience (M)
Pharmacist and home-based review+
expertise and experience > identify and
resolve problems
Lit, P
Lit CMO 08 Practitioners, older people and informal carers
are likely to make better decisions about medication,
strengthen their relationships and achieve continuity of
care (O) when they collaborate through shared decision-
making (C) because of mutual trust (M)
Collaboration and shared decision
making +mutual trust > better decisions,
relationships and continuity
Lit, OP, P, C
Lit CMO 09 Information technology used by older people,
informal carers and practitioners (C) improves access,
information sharing and support (O) by reinforcing
communication (M)
Information technology+ reinforcing
communication > improves access,
sharing, support
Lit, OP, P, C
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TABLE 21 Initial list of CMO configurations from the literature and interviews with older people, practitioners and
informal carers (continued )
Literature
Literature CMOs C+M>O short form Source
Lit CMO 10 Equipment and technology used by older
people, informal carers and practitioners (C) helps them to
cope with managing their medications (O) by supporting
what they do (M)
Equipment and technology + as support
> coping
Lit, OP, P, C
Older people
Older people CMOs C+M >O short form Source
OP CMO 01 Older people access health-care services
and practitioners (O) when they think a health problem
or medication is disrupting their day-to-day lives and
threatening their independence (C) because they want to
get back in control (M)
Problem +want control > access health
and care (help seeking)
OP
OP CMO 02 When older people and informal carers are
informed about their illnesses and medications (C), they
are more likely to use them correctly and less likely to
experience negative emotions such as worry or distress (O)
because they feel more in control (M)
Information + in control > correct
use/reduced worry
OP
OP CMO 03 When older people want to get on with their
lives (C), they will take those medications (O) that they
believe will keep them well and help them achieve their
goals (M)
Get on with life+ belief/confidence
> take medications
OP
OP CMO 04 When older people on a complex medication
regimen are informed about their medications (C), they are
more likely to make them part of their day-to-day routines
and less likely to forget them (O) because they feel more
in control (M)
Information + in control >make
routine/less forgetting
OP
OP CMO 05 Older people and informal carers are less
likely to feel burdened by their medication regimen (O)
when they have a routine (C) because they feel confident
and in control (M)
Routine+ in control/confidence
> less burden
OP, C
OP CMO 06 Older people and informal carers cope with
the practicalities of taking their medications (O) by making
adjustments (C), because they want a better fit with their
lives (M)
Making adjustments + better fit > coping OP, C
OP CMO 07 When medications look the same (colour,
shape) but have different purposes (C), older people and
informal carers are at risk (O) because it is confusing (M)
Medications similar appearance/purpose
+ confusing > at risk
OP
OP CMO 08 Older people with comorbidities question
taking medication (O) when they are free of symptoms (C)
because they feel well (M)
Symptom free + feel well > question
taking medications
OP
OP CMO 09 When older people have multiple medications
(C), they want to reduce the number they take (O) because
the medications would be easier to remember and less
difficult to fit in, day to day (M)
Polypharmacy+ easier > reduce OP
OP CMO 10 When older people have cognitive problems
(C), they may not be aware they are not managing their
medications (O) because they forget or get confused (M)
Cognitive problems + forget/confused
> unaware not managing
OP
OP CMO 11 Older people are more likely to worry about
not coping in the future (O) if they anticipate losing
capacity (dementia, functional, bereavement) (C) because
they fear losing control (M)
Loss of capacity+ fear losing control
>worry about not coping
OP
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TABLE 21 Initial list of CMO configurations from the literature and interviews with older people, practitioners and
informal carers (continued )
Older people
Older people CMOs C+M >O short form Source
OP CMO 12 When older people and informal carers trust
the practitioners they see consistently (C), they are less
likely to worry about their illnesses and medications (O)
because they feel understood and supported (M)
Practitioner trust and consistency + feel
understood and supported > less worry
OP, C
OP CMO 13 Older people’s and informal carers’ trust in
practitioners is reduced (O) when practitioners provide
inconsistent, conflicting or lack of information or advice (C)
because they struggle to make sense of it (M)
Poor information or advice + struggle to
make sense > reduced trust in practitioner
OP, C
OP CMO 14 When older people are seen by a new
practitioner (C), medication is likely to be changed (O)
because they are assessed rather than reviewed (M)
New practitioner + assessment rather than
review >medications changed
OP
OP CMO 15 When older people and informal carers have
to have multiple health and care contacts across different
sites, services, teams and practitioners (C), they find this
an additional burden (O) because it takes time and effort
(M)
Fragmentation services, teams and
practitioners+ time and effort > additional
burden
OP, C
OP CMO 16 Older people and informal carers are likely to
cope better (O) when there is consistency and stability in
services, practitioners and medications (C), because they
feel in control and can rely on them and their own
routines (M)
Consistency and stability services,
practitioners and medications + control
and reliance > coping
OP, C
OP CMO 17 Older people and informal carers are likely to
experience fewer negative emotions such as distress (O)
when they have confidence in their local health and care
services (C) because they feel they can rely on them (M)
Confidence in services + reliance
> reduced worry
OP, C
Informal carers
Informal carers (C) C+M>O short form Source
C CMO 01 Family members take on the role of informal
carer (O) when they notice problems with medication
management (forgetting, safety) (C), because they feel
responsible and want to reduce risk (M)
Problems+ feel responsibility/risk
reduction > become informal carer
C
C CMO 02 When there are problems with medication
management and family members take responsibility for it
(C), older people and practitioners agree (O) because they
are trusted as carers (M)
Problems and informal carer take
responsibility + trusted as informal carers
> older person and practitioner agree
C
C CMO 03 When informal carers identify problems and
gaps (C), they increasingly manage medication, health and
care (O) because they respond to what is needed (M)
Problems and gaps + respond to needs
> increasingly manage medications, health
and care
C
C CMO 04 When a relative is losing competence but
retains capacity (C), the informal carer’s work with them
and practitioners is made more difficult (O) because they
lack status to act in their best interest (M)
Older person losing competence but has
capacity + lack carer status >work with
older person and practitioner more
difficult
C
C CMO 05 Informal carers are under constant stress (O)
when they are dealing with changes in their relative and
medications (C), because they need to remember, monitor
frequently and make adjustments
Older person and medications changes+
need to remember, monitor and adjust
> stress
C
C CMO 06 When informal carers lack formal training (C),
they become expert (O) because they learn by experience
(M)
Lack training+ learn by experience
> expert
C
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TABLE 21 Initial list of CMO configurations from the literature and interviews with older people, practitioners and
informal carers (continued )
Informal carers
Informal carers (C) C+M>O short form Source
C CMO 07 To manage complex medication regimens (O)
informal carers devise their own routines and systems (C)
so they feel in control (M)
Devise routines and systems+ feel in
control >manage complex regimens
C
C CMO 08 Informal carers seek support from practitioners
and services (O) when they want to optimise treatment
(C), because they need to feel confident about what they
do (M)
To optimise treatment + need to feel
confident > seek support from practitioner
C
C CMO 09 Carer stress is made worse (O) when they are
dealing with changes in their relative and medications (C),
because of delays in practitioners responding or unhelpful
responses (M)
Older person and medications
changes + practitioner delays and
unhelpful responses > stress
C
C CMO 10 Informal carers challenge practitioners (O)
when they treat the diagnosis and not the person (C),
because they can see the bigger picture and the risks (M)
Practitioner treats diagnosis not
person + informal carer sees big picture
and risk > challenge practitioner
C
C CMO 11 When informal carers look after their relatives
(C), they become their advocates (O) because they have
personal knowledge and developing expertise (M)
Become informal carer + personal
knowledge and developing expertise
> become advocates
C
C CMO 12 To manage difficult situations (C), informal
carers take risks with medication (O) because they feel
desperate and do not know what else to do (M)
Manage difficulties+ desperate+ lack
alternatives > take risks
C
C CMO 13 Informal carers can feel undervalued and
unsupported (O) when they are expected to cope (C),
because their role, responsibilities and needs are not
recognised and systems are unclear (M)
Expected to cope + not recognised and
systems unclear > feel undervalued and
unsupported
C
C CMO 14 When family members take on the role of
informal carer for a relative with complex needs (C), they
give up aspects of their own lives (O) because the
demands on them are so great (M)
Become informal carer + high demands
> give up aspects of own lives
C
C CMO 15 When they look after their relatives (C),
informal carers are expected to do more than formal
carers to manage medications (O) because their role is
informal, unregulated and untrained (M)
Become informal carer + informal,
unregulated and untrained > expected to
do more than carers
C
C CMO 16 Informal carers are more likely to worry about
their relative being alone or in the future (O) if they
anticipate not being available (C), because they recognise
the significance of their role (M)
Loss of availability + recognise role
significance >worry about older person
not coping
C
Practitioners
Practitioner CMOs C +M>O short form Source
P CMO 01 Older people who might be at risk with their
medication management (C) become visible to health and
care practitioners (O) when they experience a crisis (M)
Older person at risk + crisis > visibility to
practitioners
P
P CMO 02 Practitioners assess and provide an
intervention (O) when older people are not coping (C),
because of the need to minimise the risk of harm and
maximise independence (M)
Older person not coping + risk
minimisation > intervention
P
P CMO 03 When practitioners assess and provide an
intervention (C), they draw on evidence and experience
(M) to optimise their practice (O)
Intervention+ evidence and experience
> optimise practice
P
P CMO 04 When older people need help with medication
management (C), practitioners work with formal or
Older person not coping + formal and
informal networks >manage complexity
P
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TABLE 21 Initial list of CMO configurations from the literature and interviews with older people, practitioners and
informal carers (continued )
Practitioners
Practitioner CMOs C +M>O short form Source
informal multidisciplinary teams and networks (O) because
they want to maximise expertise for a complex issue (M)
P CMO 05 When practitioners have access to timely,
accurate information (C), they are more likely to provide
better assessments and interventions (O) because they
can be more confident about the basis for making
decisions (M)
Information + crucial to work > better
interventions
P
P CMO 06 When practitioners make time and space for
older people and informal carers (C), they are more likely
to provide better assessments and interventions (O)
because they can collaborate to find solutions to
problems (M)
Time and space + collaborate and shared
decision-making > better interventions
P
P CMO 07 Carers take responsibility for medication taking
(O) when older people are not coping (C), because of the
need to minimise risk of harm (M)
Older person not coping + risk
minimisation > carers take responsibility
P
P CMO 08 When carers and nurses assist with medication
taking (C), older people are more likely to adhere (O)
because they maintain the routine and motivation (M)
Formal assistance+maintain routine and
motivation > older person adherence
P
P CMO 09 When carers assist with medication taking (C),
older people are more likely to be engaged with what they
are doing (O) because they invest time and effort (M)
Formal assistance+ time and effort
> older people engagement
P
P CMO 10 Carers take responsibility for collecting
medications (O) when older people or informal carers
agree because they are not coping (C) as part of their job
to ensure a constant supply (M)
Older person or informal carer not
coping + need to ensure supply > carers
collect
P
P CMO 11 Practitioners provide auto-ordering and third
party requests for medication (O) when older people
choose or are not coping (C), as part of their job to ensure
a constant supply (M)
Older person or informal carer not
coping + need to ensure supply > auto-
ordering and third party requests
P
P CMO 12 Practitioners provide medications in blister
packs (O) when older people or informal carers choose or
are not coping (C), to simplify taking them (M)
Older person or informal carer + simplify
taking > blister packs
P
P CMO 13 Practitioners provide home delivery of
medications (O) when older people or informal carers
choose or are not coping (C), as part of their job to ensure
a constant supply (M)
Older person or informal carer + need to
ensure supply > home delivery
P
P CMO 14 Practitioners and informal carers are likely to
cope better (O) when there is consistency and stability in
services and practitioners (C), because they are less
distracted by fragmentation and change (M)
Service and practitioner consistency and
stability + less distracted by fragmentation
and change > practitioner and informal
carer coping
P
P CMO 15 Hospital admission and discharge (C) threatens
older people’s ability to cope with their medication (O)
because it involves changes in what they take and
disruption of their routines (M)
Hospital admission and discharge + change
and disruption of routines > threatens
coping
P, OP
P CMO 16 When older people have several long-term
conditions (C), they need to see the same practitioner (O)
to deal with complexity and manage risk (M)
Older person with
comorbidities + complexity > need
practitioner consistency
P
C, informal carer; (C), context; Lit, literature; (M), mechanism; (O) outcome; OP, older person; P, practitioner.
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